id	sid	tid	token	lemma	pos
dpc-4609	1	1	dermatology	dermatology	NOUN
dpc-4609	1	2	:	:	PUNCT
dpc-4609	1	3	practical	practical	ADJ
dpc-4609	1	4	and	and	CCONJ
dpc-4609	1	5	conceptual	conceptual	ADJ
dpc-4609	1	6	review	review	NOUN
dpc-4609	1	7	|	|	ADV
dpc-4609	1	8	dermatol	dermatol	ADJ
dpc-4609	1	9	pract	pract	NOUN
dpc-4609	1	10	concept	concept	NOUN
dpc-4609	1	11	.	.	PUNCT
dpc-4609	2	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	2	2	1	1	NUM
dpc-4609	2	3	dupilumab	dupilumab	NOUN
dpc-4609	2	4	and	and	CCONJ
dpc-4609	2	5	alopecia	alopecia	NOUN
dpc-4609	2	6	areata	areata	NOUN
dpc-4609	2	7	:	:	PUNCT
dpc-4609	2	8	a	a	DET
dpc-4609	2	9	possible	possible	ADJ
dpc-4609	2	10	combined	combined	ADJ
dpc-4609	2	11	or	or	CCONJ
dpc-4609	2	12	disturbance	disturbance	NOUN
dpc-4609	2	13	therapy	therapy	NOUN
dpc-4609	2	14	?	?	PUNCT
dpc-4609	3	1	a	a	DET
dpc-4609	3	2	review	review	NOUN
dpc-4609	3	3	of	of	ADP
dpc-4609	3	4	the	the	DET
dpc-4609	3	5	literature	literature	PROPN
dpc-4609	3	6	michela	michela	PROPN
dpc-4609	3	7	starace1,2	starace1,2	PROPN
dpc-4609	3	8	,	,	PUNCT
dpc-4609	3	9	stephano	stephano	PROPN
dpc-4609	3	10	cedirian1,2	cedirian1,2	PROPN
dpc-4609	3	11	,	,	PUNCT
dpc-4609	3	12	federico	federico	PROPN
dpc-4609	3	13	quadrelli1,2	quadrelli1,2	PROPN
dpc-4609	3	14	,	,	PUNCT
dpc-4609	3	15	francesca	francesca	PROPN
dpc-4609	3	16	pampaloni1,2	pampaloni1,2	PROPN
dpc-4609	3	17	,	,	PUNCT
dpc-4609	3	18	tullio	tullio	VERB
dpc-4609	4	1	brunetti1,2	brunetti1,2	PROPN
dpc-4609	4	2	,	,	PUNCT
dpc-4609	4	3	marco	marco	PROPN
dpc-4609	4	4	adriano	adriano	PROPN
dpc-4609	4	5	chessa1,2	chessa1,2	PROPN
dpc-4609	4	6	,	,	PUNCT
dpc-4609	4	7	carlotta	carlotta	PROPN
dpc-4609	4	8	gurioli1	gurioli1	PROPN
dpc-4609	4	9	,	,	PUNCT
dpc-4609	4	10	bianca	bianca	PROPN
dpc-4609	4	11	maria	maria	PROPN
dpc-4609	4	12	piraccini1,2	piraccini1,2	PROPN
dpc-4609	4	13	,	,	PUNCT
dpc-4609	4	14	iria	iria	PROPN
dpc-4609	4	15	neri1	neri1	NOUN
dpc-4609	4	16	1	1	NUM
dpc-4609	4	17	dermatology	dermatology	NOUN
dpc-4609	4	18	unit	unit	NOUN
dpc-4609	4	19	,	,	PUNCT
dpc-4609	4	20	irccs	irccs	PROPN
dpc-4609	4	21	azienda	azienda	PROPN
dpc-4609	4	22	ospedaliero	ospedaliero	PROPN
dpc-4609	4	23	-	-	PUNCT
dpc-4609	4	24	universitaria	universitaria	PROPN
dpc-4609	4	25	di	di	PROPN
dpc-4609	4	26	bologna	bologna	PROPN
dpc-4609	4	27	,	,	PUNCT
dpc-4609	4	28	policlinico	policlinico	PROPN
dpc-4609	4	29	s.	s.	PROPN
dpc-4609	4	30	orsola	orsola	PROPN
dpc-4609	4	31	-	-	PUNCT
dpc-4609	4	32	malpighi	malpighi	PROPN
dpc-4609	4	33	,	,	PUNCT
dpc-4609	4	34	bologna	bologna	PROPN
dpc-4609	4	35	,	,	PUNCT
dpc-4609	4	36	italy	italy	PROPN
dpc-4609	4	37	2	2	NUM
dpc-4609	4	38	department	department	NOUN
dpc-4609	4	39	of	of	ADP
dpc-4609	4	40	medical	medical	ADJ
dpc-4609	4	41	and	and	CCONJ
dpc-4609	4	42	surgical	surgical	ADJ
dpc-4609	4	43	sciences	science	NOUN
dpc-4609	4	44	,	,	PUNCT
dpc-4609	4	45	alma	alma	NOUN
dpc-4609	4	46	mater	mater	PROPN
dpc-4609	4	47	studiorum	studiorum	PROPN
dpc-4609	4	48	university	university	PROPN
dpc-4609	4	49	of	of	ADP
dpc-4609	4	50	bologna	bologna	PROPN
dpc-4609	4	51	,	,	PUNCT
dpc-4609	4	52	italy	italy	PROPN
dpc-4609	4	53	key	key	ADJ
dpc-4609	4	54	words	word	NOUN
dpc-4609	4	55	:	:	PUNCT
dpc-4609	4	56	dupilumab	dupilumab	NOUN
dpc-4609	4	57	,	,	PUNCT
dpc-4609	4	58	th1	th1	PROPN
dpc-4609	4	59	-	-	NOUN
dpc-4609	4	60	inflammation	inflammation	NOUN
dpc-4609	4	61	,	,	PUNCT
dpc-4609	4	62	th2	th2	PROPN
dpc-4609	4	63	-	-	NOUN
dpc-4609	4	64	inflammation	inflammation	NOUN
dpc-4609	4	65	,	,	PUNCT
dpc-4609	4	66	alopecia	alopecia	NOUN
dpc-4609	4	67	areata	areata	NOUN
dpc-4609	4	68	,	,	PUNCT
dpc-4609	4	69	atopic	atopic	NOUN
dpc-4609	4	70	dermatitis	dermatitis	NOUN
dpc-4609	4	71	citation	citation	NOUN
dpc-4609	4	72	:	:	PUNCT
dpc-4609	4	73	starace	starace	PROPN
dpc-4609	4	74	m	m	PROPN
dpc-4609	4	75	,	,	PUNCT
dpc-4609	4	76	cedirian	cedirian	PROPN
dpc-4609	4	77	s	s	PROPN
dpc-4609	4	78	,	,	PUNCT
dpc-4609	4	79	quadrelli	quadrelli	PROPN
dpc-4609	4	80	f	f	AUX
dpc-4609	4	81	,	,	PUNCT
dpc-4609	4	82	et	et	PROPN
dpc-4609	4	83	al	al	PROPN
dpc-4609	4	84	.	.	PROPN
dpc-4609	4	85	dupilumab	dupilumab	NOUN
dpc-4609	4	86	and	and	CCONJ
dpc-4609	4	87	alopecia	alopecia	NOUN
dpc-4609	4	88	areata	areata	NOUN
dpc-4609	4	89	:	:	PUNCT
dpc-4609	4	90	a	a	DET
dpc-4609	4	91	possible	possible	ADJ
dpc-4609	4	92	combined	combined	ADJ
dpc-4609	4	93	or	or	CCONJ
dpc-4609	4	94	disturbance	disturbance	NOUN
dpc-4609	4	95	therapy	therapy	NOUN
dpc-4609	4	96	?	?	PUNCT
dpc-4609	5	1	a	a	DET
dpc-4609	5	2	review	review	NOUN
dpc-4609	5	3	of	of	ADP
dpc-4609	5	4	the	the	DET
dpc-4609	5	5	literature	literature	NOUN
dpc-4609	5	6	.	.	PUNCT
dpc-4609	6	1	dermatol	dermatol	NOUN
dpc-4609	6	2	pract	pract	PROPN
dpc-4609	6	3	concept	concept	NOUN
dpc-4609	6	4	.	.	PUNCT
dpc-4609	7	1	2024;14(4):e2024270	2024;14(4):e2024270	X
dpc-4609	7	2	.	.	PUNCT
dpc-4609	8	1	doi	doi	NOUN
dpc-4609	8	2	:	:	PUNCT
dpc-4609	8	3	https://doi.org/10.5826/dpc.1404a270	https://doi.org/10.5826/dpc.1404a270	PROPN
dpc-4609	8	4	accepted	accept	VERB
dpc-4609	8	5	:	:	PUNCT
dpc-4609	8	6	june	june	PROPN
dpc-4609	8	7	21	21	NUM
dpc-4609	8	8	,	,	PUNCT
dpc-4609	8	9	2024	2024	NUM
dpc-4609	8	10	;	;	PUNCT
dpc-4609	8	11	published	publish	VERB
dpc-4609	8	12	:	:	PUNCT
dpc-4609	9	1	october	october	PROPN
dpc-4609	9	2	2024	2024	NUM
dpc-4609	9	3	copyright	copyright	NOUN
dpc-4609	9	4	:	:	PUNCT
dpc-4609	9	5	©	©	PROPN
dpc-4609	9	6	2024	2024	NUM
dpc-4609	9	7	starace	starace	NOUN
dpc-4609	9	8	et	et	PROPN
dpc-4609	9	9	al	al	PROPN
dpc-4609	9	10	.	.	PUNCT
dpc-4609	10	1	this	this	PRON
dpc-4609	10	2	is	be	AUX
dpc-4609	10	3	an	an	DET
dpc-4609	10	4	open	open	ADJ
dpc-4609	10	5	-	-	PUNCT
dpc-4609	10	6	access	access	NOUN
dpc-4609	10	7	article	article	NOUN
dpc-4609	10	8	distributed	distribute	VERB
dpc-4609	10	9	under	under	ADP
dpc-4609	10	10	the	the	DET
dpc-4609	10	11	terms	term	NOUN
dpc-4609	10	12	of	of	ADP
dpc-4609	10	13	the	the	DET
dpc-4609	10	14	creative	creative	ADJ
dpc-4609	10	15	commons	common	NOUN
dpc-4609	10	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4609	10	17	license	license	NOUN
dpc-4609	10	18	(	(	PUNCT
dpc-4609	10	19	by	by	ADP
dpc-4609	10	20	-	-	PUNCT
dpc-4609	10	21	nc-4.0	nc-4.0	NOUN
dpc-4609	10	22	)	)	PUNCT
dpc-4609	10	23	,	,	PUNCT
dpc-4609	10	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4609	10	25	,	,	PUNCT
dpc-4609	10	26	which	which	PRON
dpc-4609	10	27	permits	permit	VERB
dpc-4609	10	28	unrestricted	unrestricted	ADJ
dpc-4609	10	29	noncommercial	noncommercial	ADJ
dpc-4609	10	30	use	use	NOUN
dpc-4609	10	31	,	,	PUNCT
dpc-4609	10	32	distribution	distribution	NOUN
dpc-4609	10	33	,	,	PUNCT
dpc-4609	10	34	and	and	CCONJ
dpc-4609	10	35	reproduction	reproduction	NOUN
dpc-4609	10	36	in	in	ADP
dpc-4609	10	37	any	any	DET
dpc-4609	10	38	medium	medium	NOUN
dpc-4609	10	39	,	,	PUNCT
dpc-4609	10	40	provided	provide	VERB
dpc-4609	10	41	the	the	DET
dpc-4609	10	42	original	original	ADJ
dpc-4609	10	43	authors	author	NOUN
dpc-4609	10	44	and	and	CCONJ
dpc-4609	10	45	source	source	NOUN
dpc-4609	10	46	are	be	AUX
dpc-4609	10	47	credited	credit	VERB
dpc-4609	10	48	.	.	PUNCT
dpc-4609	11	1	funding	funding	NOUN
dpc-4609	11	2	:	:	PUNCT
dpc-4609	11	3	none	none	NOUN
dpc-4609	11	4	.	.	PUNCT
dpc-4609	12	1	competing	compete	VERB
dpc-4609	12	2	interests	interest	NOUN
dpc-4609	12	3	:	:	PUNCT
dpc-4609	12	4	none	none	NOUN
dpc-4609	12	5	.	.	PUNCT
dpc-4609	13	1	authorship	authorship	NOUN
dpc-4609	13	2	:	:	PUNCT
dpc-4609	13	3	all	all	DET
dpc-4609	13	4	authors	author	NOUN
dpc-4609	13	5	have	have	AUX
dpc-4609	13	6	contributed	contribute	VERB
dpc-4609	13	7	significantly	significantly	ADV
dpc-4609	13	8	to	to	ADP
dpc-4609	13	9	this	this	DET
dpc-4609	13	10	publication	publication	NOUN
dpc-4609	13	11	.	.	PUNCT
dpc-4609	14	1	corresponding	correspond	VERB
dpc-4609	14	2	author	author	NOUN
dpc-4609	14	3	:	:	PUNCT
dpc-4609	14	4	bianca	bianca	PROPN
dpc-4609	14	5	maria	maria	PROPN
dpc-4609	14	6	piraccini	piraccini	PROPN
dpc-4609	14	7	md	md	PROPN
dpc-4609	14	8	,	,	PUNCT
dpc-4609	14	9	phd	phd	PROPN
dpc-4609	14	10	,	,	PUNCT
dpc-4609	14	11	via	via	ADP
dpc-4609	14	12	massarenti	massarenti	NOUN
dpc-4609	14	13	1	1	NUM
dpc-4609	14	14	,	,	PUNCT
dpc-4609	14	15	40138	40138	NUM
dpc-4609	14	16	bologna	bologna	PROPN
dpc-4609	14	17	italy	italy	PROPN
dpc-4609	14	18	.	.	PUNCT
dpc-4609	15	1	telephone	telephone	NOUN
dpc-4609	15	2	:	:	PUNCT
dpc-4609	15	3	+390512144840	+390512144840	NOUN
dpc-4609	15	4	.	.	PUNCT
dpc-4609	16	1	email	email	NOUN
dpc-4609	16	2	:	:	PUNCT
dpc-4609	16	3	biancamaria.piraccini@unibo.it	biancamaria.piraccini@unibo.it	NOUN
dpc-4609	16	4	introduction	introduction	NOUN
dpc-4609	16	5	:	:	PUNCT
dpc-4609	16	6	dupilumab	dupilumab	NOUN
dpc-4609	16	7	,	,	PUNCT
dpc-4609	16	8	a	a	DET
dpc-4609	16	9	monoclonal	monoclonal	NOUN
dpc-4609	16	10	antibody	antibody	NOUN
dpc-4609	16	11	targeting	target	VERB
dpc-4609	16	12	il-4	il-4	X
dpc-4609	16	13	receptor	receptor	NOUN
dpc-4609	16	14	subunit	subunit	NOUN
dpc-4609	16	15	alpha	alpha	PROPN
dpc-4609	16	16	,	,	PUNCT
dpc-4609	16	17	treats	treat	VERB
dpc-4609	16	18	atopic	atopic	NOUN
dpc-4609	16	19	dermatitis	dermatitis	NOUN
dpc-4609	16	20	(	(	PUNCT
dpc-4609	16	21	ad	ad	NOUN
dpc-4609	16	22	)	)	PUNCT
dpc-4609	16	23	and	and	CCONJ
dpc-4609	16	24	may	may	AUX
dpc-4609	16	25	impact	impact	VERB
dpc-4609	16	26	alopecia	alopecia	NOUN
dpc-4609	16	27	areata	areata	ADJ
dpc-4609	16	28	(	(	PUNCT
dpc-4609	16	29	aa	aa	NOUN
dpc-4609	16	30	)	)	PUNCT
dpc-4609	16	31	.	.	PUNCT
dpc-4609	17	1	aa	aa	PROPN
dpc-4609	17	2	involves	involve	VERB
dpc-4609	17	3	th1	th1	NOUN
dpc-4609	17	4	-	-	PUNCT
dpc-4609	17	5	driven	drive	VERB
dpc-4609	17	6	immune	immune	ADJ
dpc-4609	17	7	activity	activity	NOUN
dpc-4609	17	8	,	,	PUNCT
dpc-4609	17	9	and	and	CCONJ
dpc-4609	17	10	recent	recent	ADJ
dpc-4609	17	11	studies	study	NOUN
dpc-4609	17	12	suggest	suggest	VERB
dpc-4609	17	13	a	a	DET
dpc-4609	17	14	role	role	NOUN
dpc-4609	17	15	for	for	ADP
dpc-4609	17	16	th2	th2	PROPN
dpc-4609	17	17	pathways	pathway	NOUN
dpc-4609	17	18	.	.	PUNCT
dpc-4609	18	1	dupilumab	dupilumab	NOUN
dpc-4609	18	2	’s	’s	PART
dpc-4609	18	3	effects	effect	NOUN
dpc-4609	18	4	on	on	ADP
dpc-4609	18	5	aa	aa	PROPN
dpc-4609	18	6	are	be	AUX
dpc-4609	18	7	mixed	mix	VERB
dpc-4609	18	8	,	,	PUNCT
dpc-4609	18	9	with	with	ADP
dpc-4609	18	10	reports	report	NOUN
dpc-4609	18	11	of	of	ADP
dpc-4609	18	12	both	both	CCONJ
dpc-4609	18	13	improvement	improvement	NOUN
dpc-4609	18	14	and	and	CCONJ
dpc-4609	18	15	worsening	worsening	NOUN
dpc-4609	18	16	.	.	PUNCT
dpc-4609	19	1	objectives	objective	NOUN
dpc-4609	19	2	:	:	PUNCT
dpc-4609	19	3	this	this	DET
dpc-4609	19	4	study	study	NOUN
dpc-4609	19	5	aims	aim	VERB
dpc-4609	19	6	to	to	PART
dpc-4609	19	7	review	review	VERB
dpc-4609	19	8	the	the	DET
dpc-4609	19	9	effects	effect	NOUN
dpc-4609	19	10	of	of	ADP
dpc-4609	19	11	dupilumab	dupilumab	NOUN
dpc-4609	19	12	on	on	ADP
dpc-4609	19	13	aa	aa	NOUN
dpc-4609	19	14	in	in	ADP
dpc-4609	19	15	patients	patient	NOUN
dpc-4609	19	16	with	with	ADP
dpc-4609	19	17	ad	ad	NOUN
dpc-4609	19	18	,	,	PUNCT
dpc-4609	19	19	analyzing	analyze	VERB
dpc-4609	19	20	literature	literature	NOUN
dpc-4609	19	21	to	to	PART
dpc-4609	19	22	understand	understand	VERB
dpc-4609	19	23	cases	case	NOUN
dpc-4609	19	24	of	of	ADP
dpc-4609	19	25	improvement	improvement	NOUN
dpc-4609	19	26	or	or	CCONJ
dpc-4609	19	27	worsening	worsen	VERB
dpc-4609	19	28	and	and	CCONJ
dpc-4609	19	29	identifying	identify	VERB
dpc-4609	19	30	contributing	contribute	VERB
dpc-4609	19	31	factors	factor	NOUN
dpc-4609	19	32	.	.	PUNCT
dpc-4609	20	1	methods	method	NOUN
dpc-4609	20	2	:	:	PUNCT
dpc-4609	20	3	a	a	DET
dpc-4609	20	4	literature	literature	NOUN
dpc-4609	20	5	review	review	NOUN
dpc-4609	20	6	was	be	AUX
dpc-4609	20	7	conducted	conduct	VERB
dpc-4609	20	8	using	use	VERB
dpc-4609	20	9	articles	article	NOUN
dpc-4609	20	10	in	in	ADP
dpc-4609	20	11	platforms	platform	NOUN
dpc-4609	20	12	such	such	ADJ
dpc-4609	20	13	as	as	ADP
dpc-4609	20	14	pubmed	pubmed	PROPN
dpc-4609	20	15	,	,	PUNCT
dpc-4609	20	16	scopus	scopus	PROPN
dpc-4609	20	17	,	,	PUNCT
dpc-4609	20	18	and	and	CCONJ
dpc-4609	20	19	web	web	NOUN
dpc-4609	20	20	of	of	ADP
dpc-4609	20	21	science	science	NOUN
dpc-4609	20	22	written	write	VERB
dpc-4609	20	23	up	up	ADP
dpc-4609	20	24	to	to	ADP
dpc-4609	20	25	april	april	PROPN
dpc-4609	20	26	2024	2024	NUM
dpc-4609	20	27	,	,	PUNCT
dpc-4609	20	28	focusing	focus	VERB
dpc-4609	20	29	on	on	ADP
dpc-4609	20	30	studies	study	NOUN
dpc-4609	20	31	involving	involve	VERB
dpc-4609	20	32	aa	aa	NOUN
dpc-4609	20	33	,	,	PUNCT
dpc-4609	20	34	ad	ad	NOUN
dpc-4609	20	35	,	,	PUNCT
dpc-4609	20	36	and	and	CCONJ
dpc-4609	20	37	dupilumab	dupilumab	NOUN
dpc-4609	20	38	.	.	PUNCT
dpc-4609	21	1	articles	article	NOUN
dpc-4609	21	2	were	be	AUX
dpc-4609	21	3	analyzed	analyze	VERB
dpc-4609	21	4	for	for	ADP
dpc-4609	21	5	patient	patient	ADJ
dpc-4609	21	6	demographics	demographic	NOUN
dpc-4609	21	7	,	,	PUNCT
dpc-4609	21	8	disease	disease	NOUN
dpc-4609	21	9	characteristics	characteristic	NOUN
dpc-4609	21	10	,	,	PUNCT
dpc-4609	21	11	and	and	CCONJ
dpc-4609	21	12	responses	response	NOUN
dpc-4609	21	13	to	to	ADP
dpc-4609	21	14	treatment	treatment	NOUN
dpc-4609	21	15	.	.	PUNCT
dpc-4609	22	1	results	result	NOUN
dpc-4609	22	2	:	:	PUNCT
dpc-4609	22	3	out	out	ADP
dpc-4609	22	4	of	of	ADP
dpc-4609	22	5	35	35	NUM
dpc-4609	22	6	articles	article	NOUN
dpc-4609	22	7	reviewed	review	VERB
dpc-4609	22	8	,	,	PUNCT
dpc-4609	22	9	13	13	NUM
dpc-4609	22	10	aa	aa	NOUN
dpc-4609	22	11	cases	case	NOUN
dpc-4609	22	12	worsened	worsen	VERB
dpc-4609	22	13	after	after	ADP
dpc-4609	22	14	dupilumab	dupilumab	NOUN
dpc-4609	22	15	(	(	PUNCT
dpc-4609	22	16	mean	mean	VERB
dpc-4609	22	17	age	age	NOUN
dpc-4609	22	18	32.8	32.8	NUM
dpc-4609	22	19	;	;	PUNCT
dpc-4609	22	20	mostly	mostly	ADV
dpc-4609	22	21	males	male	NOUN
dpc-4609	22	22	with	with	ADP
dpc-4609	22	23	patchy	patchy	ADJ
dpc-4609	22	24	alopecia	alopecia	NOUN
dpc-4609	22	25	)	)	PUNCT
dpc-4609	22	26	,	,	PUNCT
dpc-4609	22	27	and	and	CCONJ
dpc-4609	22	28	38	38	NUM
dpc-4609	22	29	cases	case	NOUN
dpc-4609	22	30	showed	show	VERB
dpc-4609	22	31	improvement	improvement	NOUN
dpc-4609	22	32	(	(	PUNCT
dpc-4609	22	33	mean	mean	VERB
dpc-4609	22	34	age	age	NOUN
dpc-4609	22	35	27.6	27.6	NUM
dpc-4609	22	36	;	;	PUNCT
dpc-4609	22	37	majority	majority	NOUN
dpc-4609	22	38	females	female	NOUN
dpc-4609	22	39	,	,	PUNCT
dpc-4609	22	40	varying	vary	VERB
dpc-4609	22	41	aa	aa	ADJ
dpc-4609	22	42	types	type	NOUN
dpc-4609	22	43	)	)	PUNCT
dpc-4609	22	44	.	.	PUNCT
dpc-4609	23	1	full	full	ADJ
dpc-4609	23	2	hair	hair	NOUN
dpc-4609	23	3	regrowth	regrowth	NOUN
dpc-4609	23	4	occurred	occur	VERB
dpc-4609	23	5	in	in	ADP
dpc-4609	23	6	11	11	NUM
dpc-4609	23	7	improved	improved	ADJ
dpc-4609	23	8	cases	case	NOUN
dpc-4609	23	9	,	,	PUNCT
dpc-4609	23	10	while	while	SCONJ
dpc-4609	23	11	9	9	NUM
dpc-4609	23	12	had	have	VERB
dpc-4609	23	13	partial	partial	ADJ
dpc-4609	23	14	regrowth	regrowth	NOUN
dpc-4609	23	15	.	.	PUNCT
dpc-4609	24	1	conclusions	conclusion	NOUN
dpc-4609	24	2	:	:	PUNCT
dpc-4609	24	3	dupilumab	dupilumab	NOUN
dpc-4609	24	4	shows	show	VERB
dpc-4609	24	5	dual	dual	ADJ
dpc-4609	24	6	effects	effect	NOUN
dpc-4609	24	7	on	on	ADP
dpc-4609	24	8	aa	aa	NOUN
dpc-4609	24	9	,	,	PUNCT
dpc-4609	24	10	influenced	influence	VERB
dpc-4609	24	11	by	by	ADP
dpc-4609	24	12	th1	th1	PROPN
dpc-4609	24	13	/	/	SYM
dpc-4609	24	14	th2	th2	PROPN
dpc-4609	24	15	immune	immune	ADJ
dpc-4609	24	16	profiles	profile	NOUN
dpc-4609	24	17	.	.	PUNCT
dpc-4609	25	1	worsening	worsen	VERB
dpc-4609	25	2	was	be	AUX
dpc-4609	25	3	more	more	ADV
dpc-4609	25	4	common	common	ADJ
dpc-4609	25	5	in	in	ADP
dpc-4609	25	6	males	male	NOUN
dpc-4609	25	7	with	with	ADP
dpc-4609	25	8	th1	th1	NOUN
dpc-4609	25	9	-	-	PUNCT
dpc-4609	25	10	driven	drive	VERB
dpc-4609	25	11	aa	aa	NOUN
dpc-4609	25	12	,	,	PUNCT
dpc-4609	25	13	while	while	SCONJ
dpc-4609	25	14	females	female	NOUN
dpc-4609	25	15	with	with	ADP
dpc-4609	25	16	th2	th2	PROPN
dpc-4609	25	17	-	-	PUNCT
dpc-4609	25	18	skewed	skewed	ADJ
dpc-4609	25	19	aa	aa	NOUN
dpc-4609	25	20	saw	see	VERB
dpc-4609	25	21	improvement	improvement	NOUN
dpc-4609	25	22	.	.	PUNCT
dpc-4609	26	1	factors	factor	NOUN
dpc-4609	26	2	like	like	ADP
dpc-4609	26	3	age	age	NOUN
dpc-4609	26	4	,	,	PUNCT
dpc-4609	26	5	disease	disease	NOUN
dpc-4609	26	6	severity	severity	NOUN
dpc-4609	26	7	,	,	PUNCT
dpc-4609	26	8	and	and	CCONJ
dpc-4609	26	9	ige	ige	PROPN
dpc-4609	26	10	levels	level	NOUN
dpc-4609	26	11	may	may	AUX
dpc-4609	26	12	affect	affect	VERB
dpc-4609	26	13	outcomes	outcome	NOUN
dpc-4609	26	14	,	,	PUNCT
dpc-4609	26	15	suggesting	suggest	VERB
dpc-4609	26	16	a	a	DET
dpc-4609	26	17	need	need	NOUN
dpc-4609	26	18	for	for	ADP
dpc-4609	26	19	personalized	personalized	ADJ
dpc-4609	26	20	treatment	treatment	NOUN
dpc-4609	26	21	approaches	approach	NOUN
dpc-4609	26	22	for	for	ADP
dpc-4609	26	23	aa	aa	PROPN
dpc-4609	26	24	patients	patient	NOUN
dpc-4609	26	25	with	with	ADP
dpc-4609	26	26	ad	ad	NOUN
dpc-4609	26	27	.	.	PUNCT
dpc-4609	27	1	abstract	abstract	ADJ
dpc-4609	27	2	2	2	NUM
dpc-4609	27	3	review	review	NOUN
dpc-4609	27	4	|	|	ADV
dpc-4609	27	5	dermatol	dermatol	ADJ
dpc-4609	27	6	pract	pract	NOUN
dpc-4609	27	7	concept	concept	NOUN
dpc-4609	27	8	.	.	PUNCT
dpc-4609	28	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	28	2	introduction	introduction	NOUN
dpc-4609	28	3	dupilumab	dupilumab	NOUN
dpc-4609	28	4	is	be	AUX
dpc-4609	28	5	a	a	DET
dpc-4609	28	6	monoclonal	monoclonal	NOUN
dpc-4609	28	7	antibody	antibody	NOUN
dpc-4609	28	8	that	that	PRON
dpc-4609	28	9	targets	target	VERB
dpc-4609	28	10	il-4	il-4	PART
dpc-4609	28	11	receptor	receptor	NOUN
dpc-4609	28	12	subunit	subunit	NOUN
dpc-4609	28	13	alpha	alpha	NOUN
dpc-4609	28	14	(	(	PUNCT
dpc-4609	28	15	il-4r	il-4r	NOUN
dpc-4609	28	16	-	-	NOUN
dpc-4609	28	17	alpha	alpha	NOUN
dpc-4609	28	18	)	)	PUNCT
dpc-4609	28	19	,	,	PUNCT
dpc-4609	28	20	a	a	DET
dpc-4609	28	21	shared	share	VERB
dpc-4609	28	22	component	component	NOUN
dpc-4609	28	23	of	of	ADP
dpc-4609	28	24	il-4	il-4	NOUN
dpc-4609	28	25	and	and	CCONJ
dpc-4609	28	26	il-13	il-13	ADP
dpc-4609	28	27	receptors	receptor	NOUN
dpc-4609	28	28	;	;	PUNCT
dpc-4609	28	29	these	these	DET
dpc-4609	28	30	cytokines	cytokine	NOUN
dpc-4609	28	31	have	have	VERB
dpc-4609	28	32	a	a	DET
dpc-4609	28	33	pivotal	pivotal	ADJ
dpc-4609	28	34	role	role	NOUN
dpc-4609	28	35	in	in	ADP
dpc-4609	28	36	th2	th2	PROPN
dpc-4609	28	37	-	-	PUNCT
dpc-4609	28	38	driven	drive	VERB
dpc-4609	28	39	inflammation	inflammation	NOUN
dpc-4609	28	40	.	.	PUNCT
dpc-4609	29	1	dupilumab	dupilumab	NOUN
dpc-4609	29	2	has	have	AUX
dpc-4609	29	3	been	be	AUX
dpc-4609	29	4	approved	approve	VERB
dpc-4609	29	5	for	for	ADP
dpc-4609	29	6	the	the	DET
dpc-4609	29	7	treatment	treatment	NOUN
dpc-4609	29	8	of	of	ADP
dpc-4609	29	9	moderate	moderate	ADJ
dpc-4609	29	10	-	-	PUNCT
dpc-4609	29	11	to	to	ADP
dpc-4609	29	12	-	-	PUNCT
dpc-4609	29	13	severe	severe	ADJ
dpc-4609	29	14	atopic	atopic	NOUN
dpc-4609	29	15	dermatitis	dermatitis	NOUN
dpc-4609	29	16	(	(	PUNCT
dpc-4609	29	17	ad	ad	NOUN
dpc-4609	29	18	)	)	PUNCT
dpc-4609	29	19	however	however	ADV
dpc-4609	29	20	,	,	PUNCT
dpc-4609	29	21	recently	recently	ADV
dpc-4609	29	22	,	,	PUNCT
dpc-4609	29	23	it	it	PRON
dpc-4609	29	24	has	have	AUX
dpc-4609	29	25	shown	show	VERB
dpc-4609	29	26	efficacy	efficacy	NOUN
dpc-4609	29	27	in	in	ADP
dpc-4609	29	28	other	other	ADJ
dpc-4609	29	29	conditions	condition	NOUN
dpc-4609	29	30	,	,	PUNCT
dpc-4609	29	31	such	such	ADJ
dpc-4609	29	32	as	as	ADP
dpc-4609	29	33	alopecia	alopecia	NOUN
dpc-4609	29	34	areata	areata	ADJ
dpc-4609	29	35	(	(	PUNCT
dpc-4609	29	36	aa	aa	NOUN
dpc-4609	29	37	)	)	PUNCT
dpc-4609	30	1	[	[	X
dpc-4609	30	2	1	1	NUM
dpc-4609	30	3	]	]	PUNCT
dpc-4609	30	4	.	.	PUNCT
dpc-4609	31	1	aa	aa	PROPN
dpc-4609	31	2	is	be	AUX
dpc-4609	31	3	an	an	DET
dpc-4609	31	4	autoimmune	autoimmune	ADJ
dpc-4609	31	5	non	non	ADJ
dpc-4609	31	6	-	-	ADJ
dpc-4609	31	7	scarring	scar	VERB
dpc-4609	31	8	alopecia	alopecia	NOUN
dpc-4609	31	9	that	that	PRON
dpc-4609	31	10	can	can	AUX
dpc-4609	31	11	affect	affect	VERB
dpc-4609	31	12	any	any	DET
dpc-4609	31	13	hair	hair	NOUN
dpc-4609	31	14	-	-	PUNCT
dpc-4609	31	15	bearing	bear	VERB
dpc-4609	31	16	area	area	NOUN
dpc-4609	31	17	.	.	PUNCT
dpc-4609	32	1	the	the	DET
dpc-4609	32	2	(	(	PUNCT
dpc-4609	32	3	ifn)y	ifn)y	PROPN
dpc-4609	32	4	/	/	SYM
dpc-4609	32	5	th1	th1	PROPN
dpc-4609	32	6	pathway	pathway	NOUN
dpc-4609	32	7	and	and	CCONJ
dpc-4609	32	8	the	the	DET
dpc-4609	32	9	janus	janus	PROPN
dpc-4609	32	10	kinase	kinase	PROPN
dpc-4609	32	11	(	(	PUNCT
dpc-4609	32	12	jak	jak	PROPN
dpc-4609	32	13	)	)	PUNCT
dpc-4609	32	14	signaling	signal	VERB
dpc-4609	32	15	pathway	pathway	NOUN
dpc-4609	32	16	are	be	AUX
dpc-4609	32	17	the	the	DET
dpc-4609	32	18	main	main	ADJ
dpc-4609	32	19	protagonists	protagonist	NOUN
dpc-4609	32	20	of	of	ADP
dpc-4609	32	21	hair	hair	NOUN
dpc-4609	32	22	follicle	follicle	VERB
dpc-4609	32	23	immune	immune	ADJ
dpc-4609	32	24	aggression	aggression	NOUN
dpc-4609	32	25	in	in	ADP
dpc-4609	32	26	aa	aa	NOUN
dpc-4609	32	27	,	,	PUNCT
dpc-4609	32	28	although	although	SCONJ
dpc-4609	32	29	recent	recent	ADJ
dpc-4609	32	30	studies	study	NOUN
dpc-4609	32	31	have	have	AUX
dpc-4609	32	32	shown	show	VERB
dpc-4609	32	33	a	a	DET
dpc-4609	32	34	co	co	NOUN
dpc-4609	32	35	-	-	NOUN
dpc-4609	32	36	participation	participation	NOUN
dpc-4609	32	37	of	of	ADP
dpc-4609	32	38	th2	th2	PROPN
dpc-4609	32	39	-	-	PUNCT
dpc-4609	32	40	axis	axis	ADJ
dpc-4609	32	41	cytokines	cytokine	NOUN
dpc-4609	33	1	[	[	X
dpc-4609	33	2	2	2	NUM
dpc-4609	33	3	]	]	PUNCT
dpc-4609	33	4	.	.	PUNCT
dpc-4609	34	1	the	the	DET
dpc-4609	34	2	possible	possible	ADJ
dpc-4609	34	3	association	association	NOUN
dpc-4609	34	4	between	between	ADP
dpc-4609	34	5	ad	ad	NOUN
dpc-4609	34	6	and	and	CCONJ
dpc-4609	34	7	aa	aa	NOUN
dpc-4609	34	8	has	have	AUX
dpc-4609	34	9	already	already	ADV
dpc-4609	34	10	been	be	AUX
dpc-4609	34	11	published	publish	VERB
dpc-4609	34	12	,	,	PUNCT
dpc-4609	34	13	and	and	CCONJ
dpc-4609	34	14	for	for	ADP
dpc-4609	34	15	this	this	DET
dpc-4609	34	16	reason	reason	NOUN
dpc-4609	34	17	,	,	PUNCT
dpc-4609	34	18	many	many	ADJ
dpc-4609	34	19	cases	case	NOUN
dpc-4609	34	20	have	have	AUX
dpc-4609	34	21	been	be	AUX
dpc-4609	34	22	described	describe	VERB
dpc-4609	34	23	about	about	ADP
dpc-4609	34	24	the	the	DET
dpc-4609	34	25	use	use	NOUN
dpc-4609	34	26	of	of	ADP
dpc-4609	34	27	dupilumab	dupilumab	NOUN
dpc-4609	34	28	in	in	ADP
dpc-4609	34	29	patients	patient	NOUN
dpc-4609	34	30	with	with	ADP
dpc-4609	34	31	both	both	CCONJ
dpc-4609	34	32	dermatological	dermatological	ADJ
dpc-4609	34	33	diseases	disease	NOUN
dpc-4609	34	34	[	[	X
dpc-4609	34	35	3	3	NUM
dpc-4609	34	36	]	]	PUNCT
dpc-4609	34	37	.	.	PUNCT
dpc-4609	35	1	the	the	DET
dpc-4609	35	2	literature	literature	NOUN
dpc-4609	35	3	shows	show	VERB
dpc-4609	35	4	that	that	SCONJ
dpc-4609	35	5	dupilumab	dupilumab	NOUN
dpc-4609	35	6	may	may	AUX
dpc-4609	35	7	have	have	VERB
dpc-4609	35	8	a	a	DET
dpc-4609	35	9	double	double	ADJ
dpc-4609	35	10	effect	effect	NOUN
dpc-4609	35	11	on	on	ADP
dpc-4609	35	12	patients	patient	NOUN
dpc-4609	35	13	affected	affect	VERB
dpc-4609	35	14	by	by	ADP
dpc-4609	35	15	aa	aa	NOUN
dpc-4609	35	16	and	and	CCONJ
dpc-4609	35	17	ad	ad	NOUN
dpc-4609	35	18	:	:	PUNCT
dpc-4609	35	19	it	it	PRON
dpc-4609	35	20	has	have	AUX
dpc-4609	35	21	been	be	AUX
dpc-4609	35	22	reported	report	VERB
dpc-4609	35	23	that	that	SCONJ
dpc-4609	35	24	it	it	PRON
dpc-4609	35	25	may	may	AUX
dpc-4609	35	26	promote	promote	VERB
dpc-4609	35	27	aa	aa	NOUN
dpc-4609	35	28	development	development	NOUN
dpc-4609	35	29	as	as	ADV
dpc-4609	35	30	well	well	ADV
dpc-4609	35	31	as	as	ADP
dpc-4609	35	32	hair	hair	NOUN
dpc-4609	35	33	re	re	NOUN
dpc-4609	35	34	-	-	NOUN
dpc-4609	35	35	growth	growth	NOUN
dpc-4609	35	36	,	,	PUNCT
dpc-4609	35	37	something	something	PRON
dpc-4609	35	38	that	that	PRON
dpc-4609	35	39	could	could	AUX
dpc-4609	35	40	be	be	AUX
dpc-4609	35	41	related	relate	VERB
dpc-4609	35	42	to	to	ADP
dpc-4609	35	43	a	a	DET
dpc-4609	35	44	specific	specific	ADJ
dpc-4609	35	45	pattern	pattern	NOUN
dpc-4609	35	46	of	of	ADP
dpc-4609	35	47	cytokines	cytokine	NOUN
dpc-4609	35	48	associated	associate	VERB
dpc-4609	35	49	with	with	ADP
dpc-4609	35	50	aa	aa	NOUN
dpc-4609	35	51	inflammatory	inflammatory	ADJ
dpc-4609	35	52	background	background	NOUN
dpc-4609	36	1	[	[	X
dpc-4609	36	2	4,5	4,5	NUM
dpc-4609	36	3	]	]	PUNCT
dpc-4609	36	4	.	.	PUNCT
dpc-4609	37	1	objectives	objective	NOUN
dpc-4609	37	2	we	we	PRON
dpc-4609	37	3	conducted	conduct	VERB
dpc-4609	37	4	a	a	DET
dpc-4609	37	5	literature	literature	NOUN
dpc-4609	37	6	review	review	NOUN
dpc-4609	37	7	to	to	PART
dpc-4609	37	8	define	define	VERB
dpc-4609	37	9	the	the	DET
dpc-4609	37	10	different	different	ADJ
dpc-4609	37	11	effects	effect	NOUN
dpc-4609	37	12	of	of	ADP
dpc-4609	37	13	dupilumab	dupilumab	NOUN
dpc-4609	37	14	in	in	ADP
dpc-4609	37	15	patients	patient	NOUN
dpc-4609	37	16	with	with	ADP
dpc-4609	37	17	aa	aa	NOUN
dpc-4609	37	18	.	.	PUNCT
dpc-4609	38	1	more	more	ADV
dpc-4609	38	2	specifically	specifically	ADV
dpc-4609	38	3	,	,	PUNCT
dpc-4609	38	4	we	we	PRON
dpc-4609	38	5	wanted	want	VERB
dpc-4609	38	6	to	to	PART
dpc-4609	38	7	review	review	VERB
dpc-4609	38	8	the	the	DET
dpc-4609	38	9	current	current	ADJ
dpc-4609	38	10	literature	literature	NOUN
dpc-4609	38	11	on	on	ADP
dpc-4609	38	12	the	the	DET
dpc-4609	38	13	topic	topic	NOUN
dpc-4609	38	14	so	so	SCONJ
dpc-4609	38	15	as	as	SCONJ
dpc-4609	38	16	to	to	PART
dpc-4609	38	17	understand	understand	VERB
dpc-4609	38	18	any	any	DET
dpc-4609	38	19	proven	prove	VERB
dpc-4609	38	20	relationship	relationship	NOUN
dpc-4609	38	21	between	between	ADP
dpc-4609	38	22	dupilumab	dupilumab	NOUN
dpc-4609	38	23	administration	administration	NOUN
dpc-4609	38	24	and	and	CCONJ
dpc-4609	38	25	improvement	improvement	NOUN
dpc-4609	38	26	/	/	SYM
dpc-4609	38	27	worsening	worsening	NOUN
dpc-4609	38	28	of	of	ADP
dpc-4609	38	29	aa	aa	NOUN
dpc-4609	38	30	in	in	ADP
dpc-4609	38	31	patients	patient	NOUN
dpc-4609	38	32	with	with	ADP
dpc-4609	38	33	ad	ad	NOUN
dpc-4609	38	34	.	.	PUNCT
dpc-4609	39	1	furthermore	furthermore	ADV
dpc-4609	39	2	,	,	PUNCT
dpc-4609	39	3	to	to	ADP
dpc-4609	39	4	the	the	DET
dpc-4609	39	5	best	good	ADJ
dpc-4609	39	6	of	of	ADP
dpc-4609	39	7	our	our	PRON
dpc-4609	39	8	knowledge	knowledge	NOUN
dpc-4609	39	9	,	,	PUNCT
dpc-4609	39	10	we	we	PRON
dpc-4609	39	11	wanted	want	VERB
dpc-4609	39	12	to	to	PART
dpc-4609	39	13	report	report	VERB
dpc-4609	39	14	all	all	DET
dpc-4609	39	15	the	the	DET
dpc-4609	39	16	similar	similar	ADJ
dpc-4609	39	17	cases	case	NOUN
dpc-4609	39	18	that	that	PRON
dpc-4609	39	19	could	could	AUX
dpc-4609	39	20	strengthen	strengthen	VERB
dpc-4609	39	21	such	such	ADJ
dpc-4609	39	22	duality	duality	NOUN
dpc-4609	39	23	in	in	ADP
dpc-4609	39	24	dupilumab	dupilumab	NOUN
dpc-4609	39	25	use	use	NOUN
dpc-4609	39	26	.	.	PUNCT
dpc-4609	40	1	lastly	lastly	ADV
dpc-4609	40	2	,	,	PUNCT
dpc-4609	40	3	we	we	PRON
dpc-4609	40	4	wanted	want	VERB
dpc-4609	40	5	to	to	PART
dpc-4609	40	6	analyze	analyze	VERB
dpc-4609	40	7	the	the	DET
dpc-4609	40	8	data	datum	NOUN
dpc-4609	40	9	found	find	VERB
dpc-4609	40	10	and	and	CCONJ
dpc-4609	40	11	draw	draw	VERB
dpc-4609	40	12	conclusions	conclusion	NOUN
dpc-4609	40	13	on	on	ADP
dpc-4609	40	14	the	the	DET
dpc-4609	40	15	topic	topic	NOUN
dpc-4609	40	16	,	,	PUNCT
dpc-4609	40	17	based	base	VERB
dpc-4609	40	18	on	on	ADP
dpc-4609	40	19	the	the	DET
dpc-4609	40	20	existing	exist	VERB
dpc-4609	40	21	evidence	evidence	NOUN
dpc-4609	40	22	,	,	PUNCT
dpc-4609	40	23	as	as	SCONJ
dpc-4609	40	24	previously	previously	ADV
dpc-4609	40	25	stated	state	VERB
dpc-4609	40	26	.	.	PUNCT
dpc-4609	41	1	methods	method	NOUN
dpc-4609	41	2	we	we	PRON
dpc-4609	41	3	performed	perform	VERB
dpc-4609	41	4	a	a	DET
dpc-4609	41	5	literature	literature	NOUN
dpc-4609	41	6	review	review	NOUN
dpc-4609	41	7	using	use	VERB
dpc-4609	41	8	the	the	DET
dpc-4609	41	9	medical	medical	ADJ
dpc-4609	41	10	databases	database	NOUN
dpc-4609	41	11	pubmed	pubmed	PROPN
dpc-4609	41	12	,	,	PUNCT
dpc-4609	41	13	scopus	scopus	PROPN
dpc-4609	41	14	,	,	PUNCT
dpc-4609	41	15	and	and	CCONJ
dpc-4609	41	16	web	web	NOUN
dpc-4609	41	17	of	of	ADP
dpc-4609	41	18	science	science	NOUN
dpc-4609	41	19	.	.	PUNCT
dpc-4609	42	1	we	we	PRON
dpc-4609	42	2	included	include	VERB
dpc-4609	42	3	keywords	keyword	NOUN
dpc-4609	42	4	“	"	PUNCT
dpc-4609	42	5	dupilumab	dupilumab	NOUN
dpc-4609	42	6	”	"	PUNCT
dpc-4609	42	7	,	,	PUNCT
dpc-4609	42	8	“	"	PUNCT
dpc-4609	42	9	alopecia	alopecia	NOUN
dpc-4609	42	10	areata	areata	NOUN
dpc-4609	42	11	”	"	PUNCT
dpc-4609	42	12	,	,	PUNCT
dpc-4609	42	13	and	and	CCONJ
dpc-4609	42	14	“	"	PUNCT
dpc-4609	42	15	atopic	atopic	NOUN
dpc-4609	42	16	dermatitis	dermatitis	NOUN
dpc-4609	42	17	”	"	PUNCT
dpc-4609	42	18	.	.	PUNCT
dpc-4609	43	1	we	we	PRON
dpc-4609	43	2	included	include	VERB
dpc-4609	43	3	articles	article	NOUN
dpc-4609	43	4	written	write	VERB
dpc-4609	43	5	up	up	ADP
dpc-4609	43	6	to	to	ADP
dpc-4609	43	7	april	april	PROPN
dpc-4609	43	8	2024	2024	NUM
dpc-4609	43	9	.	.	PUNCT
dpc-4609	44	1	selected	select	VERB
dpc-4609	44	2	articles	article	NOUN
dpc-4609	44	3	were	be	AUX
dpc-4609	44	4	based	base	VERB
dpc-4609	44	5	on	on	ADP
dpc-4609	44	6	relevance	relevance	NOUN
dpc-4609	44	7	,	,	PUNCT
dpc-4609	44	8	focusing	focus	VERB
dpc-4609	44	9	on	on	ADP
dpc-4609	44	10	case	case	NOUN
dpc-4609	44	11	reports	report	NOUN
dpc-4609	44	12	,	,	PUNCT
dpc-4609	44	13	reviews	review	NOUN
dpc-4609	44	14	,	,	PUNCT
dpc-4609	44	15	and	and	CCONJ
dpc-4609	44	16	original	original	ADJ
dpc-4609	44	17	articles	article	NOUN
dpc-4609	44	18	.	.	PUNCT
dpc-4609	45	1	articles	article	NOUN
dpc-4609	45	2	that	that	PRON
dpc-4609	45	3	did	do	AUX
dpc-4609	45	4	not	not	PART
dpc-4609	45	5	provide	provide	VERB
dpc-4609	45	6	relevant	relevant	ADJ
dpc-4609	45	7	information	information	NOUN
dpc-4609	45	8	or	or	CCONJ
dpc-4609	45	9	were	be	AUX
dpc-4609	45	10	not	not	PART
dpc-4609	45	11	written	write	VERB
dpc-4609	45	12	in	in	ADP
dpc-4609	45	13	english	english	PROPN
dpc-4609	45	14	were	be	AUX
dpc-4609	45	15	excluded	exclude	VERB
dpc-4609	45	16	.	.	PUNCT
dpc-4609	46	1	subsequently	subsequently	ADV
dpc-4609	46	2	,	,	PUNCT
dpc-4609	46	3	we	we	PRON
dpc-4609	46	4	collected	collect	VERB
dpc-4609	46	5	all	all	DET
dpc-4609	46	6	data	datum	NOUN
dpc-4609	46	7	on	on	ADP
dpc-4609	46	8	patients	patient	NOUN
dpc-4609	46	9	demographic	demographic	ADJ
dpc-4609	46	10	characteristics	characteristic	NOUN
dpc-4609	46	11	,	,	PUNCT
dpc-4609	46	12	disease	disease	NOUN
dpc-4609	46	13	profile	profile	NOUN
dpc-4609	46	14	,	,	PUNCT
dpc-4609	46	15	and	and	CCONJ
dpc-4609	46	16	personal	personal	ADJ
dpc-4609	46	17	response	response	NOUN
dpc-4609	46	18	to	to	PART
dpc-4609	46	19	dupilumab	dupilumab	VERB
dpc-4609	46	20	.	.	PUNCT
dpc-4609	47	1	finally	finally	ADV
dpc-4609	47	2	,	,	PUNCT
dpc-4609	47	3	we	we	PRON
dpc-4609	47	4	divided	divide	VERB
dpc-4609	47	5	our	our	PRON
dpc-4609	47	6	findings	finding	NOUN
dpc-4609	47	7	into	into	ADP
dpc-4609	47	8	two	two	NUM
dpc-4609	47	9	different	different	ADJ
dpc-4609	47	10	categories	category	NOUN
dpc-4609	47	11	based	base	VERB
dpc-4609	47	12	on	on	ADP
dpc-4609	47	13	how	how	SCONJ
dpc-4609	47	14	dupilumab	dupilumab	NOUN
dpc-4609	47	15	affected	affect	VERB
dpc-4609	47	16	aa	aa	PROPN
dpc-4609	47	17	patients	patient	NOUN
dpc-4609	47	18	(	(	PUNCT
dpc-4609	47	19	tables	table	NOUN
dpc-4609	47	20	1	1	NUM
dpc-4609	47	21	and	and	CCONJ
dpc-4609	47	22	2	2	NUM
dpc-4609	47	23	)	)	PUNCT
dpc-4609	47	24	.	.	PUNCT
dpc-4609	48	1	results	result	VERB
dpc-4609	48	2	our	our	PRON
dpc-4609	48	3	review	review	NOUN
dpc-4609	48	4	of	of	ADP
dpc-4609	48	5	the	the	DET
dpc-4609	48	6	literature	literature	NOUN
dpc-4609	48	7	yielded	yield	VERB
dpc-4609	48	8	important	important	ADJ
dpc-4609	48	9	findings	finding	NOUN
dpc-4609	48	10	regarding	regard	VERB
dpc-4609	48	11	the	the	DET
dpc-4609	48	12	dual	dual	ADJ
dpc-4609	48	13	efficacy	efficacy	NOUN
dpc-4609	48	14	of	of	ADP
dpc-4609	48	15	dupilumab	dupilumab	NOUN
dpc-4609	48	16	in	in	ADP
dpc-4609	48	17	patients	patient	NOUN
dpc-4609	48	18	affected	affect	VERB
dpc-4609	48	19	with	with	ADP
dpc-4609	48	20	aa	aa	NOUN
dpc-4609	48	21	and	and	CCONJ
dpc-4609	48	22	ad	ad	NOUN
dpc-4609	48	23	.	.	PUNCT
dpc-4609	49	1	we	we	PRON
dpc-4609	49	2	found	find	VERB
dpc-4609	49	3	and	and	CCONJ
dpc-4609	49	4	analyzed	analyze	VERB
dpc-4609	49	5	a	a	DET
dpc-4609	49	6	total	total	NOUN
dpc-4609	49	7	of	of	ADP
dpc-4609	49	8	35	35	NUM
dpc-4609	49	9	relevant	relevant	ADJ
dpc-4609	49	10	articles	article	NOUN
dpc-4609	49	11	(	(	PUNCT
dpc-4609	49	12	tables	table	NOUN
dpc-4609	49	13	1	1	NUM
dpc-4609	49	14	and	and	CCONJ
dpc-4609	49	15	2	2	NUM
dpc-4609	49	16	)	)	PUNCT
dpc-4609	49	17	.	.	PUNCT
dpc-4609	50	1	among	among	ADP
dpc-4609	50	2	these	these	PRON
dpc-4609	50	3	,	,	PUNCT
dpc-4609	50	4	13	13	NUM
dpc-4609	50	5	cases	case	NOUN
dpc-4609	50	6	of	of	ADP
dpc-4609	50	7	aa	aa	NOUN
dpc-4609	50	8	worsened	worsen	VERB
dpc-4609	50	9	after	after	ADP
dpc-4609	50	10	dupilumab	dupilumab	NOUN
dpc-4609	50	11	(	(	PUNCT
dpc-4609	50	12	m	m	NOUN
dpc-4609	50	13	=	=	NOUN
dpc-4609	50	14	8	8	NUM
dpc-4609	50	15	;	;	PUNCT
dpc-4609	50	16	f	f	PROPN
dpc-4609	50	17	=	=	SYM
dpc-4609	50	18	5	5	NUM
dpc-4609	50	19	;	;	PUNCT
dpc-4609	50	20	mean	mean	VERB
dpc-4609	50	21	age	age	NOUN
dpc-4609	50	22	=	=	SYM
dpc-4609	50	23	32.8	32.8	NUM
dpc-4609	50	24	)	)	PUNCT
dpc-4609	50	25	,	,	PUNCT
dpc-4609	50	26	whilst	whilst	SCONJ
dpc-4609	50	27	38	38	NUM
dpc-4609	50	28	cases	case	NOUN
dpc-4609	50	29	of	of	ADP
dpc-4609	50	30	aa	aa	NOUN
dpc-4609	50	31	improved	improve	VERB
dpc-4609	50	32	after	after	ADP
dpc-4609	50	33	dupilumab	dupilumab	NOUN
dpc-4609	50	34	(	(	PUNCT
dpc-4609	50	35	m	m	NOUN
dpc-4609	50	36	=	=	NOUN
dpc-4609	50	37	18	18	NUM
dpc-4609	50	38	;	;	PUNCT
dpc-4609	50	39	f	f	X
dpc-4609	50	40	 	 	SPACE
dpc-4609	50	41	=	=	NOUN
dpc-4609	50	42	20	20	NUM
dpc-4609	50	43	;	;	PUNCT
dpc-4609	50	44	mean	mean	VERB
dpc-4609	50	45	age	age	NOUN
dpc-4609	50	46	=	=	SYM
dpc-4609	50	47	27.6	27.6	NUM
dpc-4609	50	48	)	)	PUNCT
dpc-4609	50	49	.	.	PUNCT
dpc-4609	51	1	the	the	DET
dpc-4609	51	2	clinical	clinical	ADJ
dpc-4609	51	3	characteristics	characteristic	NOUN
dpc-4609	51	4	of	of	ADP
dpc-4609	51	5	aa	aa	NOUN
dpc-4609	51	6	in	in	ADP
dpc-4609	51	7	patients	patient	NOUN
dpc-4609	51	8	who	who	PRON
dpc-4609	51	9	worsened	worsen	VERB
dpc-4609	51	10	after	after	ADP
dpc-4609	51	11	starting	start	VERB
dpc-4609	51	12	dupilumab	dupilumab	NOUN
dpc-4609	51	13	were	be	AUX
dpc-4609	51	14	mostly	mostly	ADV
dpc-4609	51	15	of	of	ADP
dpc-4609	51	16	a	a	DET
dpc-4609	51	17	patchy	patchy	ADJ
dpc-4609	51	18	alopecias	alopecia	NOUN
dpc-4609	51	19	(	(	PUNCT
dpc-4609	51	20	n	n	NOUN
dpc-4609	51	21	=	=	SYM
dpc-4609	51	22	9	9	NUM
dpc-4609	51	23	)	)	PUNCT
dpc-4609	51	24	,	,	PUNCT
dpc-4609	51	25	with	with	ADP
dpc-4609	51	26	three	three	NUM
dpc-4609	51	27	diffuse	diffuse	NOUN
dpc-4609	51	28	forms	form	NOUN
dpc-4609	51	29	and	and	CCONJ
dpc-4609	51	30	one	one	NUM
dpc-4609	51	31	case	case	NOUN
dpc-4609	51	32	of	of	ADP
dpc-4609	51	33	aa	aa	NOUN
dpc-4609	51	34	in	in	ADP
dpc-4609	51	35	androgenetic	androgenetic	ADJ
dpc-4609	51	36	alopecia	alopecia	NOUN
dpc-4609	51	37	pattern	pattern	NOUN
dpc-4609	51	38	.	.	PUNCT
dpc-4609	52	1	six	six	NUM
dpc-4609	52	2	patients	patient	NOUN
dpc-4609	52	3	had	have	VERB
dpc-4609	52	4	complete	complete	ADJ
dpc-4609	52	5	regrowth	regrowth	NOUN
dpc-4609	52	6	after	after	ADP
dpc-4609	52	7	discontinuation	discontinuation	NOUN
dpc-4609	52	8	of	of	ADP
dpc-4609	52	9	dupilumab	dupilumab	NOUN
dpc-4609	52	10	,	,	PUNCT
dpc-4609	52	11	whilst	whilst	SCONJ
dpc-4609	52	12	three	three	NUM
dpc-4609	52	13	patients	patient	NOUN
dpc-4609	52	14	had	have	VERB
dpc-4609	52	15	only	only	ADJ
dpc-4609	52	16	partial	partial	ADJ
dpc-4609	52	17	regrowth	regrowth	NOUN
dpc-4609	52	18	.	.	PUNCT
dpc-4609	53	1	two	two	NUM
dpc-4609	53	2	patients	patient	NOUN
dpc-4609	53	3	were	be	AUX
dpc-4609	53	4	still	still	ADV
dpc-4609	53	5	under	under	ADP
dpc-4609	53	6	treatment	treatment	NOUN
dpc-4609	53	7	at	at	ADP
dpc-4609	53	8	the	the	DET
dpc-4609	53	9	moment	moment	NOUN
dpc-4609	53	10	of	of	ADP
dpc-4609	53	11	the	the	DET
dpc-4609	53	12	publication	publication	NOUN
dpc-4609	53	13	of	of	ADP
dpc-4609	53	14	the	the	DET
dpc-4609	53	15	studies	study	NOUN
dpc-4609	53	16	,	,	PUNCT
dpc-4609	53	17	and	and	CCONJ
dpc-4609	53	18	two	two	NUM
dpc-4609	53	19	patients	patient	NOUN
dpc-4609	53	20	had	have	VERB
dpc-4609	53	21	no	no	DET
dpc-4609	53	22	information	information	NOUN
dpc-4609	53	23	about	about	ADP
dpc-4609	53	24	aa	aa	NOUN
dpc-4609	53	25	evolution	evolution	NOUN
dpc-4609	53	26	after	after	ADP
dpc-4609	53	27	the	the	DET
dpc-4609	53	28	modification	modification	NOUN
dpc-4609	53	29	of	of	ADP
dpc-4609	53	30	dupilumab	dupilumab	NOUN
dpc-4609	53	31	therapy	therapy	NOUN
dpc-4609	53	32	(	(	PUNCT
dpc-4609	53	33	table	table	NOUN
dpc-4609	53	34	1	1	NUM
dpc-4609	53	35	)	)	PUNCT
dpc-4609	53	36	.	.	PUNCT
dpc-4609	54	1	regarding	regard	VERB
dpc-4609	54	2	the	the	DET
dpc-4609	54	3	cohort	cohort	NOUN
dpc-4609	54	4	of	of	ADP
dpc-4609	54	5	patients	patient	NOUN
dpc-4609	54	6	that	that	PRON
dpc-4609	54	7	experienced	experience	VERB
dpc-4609	54	8	hair	hair	NOUN
dpc-4609	54	9	regrowth	regrowth	NOUN
dpc-4609	54	10	after	after	ADP
dpc-4609	54	11	starting	start	VERB
dpc-4609	54	12	dupilumab	dupilumab	NOUN
dpc-4609	54	13	,	,	PUNCT
dpc-4609	54	14	eleven	eleven	NUM
dpc-4609	54	15	patients	patient	NOUN
dpc-4609	54	16	had	have	VERB
dpc-4609	54	17	alopecia	alopecia	NOUN
dpc-4609	54	18	areata	areata	ADJ
dpc-4609	54	19	universalis	universali	NOUN
dpc-4609	54	20	(	(	PUNCT
dpc-4609	54	21	aau	aau	PROPN
dpc-4609	54	22	)	)	PUNCT
dpc-4609	54	23	,	,	PUNCT
dpc-4609	54	24	nine	nine	NUM
dpc-4609	54	25	patients	patient	NOUN
dpc-4609	54	26	had	have	VERB
dpc-4609	54	27	alopecia	alopecia	NOUN
dpc-4609	54	28	areata	areata	ADJ
dpc-4609	54	29	totalis	totalis	PROPN
dpc-4609	54	30	(	(	PUNCT
dpc-4609	54	31	aat	aat	PROPN
dpc-4609	54	32	)	)	PUNCT
dpc-4609	54	33	,	,	PUNCT
dpc-4609	54	34	three	three	NUM
dpc-4609	54	35	patients	patient	NOUN
dpc-4609	54	36	had	have	VERB
dpc-4609	54	37	alopecia	alopecia	NOUN
dpc-4609	54	38	areata	areata	ADJ
dpc-4609	54	39	subtotalis	subtotali	NOUN
dpc-4609	54	40	(	(	PUNCT
dpc-4609	54	41	aa	aa	NOUN
dpc-4609	54	42	with	with	ADP
dpc-4609	54	43	a	a	DET
dpc-4609	54	44	salt	salt	NOUN
dpc-4609	54	45	score	score	NOUN
dpc-4609	54	46	greater	great	ADJ
dpc-4609	54	47	than	than	ADP
dpc-4609	54	48	80	80	NUM
dpc-4609	54	49	%	%	NOUN
dpc-4609	54	50	and	and	CCONJ
dpc-4609	54	51	less	less	ADJ
dpc-4609	54	52	than	than	ADP
dpc-4609	54	53	100	100	NUM
dpc-4609	54	54	%	%	NOUN
dpc-4609	54	55	)	)	PUNCT
dpc-4609	54	56	,	,	PUNCT
dpc-4609	54	57	and	and	CCONJ
dpc-4609	54	58	15	15	NUM
dpc-4609	54	59	patients	patient	NOUN
dpc-4609	54	60	had	have	VERB
dpc-4609	54	61	a	a	DET
dpc-4609	54	62	patchy	patchy	ADJ
dpc-4609	54	63	alopecia	alopecia	NOUN
dpc-4609	54	64	.	.	PUNCT
dpc-4609	55	1	eleven	eleven	NUM
dpc-4609	55	2	patients	patient	NOUN
dpc-4609	55	3	were	be	AUX
dpc-4609	55	4	associated	associate	VERB
dpc-4609	55	5	with	with	ADP
dpc-4609	55	6	full	full	ADJ
dpc-4609	55	7	regrowth	regrowth	NOUN
dpc-4609	55	8	,	,	PUNCT
dpc-4609	55	9	whereas	whereas	SCONJ
dpc-4609	55	10	nine	nine	NUM
dpc-4609	55	11	patients	patient	NOUN
dpc-4609	55	12	reported	report	VERB
dpc-4609	55	13	partial	partial	ADJ
dpc-4609	55	14	regrowth	regrowth	NOUN
dpc-4609	55	15	(	(	PUNCT
dpc-4609	55	16	one	one	NUM
dpc-4609	55	17	of	of	ADP
dpc-4609	55	18	them	they	PRON
dpc-4609	55	19	had	have	AUX
dpc-4609	55	20	a	a	DET
dpc-4609	55	21	worsening	worsening	NOUN
dpc-4609	55	22	of	of	ADP
dpc-4609	55	23	aa	aa	PROPN
dpc-4609	55	24	partial	partial	ADJ
dpc-4609	55	25	regrowth	regrowth	NOUN
dpc-4609	55	26	after	after	ADP
dpc-4609	55	27	dupilumab	dupilumab	NOUN
dpc-4609	55	28	suspension	suspension	NOUN
dpc-4609	55	29	)	)	PUNCT
dpc-4609	55	30	(	(	PUNCT
dpc-4609	55	31	table	table	NOUN
dpc-4609	55	32	2	2	NUM
dpc-4609	55	33	)	)	PUNCT
dpc-4609	55	34	.	.	PUNCT
dpc-4609	56	1	discussion	discussion	NOUN
dpc-4609	56	2	the	the	DET
dpc-4609	56	3	results	result	NOUN
dpc-4609	56	4	of	of	ADP
dpc-4609	56	5	our	our	PRON
dpc-4609	56	6	literature	literature	NOUN
dpc-4609	56	7	review	review	NOUN
dpc-4609	56	8	provide	provide	VERB
dpc-4609	56	9	interesting	interesting	ADJ
dpc-4609	56	10	insights	insight	NOUN
dpc-4609	56	11	into	into	ADP
dpc-4609	56	12	the	the	DET
dpc-4609	56	13	dual	dual	ADJ
dpc-4609	56	14	impact	impact	NOUN
dpc-4609	56	15	of	of	ADP
dpc-4609	56	16	dupilumab	dupilumab	NOUN
dpc-4609	56	17	on	on	ADP
dpc-4609	56	18	patients	patient	NOUN
dpc-4609	56	19	affected	affect	VERB
dpc-4609	56	20	by	by	ADP
dpc-4609	56	21	aa	aa	NOUN
dpc-4609	56	22	and	and	CCONJ
dpc-4609	56	23	ad	ad	NOUN
dpc-4609	56	24	.	.	PUNCT
dpc-4609	57	1	we	we	PRON
dpc-4609	57	2	reviewed	review	VERB
dpc-4609	57	3	35	35	NUM
dpc-4609	57	4	relevant	relevant	ADJ
dpc-4609	57	5	articles	article	NOUN
dpc-4609	57	6	exploring	explore	VERB
dpc-4609	57	7	the	the	DET
dpc-4609	57	8	relationship	relationship	NOUN
dpc-4609	57	9	between	between	ADP
dpc-4609	57	10	these	these	DET
dpc-4609	57	11	conditions	condition	NOUN
dpc-4609	57	12	and	and	CCONJ
dpc-4609	57	13	the	the	DET
dpc-4609	57	14	role	role	NOUN
dpc-4609	57	15	of	of	ADP
dpc-4609	57	16	dupilumab	dupilumab	NOUN
dpc-4609	57	17	(	(	PUNCT
dpc-4609	57	18	tables	table	NOUN
dpc-4609	57	19	1	1	NUM
dpc-4609	57	20	and	and	CCONJ
dpc-4609	57	21	2	2	NUM
dpc-4609	57	22	)	)	PUNCT
dpc-4609	57	23	.	.	PUNCT
dpc-4609	58	1	our	our	PRON
dpc-4609	58	2	analysis	analysis	NOUN
dpc-4609	58	3	revealed	reveal	VERB
dpc-4609	58	4	that	that	SCONJ
dpc-4609	58	5	13	13	NUM
dpc-4609	58	6	cases	case	NOUN
dpc-4609	58	7	of	of	ADP
dpc-4609	58	8	aa	aa	NOUN
dpc-4609	58	9	worsened	worsen	VERB
dpc-4609	58	10	after	after	ADP
dpc-4609	58	11	starting	start	VERB
dpc-4609	58	12	dupilumab	dupilumab	NOUN
dpc-4609	58	13	,	,	PUNCT
dpc-4609	58	14	whereas	whereas	SCONJ
dpc-4609	58	15	38	38	NUM
dpc-4609	58	16	cases	case	NOUN
dpc-4609	58	17	of	of	ADP
dpc-4609	58	18	aa	aa	NOUN
dpc-4609	58	19	showed	show	VERB
dpc-4609	58	20	improvement	improvement	NOUN
dpc-4609	58	21	(	(	PUNCT
dpc-4609	58	22	tables	table	NOUN
dpc-4609	58	23	1	1	NUM
dpc-4609	58	24	and	and	CCONJ
dpc-4609	58	25	2	2	NUM
dpc-4609	58	26	)	)	PUNCT
dpc-4609	58	27	.	.	PUNCT
dpc-4609	59	1	this	this	PRON
dpc-4609	59	2	showcases	showcase	VERB
dpc-4609	59	3	how	how	SCONJ
dpc-4609	59	4	the	the	DET
dpc-4609	59	5	efficacy	efficacy	NOUN
dpc-4609	59	6	of	of	ADP
dpc-4609	59	7	dupilumab	dupilumab	NOUN
dpc-4609	59	8	in	in	ADP
dpc-4609	59	9	aa	aa	PROPN
dpc-4609	59	10	can	can	AUX
dpc-4609	59	11	be	be	AUX
dpc-4609	59	12	variable	variable	ADJ
dpc-4609	59	13	,	,	PUNCT
dpc-4609	59	14	likely	likely	ADJ
dpc-4609	59	15	due	due	ADP
dpc-4609	59	16	to	to	ADP
dpc-4609	59	17	individual	individual	ADJ
dpc-4609	59	18	factors	factor	NOUN
dpc-4609	59	19	.	.	PUNCT
dpc-4609	60	1	patients	patient	NOUN
dpc-4609	60	2	who	who	PRON
dpc-4609	60	3	experienced	experience	VERB
dpc-4609	60	4	a	a	DET
dpc-4609	60	5	worsening	worsening	NOUN
dpc-4609	60	6	of	of	ADP
dpc-4609	60	7	their	their	PRON
dpc-4609	60	8	condition	condition	NOUN
dpc-4609	60	9	were	be	AUX
dpc-4609	60	10	predominantly	predominantly	ADV
dpc-4609	60	11	male	male	ADJ
dpc-4609	60	12	,	,	PUNCT
dpc-4609	60	13	with	with	ADP
dpc-4609	60	14	patchy	patchy	ADJ
dpc-4609	60	15	alopecia	alopecia	NOUN
dpc-4609	60	16	.	.	PUNCT
dpc-4609	61	1	the	the	DET
dpc-4609	61	2	worsening	worsen	VERB
dpc-4609	61	3	typically	typically	ADV
dpc-4609	61	4	began	begin	VERB
dpc-4609	61	5	around	around	ADP
dpc-4609	61	6	17	17	NUM
dpc-4609	61	7	weeks	week	NOUN
dpc-4609	61	8	after	after	ADP
dpc-4609	61	9	starting	start	VERB
dpc-4609	61	10	the	the	DET
dpc-4609	61	11	drug	drug	NOUN
dpc-4609	61	12	;	;	PUNCT
dpc-4609	61	13	however	however	ADV
dpc-4609	61	14	,	,	PUNCT
dpc-4609	61	15	some	some	PRON
dpc-4609	61	16	of	of	ADP
dpc-4609	61	17	these	these	DET
dpc-4609	61	18	patients	patient	NOUN
dpc-4609	61	19	experienced	experience	VERB
dpc-4609	61	20	hair	hair	NOUN
dpc-4609	61	21	regrowth	regrowth	NOUN
dpc-4609	61	22	after	after	ADP
dpc-4609	61	23	discontinuing	discontinue	VERB
dpc-4609	61	24	dupilumab	dupilumab	NOUN
dpc-4609	61	25	(	(	PUNCT
dpc-4609	61	26	table	table	NOUN
dpc-4609	61	27	1	1	NUM
dpc-4609	61	28	)	)	PUNCT
dpc-4609	61	29	.	.	PUNCT
dpc-4609	62	1	on	on	ADP
dpc-4609	62	2	the	the	DET
dpc-4609	62	3	other	other	ADJ
dpc-4609	62	4	hand	hand	NOUN
dpc-4609	62	5	,	,	PUNCT
dpc-4609	62	6	patients	patient	NOUN
dpc-4609	62	7	who	who	PRON
dpc-4609	62	8	showed	show	VERB
dpc-4609	62	9	improvement	improvement	NOUN
dpc-4609	62	10	in	in	ADP
dpc-4609	62	11	aa	aa	NOUN
dpc-4609	62	12	after	after	ADP
dpc-4609	62	13	starting	start	VERB
dpc-4609	62	14	dupilumab	dupilumab	NOUN
dpc-4609	62	15	were	be	AUX
dpc-4609	62	16	mostly	mostly	ADV
dpc-4609	62	17	female	female	ADJ
dpc-4609	62	18	,	,	PUNCT
dpc-4609	62	19	with	with	ADP
dpc-4609	62	20	a	a	DET
dpc-4609	62	21	broader	broad	ADJ
dpc-4609	62	22	range	range	NOUN
dpc-4609	62	23	of	of	ADP
dpc-4609	62	24	severity	severity	NOUN
dpc-4609	62	25	(	(	PUNCT
dpc-4609	62	26	from	from	ADP
dpc-4609	62	27	patchy	patchy	ADJ
dpc-4609	62	28	alopecia	alopecia	NOUN
dpc-4609	62	29	to	to	ADP
dpc-4609	62	30	aau	aau	PROPN
dpc-4609	62	31	)	)	PUNCT
dpc-4609	62	32	.	.	PUNCT
dpc-4609	63	1	a	a	DET
dpc-4609	63	2	significant	significant	ADJ
dpc-4609	63	3	number	number	NOUN
dpc-4609	63	4	of	of	ADP
dpc-4609	63	5	these	these	DET
dpc-4609	63	6	patients	patient	NOUN
dpc-4609	63	7	experienced	experience	VERB
dpc-4609	63	8	full	full	ADJ
dpc-4609	63	9	hair	hair	NOUN
dpc-4609	63	10	regrowth	regrowth	NOUN
dpc-4609	63	11	,	,	PUNCT
dpc-4609	63	12	suggesting	suggest	VERB
dpc-4609	63	13	that	that	DET
dpc-4609	63	14	dupilumab	dupilumab	NOUN
dpc-4609	63	15	could	could	AUX
dpc-4609	63	16	help	help	VERB
dpc-4609	63	17	promote	promote	VERB
dpc-4609	63	18	hair	hair	NOUN
dpc-4609	63	19	regrowth	regrowth	NOUN
dpc-4609	63	20	in	in	ADP
dpc-4609	63	21	specific	specific	ADJ
dpc-4609	63	22	aa	aa	NOUN
dpc-4609	63	23	cases	case	NOUN
dpc-4609	63	24	(	(	PUNCT
dpc-4609	63	25	table	table	NOUN
dpc-4609	63	26	 	 	SPACE
dpc-4609	63	27	2	2	NUM
dpc-4609	63	28	)	)	PUNCT
dpc-4609	64	1	[	[	X
dpc-4609	64	2	6	6	NUM
dpc-4609	64	3	-	-	SYM
dpc-4609	64	4	36	36	NUM
dpc-4609	64	5	]	]	PUNCT
dpc-4609	64	6	.	.	PUNCT
dpc-4609	65	1	dupilumab	dupilumab	NOUN
dpc-4609	65	2	provides	provide	VERB
dpc-4609	65	3	a	a	DET
dpc-4609	65	4	distinct	distinct	ADJ
dpc-4609	65	5	perspective	perspective	NOUN
dpc-4609	65	6	on	on	ADP
dpc-4609	65	7	the	the	DET
dpc-4609	65	8	interplay	interplay	NOUN
dpc-4609	65	9	between	between	ADP
dpc-4609	65	10	aa	aa	NOUN
dpc-4609	65	11	and	and	CCONJ
dpc-4609	65	12	ad	ad	NOUN
dpc-4609	65	13	.	.	PUNCT
dpc-4609	66	1	the	the	DET
dpc-4609	66	2	literature	literature	NOUN
dpc-4609	66	3	suggests	suggest	VERB
dpc-4609	66	4	that	that	SCONJ
dpc-4609	66	5	this	this	DET
dpc-4609	66	6	review	review	NOUN
dpc-4609	66	7	|	|	ADV
dpc-4609	66	8	dermatol	dermatol	ADJ
dpc-4609	66	9	pract	pract	NOUN
dpc-4609	66	10	concept	concept	NOUN
dpc-4609	66	11	.	.	PUNCT
dpc-4609	67	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	67	2	3	3	NUM
dpc-4609	67	3	drug	drug	NOUN
dpc-4609	67	4	can	can	AUX
dpc-4609	67	5	have	have	VERB
dpc-4609	67	6	a	a	DET
dpc-4609	67	7	dual	dual	ADJ
dpc-4609	67	8	effect	effect	NOUN
dpc-4609	67	9	on	on	ADP
dpc-4609	67	10	these	these	DET
dpc-4609	67	11	conditions	condition	NOUN
dpc-4609	67	12	,	,	PUNCT
dpc-4609	67	13	possibly	possibly	ADV
dpc-4609	67	14	due	due	ADP
dpc-4609	67	15	to	to	ADP
dpc-4609	67	16	its	its	PRON
dpc-4609	67	17	suppression	suppression	NOUN
dpc-4609	67	18	of	of	ADP
dpc-4609	67	19	th2	th2	PROPN
dpc-4609	67	20	-	-	PUNCT
dpc-4609	67	21	axis	axis	ADJ
dpc-4609	67	22	inflammation	inflammation	NOUN
dpc-4609	67	23	[	[	X
dpc-4609	67	24	6	6	NUM
dpc-4609	67	25	-	-	SYM
dpc-4609	67	26	36	36	NUM
dpc-4609	67	27	]	]	PUNCT
dpc-4609	67	28	.	.	PUNCT
dpc-4609	68	1	on	on	ADP
dpc-4609	68	2	this	this	DET
dpc-4609	68	3	matter	matter	NOUN
dpc-4609	68	4	,	,	PUNCT
dpc-4609	68	5	recent	recent	ADJ
dpc-4609	68	6	research	research	NOUN
dpc-4609	68	7	indicates	indicate	VERB
dpc-4609	68	8	that	that	SCONJ
dpc-4609	68	9	aa	aa	PROPN
dpc-4609	68	10	may	may	AUX
dpc-4609	68	11	be	be	AUX
dpc-4609	68	12	linked	link	VERB
dpc-4609	68	13	to	to	ADP
dpc-4609	68	14	two	two	NUM
dpc-4609	68	15	distinct	distinct	ADJ
dpc-4609	68	16	pathogenetic	pathogenetic	ADJ
dpc-4609	68	17	pathways	pathway	NOUN
dpc-4609	68	18	:	:	PUNCT
dpc-4609	68	19	a	a	DET
dpc-4609	68	20	th1	th1	PROPN
dpc-4609	68	21	-	-	PUNCT
dpc-4609	68	22	skewed	skewed	ADJ
dpc-4609	68	23	and	and	CCONJ
dpc-4609	68	24	a	a	DET
dpc-4609	68	25	th2	th2	PROPN
dpc-4609	68	26	-	-	PUNCT
dpc-4609	68	27	skewed	skewed	ADJ
dpc-4609	68	28	mechanism	mechanism	NOUN
dpc-4609	68	29	[	[	X
dpc-4609	68	30	3	3	NUM
dpc-4609	68	31	]	]	PUNCT
dpc-4609	68	32	.	.	PUNCT
dpc-4609	69	1	the	the	DET
dpc-4609	69	2	existence	existence	NOUN
dpc-4609	69	3	of	of	ADP
dpc-4609	69	4	two	two	NUM
dpc-4609	69	5	different	different	ADJ
dpc-4609	69	6	pathways	pathway	NOUN
dpc-4609	69	7	may	may	AUX
dpc-4609	69	8	explain	explain	VERB
dpc-4609	69	9	the	the	DET
dpc-4609	69	10	opposing	opposing	ADJ
dpc-4609	69	11	responses	response	NOUN
dpc-4609	69	12	to	to	ADP
dpc-4609	69	13	dupilumab	dupilumab	NOUN
dpc-4609	69	14	observed	observe	VERB
dpc-4609	69	15	in	in	ADP
dpc-4609	69	16	aa	aa	PROPN
dpc-4609	69	17	patients	patient	NOUN
dpc-4609	69	18	.	.	PUNCT
dpc-4609	70	1	in	in	ADP
dpc-4609	70	2	individuals	individual	NOUN
dpc-4609	70	3	with	with	ADP
dpc-4609	70	4	th2	th2	PROPN
dpc-4609	70	5	-	-	PUNCT
dpc-4609	70	6	skewed	skewed	ADJ
dpc-4609	70	7	aa	aa	NOUN
dpc-4609	70	8	,	,	PUNCT
dpc-4609	70	9	inhibiting	inhibit	VERB
dpc-4609	70	10	th2	th2	PROPN
dpc-4609	70	11	inflammation	inflammation	NOUN
dpc-4609	70	12	with	with	ADP
dpc-4609	70	13	dupilumab	dupilumab	NOUN
dpc-4609	70	14	can	can	AUX
dpc-4609	70	15	lead	lead	VERB
dpc-4609	70	16	to	to	ADP
dpc-4609	70	17	hair	hair	NOUN
dpc-4609	70	18	regrowth	regrowth	NOUN
dpc-4609	70	19	.	.	PUNCT
dpc-4609	71	1	however	however	ADV
dpc-4609	71	2	,	,	PUNCT
dpc-4609	71	3	for	for	ADP
dpc-4609	71	4	patients	patient	NOUN
dpc-4609	71	5	with	with	ADP
dpc-4609	71	6	th1	th1	PROPN
dpc-4609	71	7	-	-	PUNCT
dpc-4609	71	8	skewed	skewed	ADJ
dpc-4609	71	9	aa	aa	NOUN
dpc-4609	71	10	,	,	PUNCT
dpc-4609	71	11	dupilumab	dupilumab	NOUN
dpc-4609	71	12	-	-	PUNCT
dpc-4609	71	13	induced	induce	VERB
dpc-4609	71	14	suppression	suppression	NOUN
dpc-4609	71	15	of	of	ADP
dpc-4609	71	16	th2	th2	PROPN
dpc-4609	71	17	may	may	AUX
dpc-4609	71	18	exacerbate	exacerbate	VERB
dpc-4609	71	19	th1	th1	NOUN
dpc-4609	71	20	-	-	PUNCT
dpc-4609	71	21	driven	drive	VERB
dpc-4609	71	22	inflammation	inflammation	NOUN
dpc-4609	71	23	,	,	PUNCT
dpc-4609	71	24	resulting	result	VERB
dpc-4609	71	25	in	in	ADP
dpc-4609	71	26	hair	hair	NOUN
dpc-4609	71	27	loss	loss	NOUN
dpc-4609	71	28	[	[	X
dpc-4609	71	29	37	37	NUM
dpc-4609	71	30	-	-	SYM
dpc-4609	71	31	39	39	NUM
dpc-4609	71	32	]	]	PUNCT
dpc-4609	71	33	.	.	PUNCT
dpc-4609	72	1	additionally	additionally	ADV
dpc-4609	72	2	,	,	PUNCT
dpc-4609	72	3	marks	mark	VERB
dpc-4609	72	4	et	et	PROPN
dpc-4609	72	5	al	al	PROPN
dpc-4609	72	6	.	.	PROPN
dpc-4609	72	7	observed	observe	VERB
dpc-4609	72	8	that	that	SCONJ
dpc-4609	72	9	female	female	ADJ
dpc-4609	72	10	patients	patient	NOUN
dpc-4609	72	11	are	be	AUX
dpc-4609	72	12	more	more	ADV
dpc-4609	72	13	likely	likely	ADJ
dpc-4609	72	14	to	to	PART
dpc-4609	72	15	have	have	VERB
dpc-4609	72	16	a	a	DET
dpc-4609	72	17	th2	th2	PROPN
dpc-4609	72	18	-	-	PUNCT
dpc-4609	72	19	skewed	skewed	ADJ
dpc-4609	72	20	condition	condition	NOUN
dpc-4609	72	21	,	,	PUNCT
dpc-4609	72	22	while	while	SCONJ
dpc-4609	72	23	males	male	NOUN
dpc-4609	72	24	are	be	AUX
dpc-4609	72	25	more	more	ADV
dpc-4609	72	26	often	often	ADV
dpc-4609	72	27	associated	associate	VERB
dpc-4609	72	28	with	with	ADP
dpc-4609	72	29	a	a	DET
dpc-4609	72	30	th1	th1	NOUN
dpc-4609	72	31	-	-	PUNCT
dpc-4609	72	32	skewed	skewed	ADJ
dpc-4609	72	33	condition	condition	NOUN
dpc-4609	72	34	.	.	PUNCT
dpc-4609	73	1	this	this	PRON
dpc-4609	73	2	is	be	AUX
dpc-4609	73	3	also	also	ADV
dpc-4609	73	4	demonstrated	demonstrate	VERB
dpc-4609	73	5	by	by	ADP
dpc-4609	73	6	our	our	PRON
dpc-4609	73	7	data	datum	NOUN
dpc-4609	73	8	,	,	PUNCT
dpc-4609	73	9	as	as	SCONJ
dpc-4609	73	10	the	the	DET
dpc-4609	73	11	cohort	cohort	NOUN
dpc-4609	73	12	of	of	ADP
dpc-4609	73	13	patients	patient	NOUN
dpc-4609	73	14	who	who	PRON
dpc-4609	73	15	improved	improve	VERB
dpc-4609	73	16	were	be	AUX
dpc-4609	73	17	predominantly	predominantly	ADV
dpc-4609	73	18	female	female	ADJ
dpc-4609	73	19	(	(	PUNCT
dpc-4609	73	20	th2	th2	PROPN
dpc-4609	73	21	-	-	PUNCT
dpc-4609	73	22	skewed	skewed	ADJ
dpc-4609	73	23	)	)	PUNCT
dpc-4609	73	24	,	,	PUNCT
dpc-4609	73	25	and	and	CCONJ
dpc-4609	73	26	those	those	PRON
dpc-4609	73	27	who	who	PRON
dpc-4609	73	28	worsened	worsen	VERB
dpc-4609	73	29	were	be	AUX
dpc-4609	73	30	mostly	mostly	ADV
dpc-4609	73	31	male	male	ADJ
dpc-4609	73	32	(	(	PUNCT
dpc-4609	73	33	th1	th1	NOUN
dpc-4609	73	34	-	-	PUNCT
dpc-4609	73	35	skewed	skewed	ADJ
dpc-4609	73	36	)	)	PUNCT
dpc-4609	74	1	[	[	X
dpc-4609	74	2	37	37	NUM
dpc-4609	74	3	]	]	PUNCT
dpc-4609	74	4	.	.	PUNCT
dpc-4609	75	1	future	future	ADJ
dpc-4609	75	2	research	research	NOUN
dpc-4609	75	3	could	could	AUX
dpc-4609	75	4	focus	focus	VERB
dpc-4609	75	5	on	on	ADP
dpc-4609	75	6	better	well	ADV
dpc-4609	75	7	identifying	identify	VERB
dpc-4609	75	8	the	the	DET
dpc-4609	75	9	underlying	underlying	ADJ
dpc-4609	75	10	pathogenic	pathogenic	ADJ
dpc-4609	75	11	mechanism	mechanism	NOUN
dpc-4609	75	12	in	in	ADP
dpc-4609	75	13	aa	aa	PROPN
dpc-4609	75	14	patients	patient	NOUN
dpc-4609	75	15	,	,	PUNCT
dpc-4609	75	16	leading	lead	VERB
dpc-4609	75	17	to	to	ADP
dpc-4609	75	18	patient	patient	NOUN
dpc-4609	75	19	-	-	PUNCT
dpc-4609	75	20	tailored	tailor	VERB
dpc-4609	75	21	treatment	treatment	NOUN
dpc-4609	75	22	.	.	PUNCT
dpc-4609	76	1	dupilumab	dupilumab	NOUN
dpc-4609	76	2	has	have	AUX
dpc-4609	76	3	shown	show	VERB
dpc-4609	76	4	efficacy	efficacy	NOUN
dpc-4609	76	5	in	in	ADP
dpc-4609	76	6	treating	treat	VERB
dpc-4609	76	7	aa	aa	NOUN
dpc-4609	76	8	in	in	ADP
dpc-4609	76	9	children	child	NOUN
dpc-4609	76	10	(	(	PUNCT
dpc-4609	76	11	<	<	X
dpc-4609	76	12	18	18	NUM
dpc-4609	76	13	years	year	NOUN
dpc-4609	76	14	old	old	ADJ
dpc-4609	76	15	)	)	PUNCT
dpc-4609	76	16	;	;	PUNCT
dpc-4609	76	17	indeed	indeed	ADV
dpc-4609	76	18	,	,	PUNCT
dpc-4609	76	19	as	as	SCONJ
dpc-4609	76	20	displayed	display	VERB
dpc-4609	76	21	in	in	ADP
dpc-4609	76	22	our	our	PRON
dpc-4609	76	23	dataset	dataset	NOUN
dpc-4609	76	24	,	,	PUNCT
dpc-4609	76	25	16	16	NUM
dpc-4609	76	26	children	child	NOUN
dpc-4609	76	27	experienced	experience	VERB
dpc-4609	76	28	hair	hair	NOUN
dpc-4609	76	29	regrowth	regrowth	NOUN
dpc-4609	76	30	after	after	ADP
dpc-4609	76	31	taking	take	VERB
dpc-4609	76	32	dupilumab	dupilumab	NOUN
dpc-4609	76	33	,	,	PUNCT
dpc-4609	76	34	while	while	SCONJ
dpc-4609	76	35	only	only	ADV
dpc-4609	76	36	mckenzie	mckenzie	PROPN
dpc-4609	76	37	et	et	PROPN
dpc-4609	76	38	al	al	PROPN
dpc-4609	76	39	.	.	PROPN
dpc-4609	76	40	reported	report	VERB
dpc-4609	76	41	two	two	NUM
dpc-4609	76	42	patients	patient	NOUN
dpc-4609	76	43	with	with	ADP
dpc-4609	76	44	worsening	worsen	VERB
dpc-4609	76	45	table	table	NOUN
dpc-4609	76	46	1	1	NUM
dpc-4609	76	47	.	.	PUNCT
dpc-4609	76	48	cases	case	NOUN
dpc-4609	76	49	of	of	ADP
dpc-4609	76	50	aa	aa	NOUN
dpc-4609	76	51	worsening	worsen	VERB
dpc-4609	76	52	after	after	ADP
dpc-4609	76	53	dupilumab	dupilumab	NOUN
dpc-4609	76	54	.	.	PUNCT
dpc-4609	77	1	no	no	PRON
dpc-4609	77	2	of	of	ADP
dpc-4609	77	3	patients	patient	NOUN
dpc-4609	77	4	sex	sex	NOUN
dpc-4609	77	5	(	(	PUNCT
dpc-4609	77	6	m	m	NOUN
dpc-4609	77	7	/	/	SYM
dpc-4609	77	8	f	f	NOUN
dpc-4609	77	9	)	)	PUNCT
dpc-4609	77	10	age	age	NOUN
dpc-4609	77	11	clinical	clinical	ADJ
dpc-4609	77	12	characteristics	characteristic	NOUN
dpc-4609	77	13	of	of	ADP
dpc-4609	77	14	aa	aa	NOUN
dpc-4609	77	15	/	/	SYM
dpc-4609	77	16	onset	onset	NOUN
dpc-4609	77	17	after	after	ADP
dpc-4609	77	18	dupilumab	dupilumab	NOUN
dpc-4609	77	19	clinical	clinical	ADJ
dpc-4609	77	20	course	course	NOUN
dpc-4609	77	21	after	after	ADP
dpc-4609	77	22	steroid	steroid	NOUN
dpc-4609	77	23	treatment	treatment	NOUN
dpc-4609	77	24	/	/	SYM
dpc-4609	77	25	cya	cya	NOUN
dpc-4609	77	26	/	/	SYM
dpc-4609	77	27	dupilumab	dupilumab	NOUN
dpc-4609	77	28	discontinuation	discontinuation	NOUN
dpc-4609	77	29	reference	reference	NOUN
dpc-4609	77	30	1	1	NUM
dpc-4609	77	31	m	m	NUM
dpc-4609	77	32	29	29	NUM
dpc-4609	77	33	aa	aa	NOUN
dpc-4609	77	34	in	in	ADP
dpc-4609	77	35	patches	patch	NOUN
dpc-4609	77	36	–	–	PUNCT
dpc-4609	77	37	5	5	NUM
dpc-4609	77	38	weeks	week	NOUN
dpc-4609	77	39	partial	partial	ADJ
dpc-4609	77	40	regrowth	regrowth	NOUN
dpc-4609	77	41	(	(	PUNCT
dpc-4609	77	42	undergoing	undergo	VERB
dpc-4609	77	43	treatment	treatment	NOUN
dpc-4609	77	44	at	at	ADP
dpc-4609	77	45	the	the	DET
dpc-4609	77	46	moment	moment	NOUN
dpc-4609	77	47	of	of	ADP
dpc-4609	77	48	the	the	DET
dpc-4609	77	49	publication	publication	NOUN
dpc-4609	77	50	of	of	ADP
dpc-4609	77	51	the	the	DET
dpc-4609	77	52	article	article	NOUN
dpc-4609	77	53	)	)	PUNCT
dpc-4609	77	54	mitchell	mitchell	PROPN
dpc-4609	77	55	k	k	PROPN
dpc-4609	77	56	et	et	PROPN
dpc-4609	77	57	al	al	PROPN
dpc-4609	77	58	.	.	PROPN
dpc-4609	78	1	(	(	PUNCT
dpc-4609	78	2	2018	2018	NUM
dpc-4609	78	3	)	)	PUNCT
dpc-4609	78	4	1	1	NUM
dpc-4609	78	5	m	m	NUM
dpc-4609	78	6	31	31	NUM
dpc-4609	78	7	aa	aa	NOUN
dpc-4609	78	8	in	in	ADP
dpc-4609	78	9	patches	patch	NOUN
dpc-4609	78	10	on	on	ADP
dpc-4609	78	11	the	the	DET
dpc-4609	78	12	anterior	anterior	ADJ
dpc-4609	78	13	scalp	scalp	NOUN
dpc-4609	78	14	–	–	PUNCT
dpc-4609	78	15	6	6	NUM
dpc-4609	78	16	weeks	week	NOUN
dpc-4609	78	17	undergoing	undergo	VERB
dpc-4609	78	18	treatment	treatment	NOUN
dpc-4609	78	19	at	at	ADP
dpc-4609	78	20	the	the	DET
dpc-4609	78	21	moment	moment	NOUN
dpc-4609	78	22	of	of	ADP
dpc-4609	78	23	the	the	DET
dpc-4609	78	24	publication	publication	NOUN
dpc-4609	78	25	of	of	ADP
dpc-4609	78	26	the	the	DET
dpc-4609	78	27	article	article	NOUN
dpc-4609	78	28	barroso	barroso	PROPN
dpc-4609	78	29	-	-	PUNCT
dpc-4609	78	30	garcia	garcia	PROPN
dpc-4609	78	31	et	et	PROPN
dpc-4609	78	32	al	al	PROPN
dpc-4609	78	33	.	.	PROPN
dpc-4609	79	1	(	(	PUNCT
dpc-4609	79	2	2018	2018	NUM
dpc-4609	79	3	)	)	PUNCT
dpc-4609	79	4	1	1	NUM
dpc-4609	79	5	m	m	NUM
dpc-4609	79	6	33	33	NUM
dpc-4609	79	7	diffuse	diffuse	VERB
dpc-4609	79	8	aa	aa	NOUN
dpc-4609	79	9	in	in	ADP
dpc-4609	79	10	the	the	DET
dpc-4609	79	11	frontal	frontal	ADJ
dpc-4609	79	12	and	and	CCONJ
dpc-4609	79	13	occipital	occipital	ADJ
dpc-4609	79	14	region	region	NOUN
dpc-4609	79	15	+	+	CCONJ
dpc-4609	79	16	beard	beard	NOUN
dpc-4609	79	17	–	–	PUNCT
dpc-4609	79	18	7	7	NUM
dpc-4609	79	19	 	 	SPACE
dpc-4609	79	20	weeks	week	NOUN
dpc-4609	79	21	complete	complete	ADJ
dpc-4609	79	22	hair	hair	NOUN
dpc-4609	79	23	regrowth	regrowth	NOUN
dpc-4609	79	24	after	after	ADP
dpc-4609	79	25	3	3	NUM
dpc-4609	79	26	 	 	SPACE
dpc-4609	79	27	months	month	NOUN
dpc-4609	79	28	salguerofernandez	salguerofernandez	PROPN
dpc-4609	79	29	et	et	PROPN
dpc-4609	79	30	al	al	PROPN
dpc-4609	79	31	.	.	PROPN
dpc-4609	80	1	(	(	PUNCT
dpc-4609	80	2	2018	2018	NUM
dpc-4609	80	3	)	)	PUNCT
dpc-4609	80	4	1	1	NUM
dpc-4609	80	5	m	m	NUM
dpc-4609	80	6	24	24	NUM
dpc-4609	80	7	aa	aa	NOUN
dpc-4609	80	8	in	in	ADP
dpc-4609	80	9	patches	patch	NOUN
dpc-4609	80	10	–	–	PUNCT
dpc-4609	80	11	1	1	NUM
dpc-4609	80	12	week	week	NOUN
dpc-4609	80	13	partial	partial	ADJ
dpc-4609	80	14	regrowth	regrowth	NOUN
dpc-4609	80	15	after	after	ADP
dpc-4609	80	16	3	3	NUM
dpc-4609	80	17	weeks	week	NOUN
dpc-4609	80	18	(	(	PUNCT
dpc-4609	80	19	ketoconazole	ketoconazole	NOUN
dpc-4609	80	20	3	3	NUM
dpc-4609	80	21	%	%	NOUN
dpc-4609	80	22	shampoo	shampoo	NOUN
dpc-4609	80	23	was	be	AUX
dpc-4609	80	24	used	use	VERB
dpc-4609	80	25	)	)	PUNCT
dpc-4609	81	1	yazdanyar	yazdanyar	PROPN
dpc-4609	81	2	s	s	PROPN
dpc-4609	81	3	et	et	NOUN
dpc-4609	81	4	al	al	PROPN
dpc-4609	81	5	.	.	PROPN
dpc-4609	82	1	(	(	PUNCT
dpc-4609	82	2	2019	2019	NUM
dpc-4609	82	3	)	)	PUNCT
dpc-4609	82	4	1	1	NUM
dpc-4609	82	5	f	f	NOUN
dpc-4609	82	6	23	23	NUM
dpc-4609	82	7	aa	aa	NOUN
dpc-4609	82	8	in	in	ADP
dpc-4609	82	9	patches	patch	NOUN
dpc-4609	82	10	in	in	ADP
dpc-4609	82	11	the	the	DET
dpc-4609	82	12	frontal	frontal	ADJ
dpc-4609	82	13	,	,	PUNCT
dpc-4609	82	14	vertex	vertex	NOUN
dpc-4609	82	15	and	and	CCONJ
dpc-4609	82	16	occipital	occipital	NOUN
dpc-4609	82	17	areas	area	NOUN
dpc-4609	82	18	–	–	PUNCT
dpc-4609	82	19	48	48	NUM
dpc-4609	82	20	hours	hour	NOUN
dpc-4609	82	21	complete	complete	ADJ
dpc-4609	82	22	regrowth	regrowth	NOUN
dpc-4609	82	23	after	after	ADP
dpc-4609	82	24	6	6	NUM
dpc-4609	82	25	months	month	NOUN
dpc-4609	82	26	(	(	PUNCT
dpc-4609	82	27	dupilumab	dupilumab	NOUN
dpc-4609	82	28	was	be	AUX
dpc-4609	82	29	discontinued	discontinue	VERB
dpc-4609	82	30	)	)	PUNCT
dpc-4609	83	1	barbarin	barbarin	NOUN
dpc-4609	83	2	c	c	PROPN
dpc-4609	83	3	et	et	PROPN
dpc-4609	83	4	al	al	PROPN
dpc-4609	83	5	.	.	PROPN
dpc-4609	84	1	(	(	PUNCT
dpc-4609	84	2	2019	2019	NUM
dpc-4609	84	3	)	)	PUNCT
dpc-4609	84	4	1	1	NUM
dpc-4609	84	5	m	m	NUM
dpc-4609	84	6	27	27	NUM
dpc-4609	84	7	aa	aa	NOUN
dpc-4609	84	8	in	in	ADP
dpc-4609	84	9	the	the	DET
dpc-4609	84	10	vertex	vertex	NOUN
dpc-4609	84	11	and	and	CCONJ
dpc-4609	84	12	temporal	temporal	ADJ
dpc-4609	84	13	areas	area	NOUN
dpc-4609	84	14	–	–	PUNCT
dpc-4609	84	15	18	18	NUM
dpc-4609	84	16	weeks	week	NOUN
dpc-4609	84	17	complete	complete	ADJ
dpc-4609	84	18	regrowth	regrowth	NOUN
dpc-4609	84	19	after	after	ADP
dpc-4609	84	20	2	2	NUM
dpc-4609	84	21	months	month	NOUN
dpc-4609	84	22	(	(	PUNCT
dpc-4609	84	23	dupilumab	dupilumab	NOUN
dpc-4609	84	24	was	be	AUX
dpc-4609	84	25	discontinued	discontinue	VERB
dpc-4609	84	26	)	)	PUNCT
dpc-4609	84	27	flanagan	flanagan	NOUN
dpc-4609	84	28	k	k	PROPN
dpc-4609	84	29	et	et	PROPN
dpc-4609	84	30	al	al	PROPN
dpc-4609	84	31	.	.	PROPN
dpc-4609	85	1	(	(	PUNCT
dpc-4609	85	2	2019	2019	NUM
dpc-4609	85	3	)	)	PUNCT
dpc-4609	85	4	1	1	NUM
dpc-4609	85	5	m	m	NUM
dpc-4609	85	6	35	35	NUM
dpc-4609	85	7	aa	aa	NOUN
dpc-4609	85	8	in	in	ADP
dpc-4609	85	9	patches	patch	NOUN
dpc-4609	85	10	,	,	PUNCT
dpc-4609	85	11	mostly	mostly	ADV
dpc-4609	85	12	in	in	ADP
dpc-4609	85	13	the	the	DET
dpc-4609	85	14	parietal	parietal	ADJ
dpc-4609	85	15	,	,	PUNCT
dpc-4609	85	16	occipital	occipital	ADJ
dpc-4609	85	17	and	and	CCONJ
dpc-4609	85	18	frontal	frontal	ADJ
dpc-4609	85	19	regions	region	NOUN
dpc-4609	85	20	–	–	PUNCT
dpc-4609	85	21	6	6	NUM
dpc-4609	85	22	weeks	week	NOUN
dpc-4609	85	23	partial	partial	ADJ
dpc-4609	85	24	regrowth	regrowth	NOUN
dpc-4609	85	25	(	(	PUNCT
dpc-4609	85	26	78	78	NUM
dpc-4609	85	27	%	%	NOUN
dpc-4609	85	28	)	)	PUNCT
dpc-4609	85	29	after	after	ADP
dpc-4609	85	30	4	4	NUM
dpc-4609	85	31	 	 	SPACE
dpc-4609	85	32	months	month	NOUN
dpc-4609	85	33	kanda	kanda	PROPN
dpc-4609	85	34	n	n	PROPN
dpc-4609	85	35	et	et	PROPN
dpc-4609	85	36	al	al	PROPN
dpc-4609	85	37	.	.	PROPN
dpc-4609	86	1	(	(	PUNCT
dpc-4609	86	2	2019	2019	NUM
dpc-4609	86	3	)	)	PUNCT
dpc-4609	86	4	1	1	NUM
dpc-4609	86	5	m	m	NUM
dpc-4609	86	6	53	53	NUM
dpc-4609	86	7	aa	aa	NOUN
dpc-4609	86	8	in	in	ADP
dpc-4609	86	9	patches	patch	NOUN
dpc-4609	86	10	–	–	PUNCT
dpc-4609	86	11	1	1	NUM
dpc-4609	86	12	year	year	NOUN
dpc-4609	86	13	complete	complete	ADJ
dpc-4609	86	14	regrowth	regrowth	NOUN
dpc-4609	86	15	after	after	ADP
dpc-4609	86	16	4	4	NUM
dpc-4609	86	17	months	month	NOUN
dpc-4609	86	18	(	(	PUNCT
dpc-4609	86	19	dupilumab	dupilumab	NOUN
dpc-4609	86	20	was	be	AUX
dpc-4609	86	21	discontinued	discontinue	VERB
dpc-4609	86	22	,	,	PUNCT
dpc-4609	86	23	and	and	CCONJ
dpc-4609	86	24	cya	cya	NOUN
dpc-4609	86	25	was	be	AUX
dpc-4609	86	26	started	start	VERB
dpc-4609	86	27	)	)	PUNCT
dpc-4609	87	1	stander	stander	PROPN
dpc-4609	87	2	s	s	PART
dpc-4609	87	3	et	et	NOUN
dpc-4609	87	4	al	al	PROPN
dpc-4609	87	5	.	.	PROPN
dpc-4609	87	6	(	(	PUNCT
dpc-4609	87	7	2020	2020	NUM
dpc-4609	87	8	)	)	PUNCT
dpc-4609	87	9	1	1	NUM
dpc-4609	87	10	f	f	NOUN
dpc-4609	87	11	42	42	NUM
dpc-4609	87	12	aa	aa	NOUN
dpc-4609	87	13	in	in	ADP
dpc-4609	87	14	androgenetic	androgenetic	ADJ
dpc-4609	87	15	alopecia	alopecia	NOUN
dpc-4609	87	16	pattern	pattern	NOUN
dpc-4609	87	17	–	–	PUNCT
dpc-4609	87	18	4	4	NUM
dpc-4609	87	19	months	month	NOUN
dpc-4609	87	20	complete	complete	ADJ
dpc-4609	87	21	regrowth	regrowth	NOUN
dpc-4609	87	22	after	after	ADP
dpc-4609	87	23	2	2	NUM
dpc-4609	87	24	months	month	NOUN
dpc-4609	87	25	carnicle	carnicle	NOUN
dpc-4609	87	26	j	j	PROPN
dpc-4609	87	27	et	et	PROPN
dpc-4609	87	28	al	al	PROPN
dpc-4609	87	29	(	(	PUNCT
dpc-4609	87	30	2021	2021	NUM
dpc-4609	87	31	)	)	PUNCT
dpc-4609	87	32	1	1	NUM
dpc-4609	87	33	f	f	PROPN
dpc-4609	87	34	45	45	NUM
dpc-4609	87	35	aa	aa	NOUN
dpc-4609	87	36	in	in	ADP
dpc-4609	87	37	oval	oval	NOUN
dpc-4609	87	38	patches	patch	NOUN
dpc-4609	87	39	in	in	ADP
dpc-4609	87	40	the	the	DET
dpc-4609	87	41	occipital	occipital	NOUN
dpc-4609	87	42	region	region	NOUN
dpc-4609	87	43	+	+	CCONJ
dpc-4609	87	44	two	two	NUM
dpc-4609	87	45	small	small	ADJ
dpc-4609	87	46	patches	patch	NOUN
dpc-4609	87	47	in	in	ADP
dpc-4609	87	48	the	the	DET
dpc-4609	87	49	temporal	temporal	ADJ
dpc-4609	87	50	region	region	NOUN
dpc-4609	87	51	–	–	PUNCT
dpc-4609	87	52	1	1	NUM
dpc-4609	87	53	year	year	NOUN
dpc-4609	87	54	complete	complete	ADJ
dpc-4609	87	55	hair	hair	NOUN
dpc-4609	87	56	regrowth	regrowth	NOUN
dpc-4609	87	57	after	after	ADP
dpc-4609	87	58	2	2	NUM
dpc-4609	87	59	 	 	SPACE
dpc-4609	87	60	months	month	NOUN
dpc-4609	87	61	beaziz	beaziz	INTJ
dpc-4609	87	62	j	j	PROPN
dpc-4609	87	63	et	et	PROPN
dpc-4609	87	64	al	al	PROPN
dpc-4609	87	65	.	.	PROPN
dpc-4609	87	66	(	(	PUNCT
dpc-4609	87	67	2021	2021	NUM
dpc-4609	87	68	)	)	PUNCT
dpc-4609	87	69	2	2	NUM
dpc-4609	87	70	f	f	NOUN
dpc-4609	87	71	=	=	SYM
dpc-4609	87	72	2	2	NUM
dpc-4609	87	73	16.5	16.5	NUM
dpc-4609	87	74	(	(	PUNCT
dpc-4609	87	75	mean	mean	NOUN
dpc-4609	87	76	age	age	NOUN
dpc-4609	87	77	)	)	PUNCT
dpc-4609	87	78	mean	mean	VERB
dpc-4609	87	79	salt	salt	NOUN
dpc-4609	87	80	=	=	NOUN
dpc-4609	87	81	91.5	91.5	NUM
dpc-4609	87	82	1	1	NUM
dpc-4609	87	83	patient	patient	NOUN
dpc-4609	87	84	reached	reach	VERB
dpc-4609	87	85	salt	salt	NOUN
dpc-4609	87	86	100	100	NUM
dpc-4609	87	87	(	(	PUNCT
dpc-4609	87	88	starting	start	VERB
dpc-4609	87	89	from	from	ADP
dpc-4609	87	90	salt98	salt98	NOUN
dpc-4609	87	91	after	after	ADP
dpc-4609	87	92	5	5	NUM
dpc-4609	87	93	 	 	SPACE
dpc-4609	87	94	months	month	NOUN
dpc-4609	87	95	of	of	ADP
dpc-4609	87	96	therapy	therapy	NOUN
dpc-4609	87	97	)	)	PUNCT
dpc-4609	87	98	;	;	PUNCT
dpc-4609	87	99	the	the	DET
dpc-4609	87	100	other	other	ADJ
dpc-4609	87	101	patient	patient	NOUN
dpc-4609	87	102	reached	reach	VERB
dpc-4609	87	103	salt98	salt98	NOUN
dpc-4609	87	104	(	(	PUNCT
dpc-4609	87	105	starting	start	VERB
dpc-4609	87	106	from	from	ADP
dpc-4609	87	107	salt85	salt85	NOUN
dpc-4609	87	108	after	after	ADP
dpc-4609	87	109	2	2	NUM
dpc-4609	87	110	months	month	NOUN
dpc-4609	87	111	of	of	ADP
dpc-4609	87	112	therapy	therapy	NOUN
dpc-4609	87	113	)	)	PUNCT
dpc-4609	87	114	.	.	PUNCT
dpc-4609	88	1	mckenzie	mckenzie	PROPN
dpc-4609	88	2	et	et	PROPN
dpc-4609	88	3	al	al	PROPN
dpc-4609	88	4	.	.	PROPN
dpc-4609	89	1	(	(	PUNCT
dpc-4609	89	2	2021	2021	NUM
dpc-4609	89	3	)	)	PUNCT
dpc-4609	89	4	1	1	NUM
dpc-4609	89	5	m	m	NUM
dpc-4609	89	6	36	36	NUM
dpc-4609	89	7	aa	aa	NOUN
dpc-4609	89	8	of	of	ADP
dpc-4609	89	9	the	the	DET
dpc-4609	89	10	beard	beard	NOUN
dpc-4609	89	11	–	–	PUNCT
dpc-4609	89	12	25	25	NUM
dpc-4609	89	13	weeks	week	NOUN
dpc-4609	89	14	information	information	NOUN
dpc-4609	89	15	not	not	PART
dpc-4609	89	16	available	available	ADJ
dpc-4609	89	17	in	in	ADP
dpc-4609	89	18	 	 	SPACE
dpc-4609	89	19	the	the	DET
dpc-4609	89	20	 	 	SPACE
dpc-4609	89	21	article	article	NOUN
dpc-4609	89	22	chromy	chromy	NOUN
dpc-4609	90	1	d	d	X
dpc-4609	90	2	et	et	PROPN
dpc-4609	90	3	al	al	PROPN
dpc-4609	90	4	.	.	PROPN
dpc-4609	91	1	(	(	PUNCT
dpc-4609	91	2	2023	2023	NUM
dpc-4609	91	3	)	)	PUNCT
dpc-4609	91	4	4	4	NUM
dpc-4609	91	5	review	review	NOUN
dpc-4609	91	6	|	|	ADV
dpc-4609	91	7	dermatol	dermatol	ADJ
dpc-4609	91	8	pract	pract	NOUN
dpc-4609	91	9	concept	concept	NOUN
dpc-4609	91	10	.	.	PUNCT
dpc-4609	92	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	92	2	ta	ta	X
dpc-4609	92	3	b	b	X
dpc-4609	92	4	le	le	X
dpc-4609	92	5	2	2	NUM
dpc-4609	92	6	.	.	PUNCT
dpc-4609	93	1	c	c	NOUN
dpc-4609	93	2	as	as	ADP
dpc-4609	93	3	es	es	X
dpc-4609	93	4	o	o	PROPN
dpc-4609	93	5	f	f	PROPN
dpc-4609	94	1	a	a	DET
dpc-4609	94	2	a	a	PRON
dpc-4609	94	3	i	i	PRON
dpc-4609	94	4	m	m	VERB
dpc-4609	94	5	pr	pr	INTJ
dpc-4609	94	6	ov	ov	INTJ
dpc-4609	94	7	ed	ed	NOUN
dpc-4609	94	8	a	a	PRON
dpc-4609	94	9	ft	ft	NOUN
dpc-4609	94	10	er	er	INTJ
dpc-4609	94	11	d	d	X
dpc-4609	94	12	up	up	ADP
dpc-4609	94	13	ilu	ilu	PROPN
dpc-4609	94	14	m	m	PROPN
dpc-4609	94	15	ab	ab	PROPN
dpc-4609	94	16	.	.	PUNCT
dpc-4609	95	1	n	n	PRON
dpc-4609	96	1	o	o	NOUN
dpc-4609	96	2	o	o	X
dpc-4609	96	3	f	f	X
dpc-4609	96	4	p	p	NOUN
dpc-4609	96	5	at	at	ADP
dpc-4609	96	6	ie	ie	X
dpc-4609	96	7	n	n	ADV
dpc-4609	96	8	ts	ts	X
dpc-4609	96	9	se	se	ADV
dpc-4609	96	10	x	x	X
dpc-4609	96	11	(	(	PUNCT
dpc-4609	96	12	m	m	PROPN
dpc-4609	96	13	/f	/f	PUNCT
dpc-4609	96	14	)	)	PUNCT
dpc-4609	97	1	a	a	DET
dpc-4609	97	2	g	g	PROPN
dpc-4609	97	3	e	e	X
dpc-4609	97	4	(	(	PUNCT
dpc-4609	97	5	y	y	PROPN
dpc-4609	97	6	ea	ea	PROPN
dpc-4609	97	7	rs	rs	PROPN
dpc-4609	97	8	)	)	PUNCT
dpc-4609	97	9	b	b	PROPN
dpc-4609	97	10	as	as	ADP
dpc-4609	97	11	el	el	PROPN
dpc-4609	97	12	in	in	ADP
dpc-4609	97	13	e	e	PROPN
dpc-4609	97	14	cl	cl	NOUN
dpc-4609	97	15	in	in	ADP
dpc-4609	97	16	ic	ic	PROPN
dpc-4609	97	17	al	al	PROPN
dpc-4609	97	18	c	c	PROPN
dpc-4609	97	19	h	h	PROPN
dpc-4609	97	20	ar	ar	PROPN
dpc-4609	97	21	ac	ac	PROPN
dpc-4609	97	22	te	te	PROPN
dpc-4609	97	23	ri	ri	PROPN
dpc-4609	97	24	st	st	PROPN
dpc-4609	97	25	ic	ic	PROPN
dpc-4609	97	26	s	s	PROPN
dpc-4609	97	27	c	c	PROPN
dpc-4609	97	28	lin	lin	PROPN
dpc-4609	97	29	ic	ic	PROPN
dpc-4609	97	30	al	al	PROPN
dpc-4609	97	31	c	c	PROPN
dpc-4609	97	32	o	o	PUNCT
dpc-4609	97	33	u	u	NOUN
dpc-4609	97	34	rs	rs	NOUN
dpc-4609	97	35	e	e	X
dpc-4609	97	36	af	af	VERB
dpc-4609	97	37	te	te	ADP
dpc-4609	97	38	r	r	NOUN
dpc-4609	97	39	d	d	PROPN
dpc-4609	97	40	u	u	X
dpc-4609	97	41	p	p	NOUN
dpc-4609	97	42	ilu	ilu	NOUN
dpc-4609	97	43	m	m	VERB
dpc-4609	97	44	ab	ab	NOUN
dpc-4609	97	45	o	o	NOUN
dpc-4609	97	46	n	n	X
dpc-4609	97	47	se	se	X
dpc-4609	97	48	t	t	PROPN
dpc-4609	97	49	r	r	NOUN
dpc-4609	97	50	ef	ef	PROPN
dpc-4609	97	51	er	er	INTJ
dpc-4609	97	52	en	en	X
dpc-4609	97	53	ce	ce	PROPN
dpc-4609	97	54	1	1	PROPN
dpc-4609	97	55	f	f	PROPN
dpc-4609	97	56	13	13	NUM
dpc-4609	97	57	a	a	DET
dpc-4609	97	58	a	a	DET
dpc-4609	97	59	t	t	NOUN
dpc-4609	97	60	r	r	NOUN
dpc-4609	97	61	eg	eg	NOUN
dpc-4609	97	62	ro	ro	X
dpc-4609	97	63	w	w	X
dpc-4609	97	64	th	th	X
dpc-4609	97	65	o	o	NOUN
dpc-4609	97	66	n	n	CCONJ
dpc-4609	97	67	60	60	NUM
dpc-4609	97	68	%	%	NOUN
dpc-4609	98	1	o	o	X
dpc-4609	98	2	f	f	PROPN
dpc-4609	98	3	sc	sc	PROPN
dpc-4609	99	1	al	al	PROPN
dpc-4609	99	2	p	p	PROPN
dpc-4609	99	3	pe	pe	PROPN
dpc-4609	99	4	nz	nz	PROPN
dpc-4609	100	1	i	i	NOUN
dpc-4609	100	2	l	l	NOUN
dpc-4609	100	3	r	r	NOUN
dpc-4609	100	4	e	e	NOUN
dpc-4609	100	5	t	t	PROPN
dpc-4609	100	6	al	al	PROPN
dpc-4609	100	7	.	.	PUNCT
dpc-4609	101	1	(	(	PUNCT
dpc-4609	101	2	20	20	NUM
dpc-4609	101	3	18	18	NUM
dpc-4609	101	4	)	)	PUNCT
dpc-4609	101	5	1	1	NUM
dpc-4609	101	6	f	f	NOUN
dpc-4609	101	7	49	49	NUM
dpc-4609	101	8	a	a	DET
dpc-4609	101	9	a	a	DET
dpc-4609	101	10	u	u	NOUN
dpc-4609	101	11	fu	fu	NOUN
dpc-4609	101	12	ll	ll	AUX
dpc-4609	101	13	re	re	VERB
dpc-4609	101	14	gr	gr	INTJ
dpc-4609	101	15	ow	ow	INTJ
dpc-4609	101	16	th	th	X
dpc-4609	101	17	a	a	DET
dpc-4609	101	18	ft	ft	NOUN
dpc-4609	101	19	er	er	INTJ
dpc-4609	101	20	8	8	NUM
dpc-4609	101	21	m	m	NOUN
dpc-4609	101	22	on	on	ADP
dpc-4609	101	23	th	th	NUM
dpc-4609	101	24	s	s	VERB
dpc-4609	101	25	a	a	DET
dpc-4609	101	26	ln	ln	ADJ
dpc-4609	102	1	ie	ie	X
dpc-4609	102	2	m	m	VERB
dpc-4609	102	3	i	i	NOUN
dpc-4609	102	4	d	d	NOUN
dpc-4609	102	5	t	t	X
dpc-4609	102	6	e	e	PROPN
dpc-4609	102	7	t	t	PROPN
dpc-4609	102	8	al	al	PROPN
dpc-4609	102	9	.	.	PUNCT
dpc-4609	103	1	(	(	PUNCT
dpc-4609	103	2	20	20	NUM
dpc-4609	103	3	18	18	NUM
dpc-4609	103	4	)	)	PUNCT
dpc-4609	103	5	1	1	NUM
dpc-4609	103	6	m	m	NUM
dpc-4609	103	7	28	28	NUM
dpc-4609	103	8	a	a	DET
dpc-4609	103	9	a	a	DET
dpc-4609	103	10	s	s	NOUN
dpc-4609	103	11	ub	ub	ADP
dpc-4609	103	12	to	to	PART
dpc-4609	103	13	ta	ta	X
dpc-4609	103	14	lis	lis	X
dpc-4609	103	15	(	(	PUNCT
dpc-4609	103	16	sa	sa	ADP
dpc-4609	103	17	lt	lt	PRON
dpc-4609	103	18	s	s	PROPN
dpc-4609	103	19	co	co	NOUN
dpc-4609	103	20	re	re	NOUN
dpc-4609	103	21	8	8	NUM
dpc-4609	103	22	7	7	NUM
dpc-4609	103	23	,	,	PUNCT
dpc-4609	103	24	4	4	NUM
dpc-4609	103	25	)	)	PUNCT
dpc-4609	103	26	in	in	ADP
dpc-4609	103	27	a	a	DET
dpc-4609	103	28	n	n	NOUN
dpc-4609	103	29	a	a	DET
dpc-4609	103	30	d	d	X
dpc-4609	103	31	p	p	NOUN
dpc-4609	103	32	at	at	ADP
dpc-4609	103	33	ie	ie	X
dpc-4609	103	34	nt	not	PART
dpc-4609	103	35	(	(	PUNCT
dpc-4609	103	36	e	e	NOUN
dpc-4609	103	37	a	a	DET
dpc-4609	103	38	si	si	PROPN
dpc-4609	103	39	s	s	X
dpc-4609	103	40	co	co	NOUN
dpc-4609	103	41	re	re	ADP
dpc-4609	103	42	:	:	PUNCT
dpc-4609	103	43	1	1	NUM
dpc-4609	103	44	4	4	NUM
dpc-4609	103	45	.	.	NOUN
dpc-4609	103	46	9	9	NUM
dpc-4609	103	47	ig	ig	NOUN
dpc-4609	103	48	e	e	NOUN
dpc-4609	103	49	=	=	NOUN
dpc-4609	103	50	1	1	NUM
dpc-4609	103	51	1	1	NUM
dpc-4609	103	52	.	.	X
dpc-4609	103	53	98	98	NUM
dpc-4609	103	54	7	7	NUM
dpc-4609	103	55	iu	iu	ADP
dpc-4609	103	56	/m	/m	PROPN
dpc-4609	103	57	l	l	NOUN
dpc-4609	103	58	)	)	PUNCT
dpc-4609	103	59	fu	fu	NOUN
dpc-4609	103	60	ll	ll	AUX
dpc-4609	103	61	re	re	VERB
dpc-4609	103	62	gr	gr	INTJ
dpc-4609	103	63	ow	ow	INTJ
dpc-4609	103	64	th	th	X
dpc-4609	103	65	a	a	DET
dpc-4609	103	66	t	t	NOUN
dpc-4609	103	67	m	m	NOUN
dpc-4609	103	68	on	on	ADP
dpc-4609	103	69	th	th	NUM
dpc-4609	103	70	6	6	NUM
dpc-4609	103	71	a	a	DET
dpc-4609	103	72	nd	nd	NOUN
dpc-4609	103	73	a	a	PROPN
dpc-4609	103	74	d	d	X
dpc-4609	103	75	s	s	X
dpc-4609	103	76	co	co	X
dpc-4609	103	77	re	re	PROPN
dpc-4609	103	78	s	s	PROPN
dpc-4609	103	79	w	w	PROPN
dpc-4609	103	80	er	er	INTJ
dpc-4609	103	81	e	e	NOUN
dpc-4609	103	82	si	si	PROPN
dpc-4609	103	83	gn	gn	PROPN
dpc-4609	103	84	ifi	ifi	PROPN
dpc-4609	103	85	ca	can	AUX
dpc-4609	103	86	nt	not	PART
dpc-4609	103	87	ly	ly	VERB
dpc-4609	103	88	re	re	VERB
dpc-4609	104	1	du	du	PROPN
dpc-4609	104	2	ce	ce	PROPN
dpc-4609	104	3	d	d	PROPN
dpc-4609	104	4	(	(	PUNCT
dpc-4609	104	5	e	e	X
dpc-4609	104	6	a	a	DET
dpc-4609	104	7	si	si	PROPN
dpc-4609	104	8	s	s	X
dpc-4609	104	9	co	co	NOUN
dpc-4609	104	10	re	re	ADP
dpc-4609	104	11	:	:	PUNCT
dpc-4609	104	12	6	6	NUM
dpc-4609	104	13	.5	.5	NUM
dpc-4609	104	14	)	)	PUNCT
dpc-4609	105	1	d	d	X
dpc-4609	105	2	ar	ar	PROPN
dpc-4609	105	3	ri	ri	PROPN
dpc-4609	105	4	ga	ga	PROPN
dpc-4609	105	5	de	de	PROPN
dpc-4609	105	6	a	a	X
dpc-4609	105	7	-s	-s	X
dpc-4609	105	8	e	e	NOUN
dpc-4609	105	9	t	t	PROPN
dpc-4609	105	10	al	al	PROPN
dpc-4609	105	11	.	.	PUNCT
dpc-4609	106	1	(	(	PUNCT
dpc-4609	106	2	2	2	NUM
dpc-4609	106	3	01	01	NUM
dpc-4609	106	4	8)	8)	NUM
dpc-4609	106	5	1	1	NUM
dpc-4609	106	6	f	f	PROPN
dpc-4609	106	7	35	35	NUM
dpc-4609	106	8	a	a	DET
dpc-4609	106	9	a	a	DET
dpc-4609	106	10	u	u	NOUN
dpc-4609	106	11	fu	fu	NOUN
dpc-4609	106	12	ll	ll	AUX
dpc-4609	106	13	re	re	VERB
dpc-4609	106	14	gr	gr	INTJ
dpc-4609	106	15	ow	ow	INTJ
dpc-4609	106	16	th	th	X
dpc-4609	106	17	a	a	DET
dpc-4609	106	18	ft	ft	INTJ
dpc-4609	106	19	er	er	INTJ
dpc-4609	106	20	1	1	NUM
dpc-4609	106	21	2	2	NUM
dpc-4609	106	22	m	m	NOUN
dpc-4609	106	23	on	on	ADP
dpc-4609	106	24	th	th	NUM
dpc-4609	106	25	s	s	X
dpc-4609	106	26	sm	sm	NOUN
dpc-4609	106	27	og	og	INTJ
dpc-4609	106	28	or	or	CCONJ
dpc-4609	106	29	ze	ze	PROPN
dpc-4609	107	1	w	w	NOUN
dpc-4609	107	2	sk	sk	INTJ
dpc-4609	108	1	i	i	INTJ
dpc-4609	108	2	j	j	PROPN
dpc-4609	108	3	e	e	PROPN
dpc-4609	108	4	t	t	PROPN
dpc-4609	108	5	al	al	PROPN
dpc-4609	108	6	.	.	PUNCT
dpc-4609	109	1	(	(	PUNCT
dpc-4609	109	2	2	2	NUM
dpc-4609	109	3	01	01	NUM
dpc-4609	109	4	9	9	NUM
dpc-4609	109	5	)	)	PUNCT
dpc-4609	109	6	1	1	NUM
dpc-4609	109	7	f	f	NOUN
dpc-4609	109	8	25	25	NUM
dpc-4609	109	9	a	a	DET
dpc-4609	109	10	a	a	DET
dpc-4609	109	11	t	t	NOUN
dpc-4609	109	12	a	a	DET
dpc-4609	109	13	lm	lm	INTJ
dpc-4609	109	14	os	os	NOUN
dpc-4609	109	15	t	t	PROPN
dpc-4609	109	16	fu	fu	PROPN
dpc-4609	109	17	ll	ll	AUX
dpc-4609	109	18	re	re	VERB
dpc-4609	109	19	gr	gr	INTJ
dpc-4609	109	20	ow	ow	INTJ
dpc-4609	109	21	th	th	X
dpc-4609	109	22	a	a	DET
dpc-4609	109	23	ft	ft	INTJ
dpc-4609	109	24	er	er	INTJ
dpc-4609	109	25	1	1	NUM
dpc-4609	109	26	1	1	NUM
dpc-4609	109	27	m	m	NOUN
dpc-4609	109	28	on	on	ADP
dpc-4609	109	29	th	th	NUM
dpc-4609	109	30	s	s	VERB
dpc-4609	109	31	a	a	DET
dpc-4609	109	32	sz	sz	NOUN
dpc-4609	109	33	od	od	PROPN
dpc-4609	109	34	i	i	PRON
dpc-4609	109	35	n	n	PROPN
dpc-4609	109	36	e	e	PROPN
dpc-4609	109	37	t	t	PROPN
dpc-4609	109	38	al	al	PROPN
dpc-4609	109	39	.	.	PUNCT
dpc-4609	110	1	(	(	PUNCT
dpc-4609	110	2	20	20	NUM
dpc-4609	110	3	19	19	NUM
dpc-4609	110	4	)	)	PUNCT
dpc-4609	110	5	2	2	NUM
dpc-4609	110	6	m	m	NOUN
dpc-4609	110	7	m	m	VERB
dpc-4609	110	8	38	38	NUM
dpc-4609	110	9	3	3	NUM
dpc-4609	110	10	2	2	NUM
dpc-4609	110	11	a	a	DET
dpc-4609	110	12	a	a	DET
dpc-4609	110	13	u	u	NOUN
dpc-4609	110	14	–	–	PUNCT
dpc-4609	110	15	a	a	DET
dpc-4609	110	16	a	a	NOUN
dpc-4609	110	17	w	w	NOUN
dpc-4609	111	1	it	it	PRON
dpc-4609	112	1	h	h	NOUN
dpc-4609	112	2	op	op	NOUN
dpc-4609	112	3	hi	hi	INTJ
dpc-4609	112	4	as	as	SCONJ
dpc-4609	112	5	is	be	AUX
dpc-4609	112	6	p	p	NOUN
dpc-4609	112	7	at	at	ADP
dpc-4609	112	8	te	te	PROPN
dpc-4609	112	9	rn	rn	PROPN
dpc-4609	112	10	fu	fu	PROPN
dpc-4609	112	11	ll	ll	AUX
dpc-4609	112	12	re	re	VERB
dpc-4609	112	13	gr	gr	INTJ
dpc-4609	112	14	ow	ow	INTJ
dpc-4609	112	15	th	th	X
dpc-4609	112	16	–	–	PUNCT
dpc-4609	112	17	f	f	X
dpc-4609	112	18	ul	ul	INTJ
dpc-4609	112	19	l	l	NOUN
dpc-4609	112	20	r	r	NOUN
dpc-4609	112	21	eg	eg	NOUN
dpc-4609	112	22	ro	ro	X
dpc-4609	112	23	w	w	PROPN
dpc-4609	112	24	th	th	X
dpc-4609	112	25	l	l	NOUN
dpc-4609	112	26	ud	ud	INTJ
dpc-4609	112	27	ri	ri	PROPN
dpc-4609	112	28	ks	ks	PROPN
dpc-4609	112	29	on	on	ADP
dpc-4609	112	30	e	e	PROPN
dpc-4609	112	31	l	l	NOUN
dpc-4609	112	32	e	e	PROPN
dpc-4609	112	33	t	t	PROPN
dpc-4609	112	34	al	al	PROPN
dpc-4609	112	35	.	.	PUNCT
dpc-4609	113	1	(	(	PUNCT
dpc-4609	113	2	2	2	NUM
dpc-4609	113	3	01	01	NUM
dpc-4609	113	4	9	9	NUM
dpc-4609	113	5	)	)	PUNCT
dpc-4609	113	6	1	1	NUM
dpc-4609	113	7	m	m	NOUN
dpc-4609	113	8	44	44	NUM
dpc-4609	113	9	a	a	DET
dpc-4609	113	10	a	a	NOUN
dpc-4609	113	11	in	in	ADP
dpc-4609	113	12	f	f	PROPN
dpc-4609	113	13	oc	oc	ADP
dpc-4609	113	14	al	al	PROPN
dpc-4609	113	15	p	p	PROPN
dpc-4609	113	16	at	at	ADP
dpc-4609	113	17	ch	ch	NOUN
dpc-4609	113	18	es	es	PROPN
dpc-4609	113	19	(	(	PUNCT
dpc-4609	113	20	sa	sa	PROPN
dpc-4609	113	21	lt	lt	PRON
dpc-4609	113	22	6	6	NUM
dpc-4609	113	23	1	1	NUM
dpc-4609	113	24	.	.	NOUN
dpc-4609	113	25	6	6	NUM
dpc-4609	113	26	)	)	PUNCT
dpc-4609	113	27	in	in	ADP
dpc-4609	113	28	a	a	DET
dpc-4609	113	29	n	n	NOUN
dpc-4609	113	30	at	at	ADP
dpc-4609	113	31	op	op	NOUN
dpc-4609	113	32	ic	ic	PROPN
dpc-4609	113	33	de	de	PROPN
dpc-4609	113	34	rm	rm	PROPN
dpc-4609	113	35	at	at	ADP
dpc-4609	113	36	it	it	PRON
dpc-4609	113	37	is	be	AUX
dpc-4609	113	38	p	p	NOUN
dpc-4609	113	39	at	at	ADP
dpc-4609	113	40	ie	ie	ADV
dpc-4609	113	41	nt	not	PART
dpc-4609	113	42	(	(	PUNCT
dpc-4609	113	43	e	e	NOUN
dpc-4609	113	44	a	a	DET
dpc-4609	113	45	si	si	PROPN
dpc-4609	113	46	s	s	X
dpc-4609	113	47	co	co	NOUN
dpc-4609	113	48	re	re	ADP
dpc-4609	113	49	:	:	PUNCT
dpc-4609	114	1	4	4	NUM
dpc-4609	114	2	6	6	NUM
dpc-4609	114	3	.	.	NOUN
dpc-4609	114	4	7	7	NUM
dpc-4609	114	5	ig	ig	PROPN
dpc-4609	114	6	e	e	NOUN
dpc-4609	114	7	=	=	NOUN
dpc-4609	114	8	4	4	NUM
dpc-4609	114	9	43	43	NUM
dpc-4609	114	10	00	00	PUNCT
dpc-4609	114	11	i	i	PRON
dpc-4609	114	12	u	u	PROPN
dpc-4609	114	13	/m	/m	PROPN
dpc-4609	114	14	l	l	NOUN
dpc-4609	114	15	)	)	PUNCT
dpc-4609	114	16	a	a	DET
dpc-4609	114	17	lm	lm	INTJ
dpc-4609	114	18	os	os	NOUN
dpc-4609	114	19	t	t	PROPN
dpc-4609	114	20	fu	fu	PROPN
dpc-4609	114	21	ll	ll	AUX
dpc-4609	114	22	re	re	VERB
dpc-4609	114	23	gr	gr	INTJ
dpc-4609	114	24	ow	ow	INTJ
dpc-4609	114	25	th	th	X
dpc-4609	114	26	a	a	PRON
dpc-4609	114	27	nd	nd	INTJ
dpc-4609	114	28	i	i	PRON
dpc-4609	114	29	m	m	VERB
dpc-4609	114	30	pr	pr	INTJ
dpc-4609	114	31	ov	ov	INTJ
dpc-4609	114	32	em	em	PRON
dpc-4609	114	33	en	en	PROPN
dpc-4609	114	34	t	t	PROPN
dpc-4609	114	35	of	of	ADP
dpc-4609	114	36	t	t	PROPN
dpc-4609	114	37	he	he	PRON
dpc-4609	114	38	s	s	VERB
dpc-4609	114	39	ki	ki	PROPN
dpc-4609	114	40	n	n	ADV
dpc-4609	114	41	m	m	VERB
dpc-4609	114	42	an	an	DET
dpc-4609	114	43	if	if	SCONJ
dpc-4609	114	44	es	es	X
dpc-4609	114	45	ta	ta	X
dpc-4609	114	46	ti	ti	NOUN
dpc-4609	114	47	on	on	ADP
dpc-4609	114	48	s	s	PROPN
dpc-4609	114	49	(	(	PUNCT
dpc-4609	114	50	i	i	NOUN
dpc-4609	114	51	n	n	PROPN
dpc-4609	114	52	3	3	NUM
dpc-4609	114	53	m	m	VERB
dpc-4609	114	54	on	on	ADP
dpc-4609	114	55	th	th	NUM
dpc-4609	114	56	s	s	X
dpc-4609	114	57	e	e	NOUN
dpc-4609	114	58	a	a	DET
dpc-4609	114	59	si	si	X
dpc-4609	114	60	s	s	X
dpc-4609	114	61	co	co	NOUN
dpc-4609	114	62	re	re	ADP
dpc-4609	114	63	:	:	PUNCT
dpc-4609	115	1	2	2	NUM
dpc-4609	115	2	5	5	NUM
dpc-4609	115	3	)	)	PUNCT
dpc-4609	115	4	u	u	NOUN
dpc-4609	115	5	ch	ch	NOUN
dpc-4609	116	1	i	i	PROPN
dpc-4609	116	2	d	d	PROPN
dpc-4609	116	3	a	a	DET
dpc-4609	116	4	h	h	NOUN
dpc-4609	116	5	e	e	PROPN
dpc-4609	116	6	t	t	PROPN
dpc-4609	116	7	al	al	PROPN
dpc-4609	116	8	.	.	PUNCT
dpc-4609	117	1	(	(	PUNCT
dpc-4609	117	2	20	20	NUM
dpc-4609	117	3	19	19	NUM
dpc-4609	117	4	)	)	PUNCT
dpc-4609	117	5	1	1	NUM
dpc-4609	117	6	m	m	NOUN
dpc-4609	117	7	49	49	NUM
dpc-4609	117	8	a	a	DET
dpc-4609	117	9	a	a	NOUN
dpc-4609	117	10	in	in	ADP
dpc-4609	117	11	f	f	PROPN
dpc-4609	117	12	oc	oc	ADP
dpc-4609	117	13	al	al	PROPN
dpc-4609	117	14	p	p	PROPN
dpc-4609	117	15	at	at	ADP
dpc-4609	117	16	ch	ch	NOUN
dpc-4609	117	17	es	es	X
dpc-4609	117	18	fu	fu	PROPN
dpc-4609	118	1	ll	ll	AUX
dpc-4609	118	2	re	re	VERB
dpc-4609	118	3	gr	gr	INTJ
dpc-4609	118	4	ow	ow	INTJ
dpc-4609	118	5	th	th	X
dpc-4609	118	6	a	a	DET
dpc-4609	118	7	ft	ft	NOUN
dpc-4609	118	8	er	er	INTJ
dpc-4609	118	9	3	3	NUM
dpc-4609	118	10	m	m	NOUN
dpc-4609	118	11	on	on	ADP
dpc-4609	118	12	th	th	NUM
dpc-4609	118	13	s	s	NOUN
dpc-4609	118	14	m	m	NOUN
dpc-4609	118	15	ag	ag	PROPN
dpc-4609	118	16	da	da	X
dpc-4609	118	17	le	le	PUNCT
dpc-4609	118	18	no	no	INTJ
dpc-4609	118	19	-t	-t	PROPN
dpc-4609	118	20	ap	ap	PROPN
dpc-4609	118	21	ia	ia	PROPN
dpc-4609	118	22	l	l	PROPN
dpc-4609	118	23	j	j	PROPN
dpc-4609	118	24	et	et	PROPN
dpc-4609	118	25	a	a	DET
dpc-4609	118	26	l.	l.	PROPN
dpc-4609	118	27	(	(	PUNCT
dpc-4609	118	28	2	2	NUM
dpc-4609	118	29	01	01	NUM
dpc-4609	118	30	9	9	NUM
dpc-4609	118	31	)	)	PUNCT
dpc-4609	118	32	1	1	NUM
dpc-4609	118	33	f	f	PROPN
dpc-4609	118	34	33	33	NUM
dpc-4609	118	35	a	a	PRON
dpc-4609	118	36	a	a	NOUN
dpc-4609	118	37	in	in	ADP
dpc-4609	118	38	p	p	NOUN
dpc-4609	118	39	at	at	ADP
dpc-4609	118	40	ch	ch	NOUN
dpc-4609	118	41	es	es	X
dpc-4609	118	42	c	c	PROPN
dpc-4609	118	43	om	om	PROPN
dpc-4609	118	44	pl	pl	PROPN
dpc-4609	118	45	ic	ic	PROPN
dpc-4609	118	46	at	at	ADP
dpc-4609	118	47	ed	ed	PROPN
dpc-4609	118	48	w	w	PROPN
dpc-4609	118	49	it	it	PRON
dpc-4609	118	50	h	h	VERB
dpc-4609	118	51	tr	tr	VERB
dpc-4609	119	1	ic	ic	PROPN
dpc-4609	119	2	ho	ho	PROPN
dpc-4609	119	3	ti	ti	PROPN
dpc-4609	120	1	llo	llo	NOUN
dpc-4609	120	2	m	m	VERB
dpc-4609	120	3	an	an	DET
dpc-4609	120	4	ia	ia	NOUN
dpc-4609	120	5	in	in	ADP
dpc-4609	120	6	a	a	DET
dpc-4609	120	7	n	n	NOUN
dpc-4609	120	8	at	at	ADP
dpc-4609	120	9	op	op	NOUN
dpc-4609	120	10	ic	ic	PROPN
dpc-4609	121	1	d	d	X
dpc-4609	121	2	er	er	INTJ
dpc-4609	121	3	m	m	VERB
dpc-4609	121	4	at	at	ADP
dpc-4609	121	5	it	it	PRON
dpc-4609	121	6	is	be	AUX
dpc-4609	121	7	p	p	NOUN
dpc-4609	121	8	at	at	ADP
dpc-4609	121	9	ie	ie	ADV
dpc-4609	121	10	nt	not	PART
dpc-4609	121	11	(	(	PUNCT
dpc-4609	121	12	e	e	NOUN
dpc-4609	121	13	a	a	DET
dpc-4609	121	14	si	si	PROPN
dpc-4609	121	15	s	s	X
dpc-4609	121	16	co	co	NOUN
dpc-4609	121	17	re	re	ADP
dpc-4609	121	18	:	:	PUNCT
dpc-4609	121	19	4	4	NUM
dpc-4609	121	20	6	6	NUM
dpc-4609	121	21	)	)	PUNCT
dpc-4609	121	22	a	a	DET
dpc-4609	121	23	lm	lm	INTJ
dpc-4609	121	24	os	os	NOUN
dpc-4609	121	25	t	t	PROPN
dpc-4609	121	26	co	co	X
dpc-4609	121	27	m	m	PROPN
dpc-4609	121	28	pl	pl	VERB
dpc-4609	121	29	et	et	NOUN
dpc-4609	121	30	e	e	X
dpc-4609	121	31	re	re	X
dpc-4609	121	32	gr	gr	PROPN
dpc-4609	121	33	ow	ow	INTJ
dpc-4609	121	34	th	th	X
dpc-4609	122	1	a	a	PRON
dpc-4609	122	2	ft	ft	INTJ
dpc-4609	122	3	er	er	INTJ
dpc-4609	122	4	1	1	NUM
dpc-4609	122	5	9	9	NUM
dpc-4609	122	6	w	w	PROPN
dpc-4609	122	7	ee	ee	PROPN
dpc-4609	122	8	ks	ks	PROPN
dpc-4609	122	9	.	.	PUNCT
dpc-4609	123	1	t	t	PROPN
dpc-4609	123	2	he	he	PRON
dpc-4609	123	3	p	p	X
dpc-4609	123	4	at	at	ADP
dpc-4609	123	5	ie	ie	ADV
dpc-4609	123	6	nt	not	PART
dpc-4609	123	7	’s	’s	ADJ
dpc-4609	123	8	sk	sk	NOUN
dpc-4609	123	9	in	in	ADP
dpc-4609	123	10	c	c	PROPN
dpc-4609	123	11	on	on	ADP
dpc-4609	123	12	di	di	X
dpc-4609	123	13	ti	ti	NOUN
dpc-4609	123	14	on	on	ADP
dpc-4609	123	15	h	h	PROPN
dpc-4609	123	16	ad	ad	NOUN
dpc-4609	123	17	a	a	DET
dpc-4609	123	18	ls	ls	ADJ
dpc-4609	123	19	o	o	X
dpc-4609	124	1	i	i	PRON
dpc-4609	124	2	m	m	VERB
dpc-4609	124	3	pr	pr	INTJ
dpc-4609	124	4	ov	ov	INTJ
dpc-4609	124	5	ed	ed	NOUN
dpc-4609	124	6	(	(	PUNCT
dpc-4609	124	7	e	e	X
dpc-4609	124	8	a	a	DET
dpc-4609	124	9	si	si	PROPN
dpc-4609	124	10	s	s	X
dpc-4609	124	11	co	co	NOUN
dpc-4609	124	12	re	re	ADP
dpc-4609	124	13	:	:	PUNCT
dpc-4609	124	14	9	9	NUM
dpc-4609	124	15	.6	.6	NUM
dpc-4609	124	16	)	)	PUNCT
dpc-4609	124	17	.	.	PUNCT
dpc-4609	125	1	u	u	NOUN
dpc-4609	125	2	sh	sh	INTJ
dpc-4609	125	3	i	i	PROPN
dpc-4609	125	4	d	d	PROPN
dpc-4609	125	5	a	a	DET
dpc-4609	125	6	m	m	NOUN
dpc-4609	125	7	e	e	NOUN
dpc-4609	125	8	t	t	PROPN
dpc-4609	125	9	al	al	PROPN
dpc-4609	125	10	.	.	PUNCT
dpc-4609	126	1	(	(	PUNCT
dpc-4609	126	2	20	20	NUM
dpc-4609	126	3	20	20	NUM
dpc-4609	126	4	)	)	PUNCT
dpc-4609	126	5	7	7	NUM
dpc-4609	126	6	f	f	NOUN
dpc-4609	126	7	=	=	SYM
dpc-4609	126	8	2	2	NUM
dpc-4609	126	9	;	;	PUNCT
dpc-4609	126	10	m	m	VERB
dpc-4609	126	11	=	=	NOUN
dpc-4609	126	12	5	5	NUM
dpc-4609	126	13	40	40	NUM
dpc-4609	126	14	(	(	PUNCT
dpc-4609	126	15	m	m	PROPN
dpc-4609	126	16	ea	ea	PROPN
dpc-4609	126	17	n	n	CCONJ
dpc-4609	126	18	ag	ag	PROPN
dpc-4609	126	19	e	e	PROPN
dpc-4609	126	20	)	)	PUNCT
dpc-4609	126	21	m	m	PROPN
dpc-4609	126	22	ea	ea	NOUN
dpc-4609	126	23	n	n	PART
dpc-4609	126	24	sa	sa	NOUN
dpc-4609	126	25	lt	lt	NOUN
dpc-4609	127	1	=	=	NOUN
dpc-4609	127	2	7	7	NUM
dpc-4609	127	3	9	9	NUM
dpc-4609	127	4	.	.	SYM
dpc-4609	127	5	2	2	NUM
dpc-4609	127	6	(	(	PUNCT
dpc-4609	127	7	m	m	NOUN
dpc-4609	127	8	ea	ea	ADP
dpc-4609	127	9	n	n	NUM
dpc-4609	127	10	e	e	NOUN
dpc-4609	127	11	a	a	DET
dpc-4609	127	12	si	si	X
dpc-4609	127	13	=	=	SYM
dpc-4609	127	14	3	3	NUM
dpc-4609	127	15	9	9	NUM
dpc-4609	127	16	.	.	X
dpc-4609	128	1	93	93	NUM
dpc-4609	128	2	;	;	PUNCT
dpc-4609	128	3	m	m	VERB
dpc-4609	128	4	ea	ea	NOUN
dpc-4609	128	5	n	n	CCONJ
dpc-4609	128	6	ig	ig	PROPN
dpc-4609	128	7	e	e	NOUN
dpc-4609	128	8	=	=	NOUN
dpc-4609	128	9	1	1	NUM
dpc-4609	128	10	07	07	NUM
dpc-4609	128	11	94	94	NUM
dpc-4609	128	12	.7	.7	NUM
dpc-4609	128	13	u	u	PROPN
dpc-4609	128	14	i/	i/	NOUN
dpc-4609	128	15	m	m	PROPN
dpc-4609	128	16	l	l	NOUN
dpc-4609	128	17	)	)	PUNCT
dpc-4609	129	1	m	m	VERB
dpc-4609	129	2	ea	ea	NOUN
dpc-4609	129	3	n	n	PART
dpc-4609	129	4	sa	sa	NOUN
dpc-4609	129	5	lt	lt	PRON
dpc-4609	129	6	o	o	NOUN
dpc-4609	129	7	f	f	PROPN
dpc-4609	130	1	28	28	NUM
dpc-4609	130	2	.5	.5	NUM
dpc-4609	130	3	a	a	DET
dpc-4609	130	4	ft	ft	NOUN
dpc-4609	130	5	er	er	INTJ
dpc-4609	130	6	t	t	PROPN
dpc-4609	130	7	re	re	NOUN
dpc-4609	130	8	at	at	ADP
dpc-4609	130	9	m	m	PROPN
dpc-4609	130	10	en	en	ADP
dpc-4609	130	11	t	t	PROPN
dpc-4609	130	12	m	m	PROPN
dpc-4609	130	13	ed	ed	PROPN
dpc-4609	130	14	ia	ia	PROPN
dpc-4609	130	15	n	n	CCONJ
dpc-4609	130	16	du	du	PROPN
dpc-4609	130	17	ra	ra	PROPN
dpc-4609	130	18	ti	ti	NOUN
dpc-4609	130	19	on	on	ADP
dpc-4609	130	20	of	of	ADP
dpc-4609	130	21	2	2	NUM
dpc-4609	130	22	4	4	NUM
dpc-4609	130	23	w	w	PROPN
dpc-4609	130	24	ee	ee	PROPN
dpc-4609	130	25	ks	ks	PROPN
dpc-4609	130	26	)	)	PUNCT
dpc-4609	130	27	h	h	PROPN
dpc-4609	130	28	ar	ar	NOUN
dpc-4609	130	29	ad	ad	PROPN
dpc-4609	130	30	a	a	DET
dpc-4609	130	31	k	k	X
dpc-4609	130	32	e	e	PROPN
dpc-4609	130	33	t	t	PROPN
dpc-4609	130	34	al	al	PROPN
dpc-4609	130	35	.	.	PUNCT
dpc-4609	131	1	(	(	PUNCT
dpc-4609	131	2	20	20	NUM
dpc-4609	131	3	20	20	NUM
dpc-4609	131	4	)	)	PUNCT
dpc-4609	131	5	1	1	NUM
dpc-4609	131	6	f	f	PROPN
dpc-4609	131	7	13	13	NUM
dpc-4609	131	8	a	a	DET
dpc-4609	131	9	a	a	DET
dpc-4609	131	10	t	t	NOUN
dpc-4609	131	11	fu	fu	NOUN
dpc-4609	131	12	ll	ll	AUX
dpc-4609	131	13	re	re	VERB
dpc-4609	131	14	gr	gr	INTJ
dpc-4609	131	15	ow	ow	INTJ
dpc-4609	131	16	th	th	X
dpc-4609	131	17	a	a	DET
dpc-4609	131	18	ft	ft	NOUN
dpc-4609	131	19	er	er	INTJ
dpc-4609	131	20	4	4	NUM
dpc-4609	131	21	m	m	NOUN
dpc-4609	131	22	on	on	ADP
dpc-4609	131	23	th	th	NUM
dpc-4609	131	24	s	s	X
dpc-4609	131	25	(	(	PUNCT
dpc-4609	131	26	m	m	VERB
dpc-4609	131	27	in	in	ADP
dpc-4609	131	28	i	i	PROPN
dpc-4609	131	29	m	m	VERB
dpc-4609	131	30	al	al	PROPN
dpc-4609	131	31	e	e	PROPN
dpc-4609	131	32	ye	ye	NOUN
dpc-4609	131	33	la	la	VERB
dpc-4609	131	34	sh	sh	PROPN
dpc-4609	131	35	a	a	DET
dpc-4609	131	36	nd	nd	NOUN
dpc-4609	131	37	e	e	NOUN
dpc-4609	131	38	ye	ye	NOUN
dpc-4609	131	39	br	br	INTJ
dpc-4609	131	40	ow	ow	INTJ
dpc-4609	131	41	re	re	INTJ
dpc-4609	131	42	gr	gr	INTJ
dpc-4609	131	43	ow	ow	INTJ
dpc-4609	131	44	th	th	INTJ
dpc-4609	131	45	)	)	PUNCT
dpc-4609	132	1	g	g	PROPN
dpc-4609	132	2	ru	ru	PROPN
dpc-4609	132	3	en	en	PROPN
dpc-4609	132	4	st	st	PROPN
dpc-4609	132	5	ei	ei	PROPN
dpc-4609	132	6	n	n	PROPN
dpc-4609	132	7	d	d	PROPN
dpc-4609	132	8	e	e	PROPN
dpc-4609	132	9	t	t	PROPN
dpc-4609	132	10	al	al	PROPN
dpc-4609	132	11	.	.	PUNCT
dpc-4609	133	1	(	(	PUNCT
dpc-4609	133	2	2	2	NUM
dpc-4609	133	3	02	02	NUM
dpc-4609	133	4	0	0	NUM
dpc-4609	133	5	)	)	PUNCT
dpc-4609	133	6	1	1	NUM
dpc-4609	133	7	f	f	NOUN
dpc-4609	133	8	34	34	NUM
dpc-4609	133	9	a	a	PRON
dpc-4609	133	10	a	a	DET
dpc-4609	133	11	u	u	NOUN
dpc-4609	133	12	c	c	NOUN
dpc-4609	133	13	om	om	NOUN
dpc-4609	133	14	pl	pl	X
dpc-4609	133	15	et	et	NOUN
dpc-4609	133	16	e	e	X
dpc-4609	133	17	re	re	X
dpc-4609	133	18	gr	gr	PROPN
dpc-4609	133	19	ow	ow	INTJ
dpc-4609	133	20	th	th	X
dpc-4609	133	21	o	o	X
dpc-4609	133	22	f	f	X
dpc-4609	133	23	co	co	VERB
dpc-4609	133	24	ur	ur	PROPN
dpc-4609	133	25	se	se	PROPN
dpc-4609	133	26	t	t	PROPN
dpc-4609	133	27	er	er	INTJ
dpc-4609	133	28	m	m	VERB
dpc-4609	133	29	in	in	ADP
dpc-4609	133	30	al	al	PROPN
dpc-4609	133	31	h	h	PROPN
dpc-4609	133	32	ai	ai	VERB
dpc-4609	133	33	r	r	NOUN
dpc-4609	133	34	on	on	ADP
dpc-4609	133	35	t	t	NOUN
dpc-4609	134	1	he	he	PRON
dpc-4609	134	2	s	s	VERB
dpc-4609	134	3	ca	can	AUX
dpc-4609	134	4	lp	lp	NOUN
dpc-4609	134	5	,	,	PUNCT
dpc-4609	134	6	fa	fa	PROPN
dpc-4609	134	7	ce	ce	PROPN
dpc-4609	134	8	,	,	PUNCT
dpc-4609	134	9	f	f	PROPN
dpc-4609	134	10	or	or	CCONJ
dpc-4609	134	11	ea	ea	PROPN
dpc-4609	134	12	rm	rm	PROPN
dpc-4609	134	13	s	s	PROPN
dpc-4609	134	14	,	,	PUNCT
dpc-4609	134	15	p	p	X
dpc-4609	134	16	ub	ub	INTJ
dpc-4609	134	17	ic	ic	PROPN
dpc-4609	134	18	a	a	DET
dpc-4609	134	19	re	re	X
dpc-4609	134	20	a	a	NOUN
dpc-4609	134	21	,	,	PUNCT
dpc-4609	134	22	a	a	DET
dpc-4609	134	23	nd	nd	ADV
dpc-4609	134	24	le	le	X
dpc-4609	134	25	gs	gs	PROPN
dpc-4609	134	26	a	a	DET
dpc-4609	134	27	ft	ft	NOUN
dpc-4609	134	28	er	er	INTJ
dpc-4609	134	29	1	1	NUM
dpc-4609	134	30	0	0	NUM
dpc-4609	134	31	m	m	VERB
dpc-4609	134	32	on	on	ADP
dpc-4609	134	33	th	th	NUM
dpc-4609	134	34	s	s	X
dpc-4609	134	35	c	c	NOUN
dpc-4609	134	36	al	al	PROPN
dpc-4609	134	37	l	l	PROPN
dpc-4609	134	38	j	j	PROPN
dpc-4609	134	39	e	e	PROPN
dpc-4609	134	40	e	e	PROPN
dpc-4609	134	41	t	t	PROPN
dpc-4609	134	42	al	al	PROPN
dpc-4609	134	43	.	.	PUNCT
dpc-4609	135	1	(	(	PUNCT
dpc-4609	135	2	20	20	NUM
dpc-4609	135	3	20	20	NUM
dpc-4609	135	4	)	)	PUNCT
dpc-4609	135	5	1	1	NUM
dpc-4609	135	6	f	f	NOUN
dpc-4609	135	7	30	30	NUM
dpc-4609	135	8	a	a	DET
dpc-4609	135	9	a	a	DET
dpc-4609	135	10	t	t	NOUN
dpc-4609	135	11	in	in	ADP
dpc-4609	135	12	a	a	DET
dpc-4609	135	13	n	n	NOUN
dpc-4609	135	14	at	at	ADP
dpc-4609	135	15	op	op	NOUN
dpc-4609	135	16	ic	ic	PROPN
dpc-4609	136	1	d	d	X
dpc-4609	136	2	er	er	INTJ
dpc-4609	136	3	m	m	VERB
dpc-4609	136	4	at	at	ADP
dpc-4609	136	5	it	it	PRON
dpc-4609	136	6	is	be	AUX
dpc-4609	136	7	p	p	NOUN
dpc-4609	136	8	at	at	ADP
dpc-4609	136	9	ie	ie	ADV
dpc-4609	136	10	nt	not	PART
dpc-4609	136	11	(	(	PUNCT
dpc-4609	136	12	e	e	NOUN
dpc-4609	136	13	a	a	DET
dpc-4609	136	14	si	si	PROPN
dpc-4609	136	15	s	s	X
dpc-4609	136	16	co	co	NOUN
dpc-4609	136	17	re	re	ADP
dpc-4609	136	18	:	:	PUNCT
dpc-4609	136	19	3	3	NUM
dpc-4609	136	20	6	6	NUM
dpc-4609	137	1	)	)	PUNCT
dpc-4609	137	2	c	c	AUX
dpc-4609	137	3	om	om	PROPN
dpc-4609	137	4	pl	pl	VERB
dpc-4609	137	5	et	et	NOUN
dpc-4609	137	6	e	e	X
dpc-4609	137	7	re	re	X
dpc-4609	137	8	gr	gr	PROPN
dpc-4609	137	9	ow	ow	INTJ
dpc-4609	137	10	th	th	X
dpc-4609	137	11	a	a	DET
dpc-4609	137	12	ft	ft	NOUN
dpc-4609	137	13	er	er	INTJ
dpc-4609	137	14	3	3	NUM
dpc-4609	137	15	m	m	NOUN
dpc-4609	137	16	on	on	ADP
dpc-4609	137	17	th	th	NUM
dpc-4609	137	18	s	s	VERB
dpc-4609	137	19	an	an	DET
dpc-4609	137	20	d	d	NOUN
dpc-4609	137	21	an	an	PRON
dpc-4609	138	1	i	i	PRON
dpc-4609	138	2	m	m	VERB
dpc-4609	138	3	pr	pr	INTJ
dpc-4609	138	4	ov	ov	INTJ
dpc-4609	138	5	em	em	PRON
dpc-4609	138	6	en	en	PROPN
dpc-4609	138	7	t	t	PROPN
dpc-4609	138	8	in	in	ADP
dpc-4609	138	9	a	a	DET
dpc-4609	138	10	d	d	NOUN
dpc-4609	138	11	(	(	PUNCT
dpc-4609	138	12	e	e	X
dpc-4609	138	13	a	a	DET
dpc-4609	138	14	si	si	PROPN
dpc-4609	138	15	s	s	X
dpc-4609	138	16	co	co	NOUN
dpc-4609	138	17	re	re	ADP
dpc-4609	138	18	:	:	PUNCT
dpc-4609	138	19	9	9	NUM
dpc-4609	138	20	.6	.6	NUM
dpc-4609	138	21	)	)	PUNCT
dpc-4609	139	1	sz	sz	PROPN
dpc-4609	139	2	ek	ek	PROPN
dpc-4609	139	3	el	el	PROPN
dpc-4609	139	4	y	y	PROPN
dpc-4609	139	5	s	s	PROPN
dpc-4609	139	6	et	et	PROPN
dpc-4609	139	7	a	a	DET
dpc-4609	139	8	l.	l.	PROPN
dpc-4609	139	9	(	(	PUNCT
dpc-4609	139	10	2	2	NUM
dpc-4609	139	11	02	02	NUM
dpc-4609	139	12	0	0	NUM
dpc-4609	139	13	)	)	PUNCT
dpc-4609	139	14	1	1	NUM
dpc-4609	139	15	f	f	NOUN
dpc-4609	139	16	21	21	NUM
dpc-4609	139	17	a	a	PRON
dpc-4609	139	18	a	a	DET
dpc-4609	139	19	u	u	NOUN
dpc-4609	139	20	pa	pa	PROPN
dpc-4609	139	21	rt	rt	PROPN
dpc-4609	139	22	ia	ia	PROPN
dpc-4609	139	23	l	l	PROPN
dpc-4609	139	24	r	r	NOUN
dpc-4609	139	25	eg	eg	NOUN
dpc-4609	139	26	ro	ro	X
dpc-4609	139	27	w	w	X
dpc-4609	139	28	th	th	INTJ
dpc-4609	139	29	w	w	VERB
dpc-4609	139	30	it	it	PRON
dpc-4609	139	31	h	h	NOUN
dpc-4609	139	32	a	a	DET
dpc-4609	139	33	si	si	INTJ
dpc-4609	139	34	ng	ng	PROPN
dpc-4609	139	35	le	le	PROPN
dpc-4609	140	1	p	p	PROPN
dpc-4609	140	2	at	at	ADP
dpc-4609	140	3	ch	ch	PROPN
dpc-4609	140	4	le	le	X
dpc-4609	140	5	ft	ft	PROPN
dpc-4609	140	6	a	a	DET
dpc-4609	140	7	ft	ft	NOUN
dpc-4609	140	8	er	er	INTJ
dpc-4609	140	9	4	4	NUM
dpc-4609	140	10	m	m	NOUN
dpc-4609	140	11	on	on	ADP
dpc-4609	140	12	th	th	NUM
dpc-4609	140	13	s	s	VERB
dpc-4609	140	14	a	a	DET
dpc-4609	140	15	lo	lo	NOUN
dpc-4609	140	16	ta	ta	ADP
dpc-4609	140	17	ib	ib	INTJ
dpc-4609	141	1	i	i	NOUN
dpc-4609	141	2	e	e	PROPN
dpc-4609	141	3	t	t	PROPN
dpc-4609	141	4	al	al	PROPN
dpc-4609	141	5	.	.	PUNCT
dpc-4609	142	1	(	(	PUNCT
dpc-4609	142	2	20	20	NUM
dpc-4609	142	3	21	21	NUM
dpc-4609	142	4	)	)	PUNCT
dpc-4609	142	5	review	review	NOUN
dpc-4609	142	6	|	|	ADV
dpc-4609	142	7	dermatol	dermatol	ADJ
dpc-4609	142	8	pract	pract	NOUN
dpc-4609	142	9	concept	concept	NOUN
dpc-4609	142	10	.	.	PUNCT
dpc-4609	143	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	143	2	5	5	NUM
dpc-4609	143	3	5	5	NUM
dpc-4609	143	4	m	m	NOUN
dpc-4609	143	5	=	=	NOUN
dpc-4609	143	6	3	3	NUM
dpc-4609	143	7	;	;	PUNCT
dpc-4609	143	8	f	f	PROPN
dpc-4609	143	9	=	=	SYM
dpc-4609	143	10	2	2	NUM
dpc-4609	143	11	12	12	NUM
dpc-4609	143	12	.8	.8	NUM
dpc-4609	143	13	(	(	PUNCT
dpc-4609	143	14	m	m	PROPN
dpc-4609	143	15	ea	ea	PROPN
dpc-4609	143	16	n	n	CCONJ
dpc-4609	143	17	ag	ag	PROPN
dpc-4609	143	18	e	e	PROPN
dpc-4609	143	19	)	)	PUNCT
dpc-4609	143	20	57	57	NUM
dpc-4609	143	21	(	(	PUNCT
dpc-4609	143	22	m	m	NOUN
dpc-4609	143	23	ea	ea	PROPN
dpc-4609	143	24	n	n	ADP
dpc-4609	143	25	sa	sa	PROPN
dpc-4609	143	26	lt	lt	PRON
dpc-4609	143	27	)	)	PUNCT
dpc-4609	143	28	1	1	NUM
dpc-4609	143	29	pa	pa	PROPN
dpc-4609	143	30	ti	ti	PROPN
dpc-4609	143	31	en	en	ADP
dpc-4609	143	32	t	t	PROPN
dpc-4609	143	33	w	w	PROPN
dpc-4609	143	34	en	en	PROPN
dpc-4609	143	35	t	t	PROPN
dpc-4609	143	36	fr	fr	INTJ
dpc-4609	144	1	om	om	PROPN
dpc-4609	144	2	s	s	PROPN
dpc-4609	144	3	a	a	DET
dpc-4609	144	4	lt	lt	PRON
dpc-4609	144	5	25	25	NUM
dpc-4609	144	6	t	t	NOUN
dpc-4609	144	7	o	o	X
dpc-4609	144	8	sa	sa	PROPN
dpc-4609	145	1	lt	lt	PRON
dpc-4609	145	2	0	0	NUM
dpc-4609	145	3	af	af	VERB
dpc-4609	145	4	te	te	ADP
dpc-4609	145	5	r	r	NOUN
dpc-4609	145	6	12	12	NUM
dpc-4609	145	7	m	m	NOUN
dpc-4609	145	8	on	on	ADP
dpc-4609	145	9	th	th	NUM
dpc-4609	145	10	s	s	NOUN
dpc-4609	145	11	of	of	ADP
dpc-4609	145	12	t	t	PROPN
dpc-4609	145	13	he	he	PRON
dpc-4609	145	14	ra	ra	INTJ
dpc-4609	145	15	py	py	INTJ
dpc-4609	145	16	;	;	PUNCT
dpc-4609	145	17	1	1	NUM
dpc-4609	145	18	p	p	NOUN
dpc-4609	145	19	at	at	ADP
dpc-4609	145	20	ie	ie	PROPN
dpc-4609	145	21	nt	not	PART
dpc-4609	145	22	w	w	PROPN
dpc-4609	145	23	en	en	PROPN
dpc-4609	145	24	t	t	PROPN
dpc-4609	145	25	fr	fr	INTJ
dpc-4609	146	1	om	om	PROPN
dpc-4609	146	2	s	s	PROPN
dpc-4609	146	3	a	a	DET
dpc-4609	146	4	lt	lt	NUM
dpc-4609	146	5	35	35	NUM
dpc-4609	146	6	t	t	NOUN
dpc-4609	146	7	o	o	X
dpc-4609	146	8	sa	sa	PROPN
dpc-4609	147	1	lt	lt	PRON
dpc-4609	147	2	8	8	NUM
dpc-4609	147	3	af	af	NOUN
dpc-4609	147	4	te	te	ADP
dpc-4609	147	5	r	r	NOUN
dpc-4609	147	6	7	7	NUM
dpc-4609	147	7	m	m	NOUN
dpc-4609	147	8	on	on	ADP
dpc-4609	147	9	th	th	NUM
dpc-4609	147	10	s	s	NOUN
dpc-4609	147	11	of	of	ADP
dpc-4609	147	12	t	t	PROPN
dpc-4609	147	13	he	he	PRON
dpc-4609	147	14	ra	ra	INTJ
dpc-4609	147	15	py	py	INTJ
dpc-4609	147	16	;	;	PUNCT
dpc-4609	147	17	1	1	NUM
dpc-4609	147	18	p	p	NOUN
dpc-4609	147	19	at	at	ADP
dpc-4609	147	20	ie	ie	PROPN
dpc-4609	147	21	nt	not	PART
dpc-4609	147	22	w	w	PROPN
dpc-4609	147	23	en	en	PROPN
dpc-4609	147	24	t	t	PROPN
dpc-4609	148	1	fr	fr	INTJ
dpc-4609	148	2	om	om	PROPN
dpc-4609	148	3	s	s	PROPN
dpc-4609	148	4	a	a	DET
dpc-4609	148	5	lt	lt	DET
dpc-4609	148	6	10	10	NUM
dpc-4609	148	7	0	0	NUM
dpc-4609	148	8	to	to	PART
dpc-4609	148	9	sa	sa	VERB
dpc-4609	148	10	lt	lt	DET
dpc-4609	148	11	98	98	PROPN
dpc-4609	148	12	a	a	DET
dpc-4609	148	13	ft	ft	NOUN
dpc-4609	148	14	er	er	INTJ
dpc-4609	148	15	1	1	NUM
dpc-4609	148	16	2	2	NUM
dpc-4609	148	17	m	m	NOUN
dpc-4609	148	18	on	on	ADP
dpc-4609	148	19	th	th	NUM
dpc-4609	148	20	s	s	NOUN
dpc-4609	148	21	of	of	ADP
dpc-4609	148	22	t	t	PROPN
dpc-4609	149	1	he	he	PRON
dpc-4609	149	2	ra	ra	INTJ
dpc-4609	149	3	py	py	INTJ
dpc-4609	149	4	;	;	PUNCT
dpc-4609	149	5	1	1	NUM
dpc-4609	149	6	p	p	NOUN
dpc-4609	149	7	at	at	ADP
dpc-4609	149	8	ie	ie	PROPN
dpc-4609	149	9	nt	not	PART
dpc-4609	149	10	w	w	PROPN
dpc-4609	149	11	en	en	PROPN
dpc-4609	149	12	t	t	PROPN
dpc-4609	149	13	fr	fr	INTJ
dpc-4609	149	14	om	om	PROPN
dpc-4609	149	15	sa	sa	PROPN
dpc-4609	149	16	lt	lt	PRON
dpc-4609	149	17	10	10	NUM
dpc-4609	149	18	0	0	NUM
dpc-4609	149	19	to	to	ADP
dpc-4609	149	20	s	s	PROPN
dpc-4609	149	21	a	a	DET
dpc-4609	149	22	lt	lt	PRON
dpc-4609	149	23	50	50	NUM
dpc-4609	149	24	a	a	DET
dpc-4609	149	25	ft	ft	NOUN
dpc-4609	149	26	er	er	INTJ
dpc-4609	149	27	1	1	NUM
dpc-4609	149	28	1	1	NUM
dpc-4609	149	29	m	m	NOUN
dpc-4609	149	30	on	on	ADP
dpc-4609	149	31	th	th	NUM
dpc-4609	149	32	s	s	NOUN
dpc-4609	149	33	of	of	ADP
dpc-4609	149	34	t	t	PROPN
dpc-4609	149	35	he	he	PRON
dpc-4609	149	36	ra	ra	INTJ
dpc-4609	149	37	py	py	INTJ
dpc-4609	149	38	;	;	PUNCT
dpc-4609	149	39	1	1	NUM
dpc-4609	149	40	p	p	NOUN
dpc-4609	149	41	at	at	ADP
dpc-4609	149	42	ie	ie	PROPN
dpc-4609	149	43	nt	not	PART
dpc-4609	149	44	w	w	PROPN
dpc-4609	149	45	en	en	PROPN
dpc-4609	149	46	t	t	PROPN
dpc-4609	150	1	fr	fr	INTJ
dpc-4609	150	2	om	om	PROPN
dpc-4609	150	3	s	s	PROPN
dpc-4609	150	4	a	a	DET
dpc-4609	150	5	lt	lt	PRON
dpc-4609	150	6	25	25	NUM
dpc-4609	150	7	t	t	NOUN
dpc-4609	150	8	o	o	X
dpc-4609	150	9	sa	sa	PROPN
dpc-4609	151	1	lt	lt	PRON
dpc-4609	151	2	0	0	NUM
dpc-4609	151	3	af	af	VERB
dpc-4609	151	4	te	te	ADP
dpc-4609	151	5	r	r	NOUN
dpc-4609	151	6	12	12	NUM
dpc-4609	151	7	m	m	NOUN
dpc-4609	151	8	on	on	ADP
dpc-4609	151	9	th	th	NUM
dpc-4609	151	10	s	s	NOUN
dpc-4609	151	11	of	of	ADP
dpc-4609	151	12	t	t	PROPN
dpc-4609	151	13	he	he	PRON
dpc-4609	151	14	ra	ra	INTJ
dpc-4609	151	15	py	py	INTJ
dpc-4609	151	16	.	.	PUNCT
dpc-4609	152	1	m	m	VERB
dpc-4609	152	2	ck	ck	INTJ
dpc-4609	153	1	en	en	X
dpc-4609	153	2	zi	zi	X
dpc-4609	153	3	e	e	PROPN
dpc-4609	153	4	et	et	PROPN
dpc-4609	153	5	a	a	DET
dpc-4609	153	6	l.	l.	PROPN
dpc-4609	153	7	(	(	PUNCT
dpc-4609	153	8	2	2	NUM
dpc-4609	153	9	02	02	NUM
dpc-4609	153	10	1	1	NUM
dpc-4609	153	11	)	)	PUNCT
dpc-4609	153	12	1	1	NUM
dpc-4609	153	13	f	f	NOUN
dpc-4609	153	14	46	46	NUM
dpc-4609	153	15	a	a	PRON
dpc-4609	153	16	a	a	DET
dpc-4609	153	17	u	u	NOUN
dpc-4609	153	18	pa	pa	PROPN
dpc-4609	153	19	rt	rt	PROPN
dpc-4609	153	20	ia	ia	PROPN
dpc-4609	153	21	l	l	PROPN
dpc-4609	153	22	r	r	NOUN
dpc-4609	153	23	eg	eg	NOUN
dpc-4609	153	24	ro	ro	X
dpc-4609	153	25	w	w	PROPN
dpc-4609	153	26	th	th	X
dpc-4609	153	27	o	o	X
dpc-4609	153	28	f	f	X
dpc-4609	153	29	th	th	X
dpc-4609	153	30	e	e	X
dpc-4609	153	31	fa	fa	X
dpc-4609	153	32	ce	ce	PROPN
dpc-4609	153	33	,	,	PUNCT
dpc-4609	153	34	s	s	VERB
dpc-4609	153	35	ca	can	AUX
dpc-4609	153	36	lp	lp	PROPN
dpc-4609	153	37	,	,	PUNCT
dpc-4609	153	38	a	a	DET
dpc-4609	153	39	nd	nd	NOUN
dpc-4609	153	40	lo	lo	PROPN
dpc-4609	153	41	w	w	PROPN
dpc-4609	153	42	er	er	INTJ
dpc-4609	153	43	le	le	X
dpc-4609	153	44	gs	gs	NOUN
dpc-4609	154	1	r	r	NOUN
dpc-4609	154	2	ei	ei	X
dpc-4609	154	3	nh	nh	PROPN
dpc-4609	154	4	ol	ol	PROPN
dpc-4609	154	5	d	d	X
dpc-4609	154	6	l	l	NOUN
dpc-4609	154	7	e	e	PROPN
dpc-4609	154	8	t	t	PROPN
dpc-4609	154	9	al	al	PROPN
dpc-4609	154	10	.	.	PUNCT
dpc-4609	155	1	(	(	PUNCT
dpc-4609	155	2	20	20	NUM
dpc-4609	155	3	22	22	NUM
dpc-4609	155	4	)	)	PUNCT
dpc-4609	155	5	1	1	NUM
dpc-4609	155	6	m	m	NOUN
dpc-4609	155	7	16	16	NUM
dpc-4609	155	8	a	a	PRON
dpc-4609	155	9	a	a	DET
dpc-4609	155	10	t	t	NOUN
dpc-4609	155	11	c	c	X
dpc-4609	155	12	om	om	PROPN
dpc-4609	155	13	pl	pl	X
dpc-4609	155	14	et	et	NOUN
dpc-4609	155	15	e	e	X
dpc-4609	155	16	re	re	X
dpc-4609	155	17	gr	gr	PROPN
dpc-4609	155	18	ow	ow	INTJ
dpc-4609	155	19	th	th	X
dpc-4609	155	20	a	a	DET
dpc-4609	155	21	ft	ft	NOUN
dpc-4609	155	22	er	er	INTJ
dpc-4609	155	23	3	3	NUM
dpc-4609	155	24	y	y	PROPN
dpc-4609	155	25	ea	ea	NOUN
dpc-4609	155	26	rs	rs	INTJ
dpc-4609	156	1	k	k	INTJ
dpc-4609	156	2	ul	ul	INTJ
dpc-4609	156	3	ka	ka	PROPN
dpc-4609	156	4	rn	rn	PROPN
dpc-4609	156	5	i	i	PROPN
dpc-4609	156	6	m	m	VERB
dpc-4609	156	7	e	e	PROPN
dpc-4609	156	8	t	t	PROPN
dpc-4609	156	9	al	al	PROPN
dpc-4609	156	10	.	.	PUNCT
dpc-4609	157	1	(	(	PUNCT
dpc-4609	157	2	20	20	NUM
dpc-4609	157	3	22	22	NUM
dpc-4609	157	4	)	)	PUNCT
dpc-4609	157	5	5	5	NUM
dpc-4609	157	6	m	m	NOUN
dpc-4609	157	7	=	=	SYM
dpc-4609	157	8	2	2	NUM
dpc-4609	157	9	;	;	PUNCT
dpc-4609	157	10	f	f	PROPN
dpc-4609	157	11	=	=	SYM
dpc-4609	157	12	3	3	NUM
dpc-4609	157	13	4	4	NUM
dpc-4609	157	14	.	.	NOUN
dpc-4609	157	15	6	6	NUM
dpc-4609	157	16	(	(	PUNCT
dpc-4609	157	17	m	m	PROPN
dpc-4609	157	18	ea	ea	PROPN
dpc-4609	157	19	n	n	CCONJ
dpc-4609	157	20	ag	ag	PROPN
dpc-4609	157	21	e	e	PROPN
dpc-4609	157	22	)	)	PUNCT
dpc-4609	157	23	m	m	PROPN
dpc-4609	157	24	ea	ea	NOUN
dpc-4609	157	25	n	n	NUM
dpc-4609	157	26	sa	sa	NOUN
dpc-4609	157	27	lt	lt	NOUN
dpc-4609	158	1	=	=	NOUN
dpc-4609	158	2	6	6	NUM
dpc-4609	158	3	0	0	NUM
dpc-4609	158	4	.	.	NOUN
dpc-4609	158	5	8	8	NUM
dpc-4609	158	6	4	4	NUM
dpc-4609	158	7	pa	pa	NOUN
dpc-4609	158	8	ti	ti	X
dpc-4609	158	9	en	en	ADV
dpc-4609	158	10	ts	ts	ADP
dpc-4609	158	11	r	r	PROPN
dpc-4609	158	12	ea	ea	PROPN
dpc-4609	158	13	ch	ch	NOUN
dpc-4609	158	14	ed	ed	PROPN
dpc-4609	158	15	s	s	PROPN
dpc-4609	158	16	a	a	DET
dpc-4609	158	17	lt	lt	NOUN
dpc-4609	158	18	0	0	NUM
dpc-4609	158	19	,	,	PUNCT
dpc-4609	158	20	a	a	DET
dpc-4609	158	21	nd	nd	NOUN
dpc-4609	158	22	1	1	NUM
dpc-4609	158	23	p	p	NOUN
dpc-4609	158	24	at	at	ADP
dpc-4609	158	25	ie	ie	X
dpc-4609	158	26	nt	not	PART
dpc-4609	158	27	r	r	NOUN
dpc-4609	158	28	ea	ea	PROPN
dpc-4609	158	29	ch	ch	NOUN
dpc-4609	158	30	ed	ed	PROPN
dpc-4609	158	31	s	s	PROPN
dpc-4609	158	32	a	a	DET
dpc-4609	158	33	lt	lt	NOUN
dpc-4609	158	34	20	20	NUM
dpc-4609	158	35	.	.	PUNCT
dpc-4609	159	1	(	(	PUNCT
dpc-4609	159	2	n	n	CCONJ
dpc-4609	159	3	o	o	NOUN
dpc-4609	159	4	ti	ti	X
dpc-4609	159	5	m	m	PROPN
dpc-4609	159	6	eof	eof	X
dpc-4609	159	7	-t	-t	PUNCT
dpc-4609	159	8	re	re	X
dpc-4609	159	9	at	at	ADP
dpc-4609	159	10	m	m	PROPN
dpc-4609	159	11	en	en	PROPN
dpc-4609	159	12	t	t	PROPN
dpc-4609	159	13	is	be	AUX
dpc-4609	159	14	g	g	PROPN
dpc-4609	159	15	iv	iv	NUM
dpc-4609	159	16	en	en	PROPN
dpc-4609	159	17	f	f	PROPN
dpc-4609	159	18	or	or	CCONJ
dpc-4609	159	19	t	t	PROPN
dpc-4609	159	20	he	he	PRON
dpc-4609	159	21	5	5	NUM
dpc-4609	159	22	p	p	NOUN
dpc-4609	159	23	at	at	ADP
dpc-4609	159	24	ie	ie	X
dpc-4609	159	25	nt	nt	PROPN
dpc-4609	159	26	s	s	PART
dpc-4609	159	27	)	)	PUNCT
dpc-4609	159	28	.	.	PUNCT
dpc-4609	160	1	t	t	PROPN
dpc-4609	160	2	hr	hr	PROPN
dpc-4609	160	3	ee	ee	PROPN
dpc-4609	160	4	ou	ou	ADP
dpc-4609	160	5	t	t	PROPN
dpc-4609	160	6	of	of	ADP
dpc-4609	160	7	6	6	NUM
dpc-4609	160	8	w	w	NOUN
dpc-4609	160	9	er	er	INTJ
dpc-4609	160	10	e	e	X
dpc-4609	160	11	si	si	X
dpc-4609	160	12	m	m	PROPN
dpc-4609	160	13	ul	ul	INTJ
dpc-4609	160	14	ta	ta	X
dpc-4609	160	15	ne	ne	PROPN
dpc-4609	160	16	ou	ou	PROPN
dpc-4609	160	17	sl	sl	INTJ
dpc-4609	160	18	y	y	PROPN
dpc-4609	160	19	tr	tr	NOUN
dpc-4609	160	20	ea	ea	NOUN
dpc-4609	160	21	te	te	PROPN
dpc-4609	161	1	d	d	PROPN
dpc-4609	161	2	w	w	VERB
dpc-4609	161	3	it	it	PRON
dpc-4609	161	4	h	h	NOUN
dpc-4609	161	5	or	or	CCONJ
dpc-4609	161	6	al	al	PROPN
dpc-4609	161	7	m	m	PROPN
dpc-4609	161	8	in	in	ADP
dpc-4609	161	9	ox	ox	NOUN
dpc-4609	161	10	i	i	PROPN
dpc-4609	161	11	d	d	PROPN
dpc-4609	161	12	il	il	PROPN
dpc-4609	161	13	+	+	CCONJ
dpc-4609	161	14	to	to	ADP
dpc-4609	161	15	pi	pi	NOUN
dpc-4609	161	16	ca	ca	PROPN
dpc-4609	161	17	l	l	PROPN
dpc-4609	161	18	t	t	PROPN
dpc-4609	161	19	of	of	ADP
dpc-4609	161	20	ac	ac	PROPN
dpc-4609	161	21	it	it	PRON
dpc-4609	161	22	in	in	ADP
dpc-4609	161	23	ib	ib	PROPN
dpc-4609	161	24	,	,	PUNCT
dpc-4609	161	25	t	t	PROPN
dpc-4609	161	26	op	op	NOUN
dpc-4609	162	1	ic	ic	PROPN
dpc-4609	162	2	al	al	PROPN
dpc-4609	162	3	m	m	PROPN
dpc-4609	162	4	in	in	ADP
dpc-4609	162	5	ox	ox	NOUN
dpc-4609	162	6	i	i	PROPN
dpc-4609	162	7	d	d	PROPN
dpc-4609	162	8	il	il	PROPN
dpc-4609	163	1	+	+	CCONJ
dpc-4609	163	2	to	to	ADP
dpc-4609	163	3	pi	pi	NOUN
dpc-4609	163	4	ca	ca	PROPN
dpc-4609	163	5	l	l	PROPN
dpc-4609	163	6	t	t	PROPN
dpc-4609	163	7	of	of	ADP
dpc-4609	163	8	ac	ac	PROPN
dpc-4609	163	9	it	it	PRON
dpc-4609	163	10	in	in	ADP
dpc-4609	163	11	ib	ib	PROPN
dpc-4609	163	12	an	an	PROPN
dpc-4609	163	13	d	d	X
dpc-4609	163	14	pu	pu	PROPN
dpc-4609	163	15	ls	ls	PROPN
dpc-4609	164	1	ed	ed	PROPN
dpc-4609	164	2	p	p	X
dpc-4609	164	3	re	re	ADP
dpc-4609	164	4	dn	dn	PROPN
dpc-4609	164	5	is	be	AUX
dpc-4609	164	6	on	on	ADP
dpc-4609	164	7	e	e	PROPN
dpc-4609	164	8	+	+	NOUN
dpc-4609	164	9	or	or	CCONJ
dpc-4609	164	10	al	al	PROPN
dpc-4609	164	11	m	m	PROPN
dpc-4609	164	12	in	in	ADP
dpc-4609	164	13	ox	ox	PROPN
dpc-4609	164	14	i	i	PROPN
dpc-4609	164	15	d	d	PROPN
dpc-4609	164	16	il	il	PROPN
dpc-4609	164	17	,	,	PUNCT
dpc-4609	164	18	r	r	NOUN
dpc-4609	164	19	es	es	X
dpc-4609	164	20	pe	pe	INTJ
dpc-4609	164	21	ct	ct	NUM
dpc-4609	164	22	iv	iv	NUM
dpc-4609	165	1	el	el	PROPN
dpc-4609	165	2	y.	y.	PROPN
dpc-4609	165	3	c	c	PROPN
dpc-4609	165	4	ho	ho	PROPN
dpc-4609	165	5	e	e	PROPN
dpc-4609	165	6	t	t	PROPN
dpc-4609	165	7	al	al	PROPN
dpc-4609	165	8	.	.	PUNCT
dpc-4609	166	1	(	(	PUNCT
dpc-4609	166	2	20	20	NUM
dpc-4609	166	3	23	23	NUM
dpc-4609	166	4	)	)	PUNCT
dpc-4609	166	5	1	1	NUM
dpc-4609	166	6	f	f	NOUN
dpc-4609	166	7	9	9	NUM
dpc-4609	166	8	a	a	DET
dpc-4609	166	9	a	a	DET
dpc-4609	166	10	s	s	NOUN
dpc-4609	166	11	ub	ub	ADP
dpc-4609	166	12	to	to	PART
dpc-4609	166	13	ta	ta	ADP
dpc-4609	166	14	lis	lis	PROPN
dpc-4609	166	15	s	s	PROPN
dpc-4609	166	16	a	a	PRON
dpc-4609	166	17	lt	lt	PRON
dpc-4609	166	18	s	s	X
dpc-4609	166	19	co	co	NOUN
dpc-4609	166	20	re	re	PROPN
dpc-4609	166	21	9	9	NUM
dpc-4609	166	22	8	8	NUM
dpc-4609	166	23	(	(	PUNCT
dpc-4609	166	24	i	i	PRON
dpc-4609	166	25	ge	ge	NOUN
dpc-4609	166	26	=	=	NOUN
dpc-4609	166	27	9	9	NUM
dpc-4609	166	28	99	99	NUM
dpc-4609	167	1	.6	.6	NUM
dpc-4609	167	2	i	i	PRON
dpc-4609	167	3	u	u	NOUN
dpc-4609	167	4	/m	/m	PROPN
dpc-4609	167	5	l	l	NOUN
dpc-4609	167	6	)	)	PUNCT
dpc-4609	168	1	h	h	NOUN
dpc-4609	168	2	ai	ai	VERB
dpc-4609	168	3	r	r	NOUN
dpc-4609	168	4	re	re	NOUN
dpc-4609	168	5	gr	gr	INTJ
dpc-4609	168	6	ow	ow	INTJ
dpc-4609	168	7	th	th	INTJ
dpc-4609	168	8	,	,	PUNCT
dpc-4609	168	9	t	t	PROPN
dpc-4609	169	1	og	og	INTJ
dpc-4609	169	2	et	et	INTJ
dpc-4609	170	1	he	he	PRON
dpc-4609	170	2	r	r	VERB
dpc-4609	171	1	w	w	NOUN
dpc-4609	171	2	it	it	PRON
dpc-4609	171	3	h	h	NOUN
dpc-4609	171	4	re	re	ADP
dpc-4609	171	5	pi	pi	NOUN
dpc-4609	171	6	gm	gm	PROPN
dpc-4609	171	7	en	en	INTJ
dpc-4609	171	8	ta	ta	X
dpc-4609	171	9	ti	ti	PROPN
dpc-4609	171	10	on	on	ADP
dpc-4609	171	11	o	o	PROPN
dpc-4609	171	12	f	f	X
dpc-4609	171	13	re	re	VERB
dpc-4609	171	14	gr	gr	INTJ
dpc-4609	171	15	ow	ow	INTJ
dpc-4609	171	16	n	n	PROPN
dpc-4609	171	17	w	w	VERB
dpc-4609	172	1	hi	hi	INTJ
dpc-4609	172	2	te	te	INTJ
dpc-4609	172	3	t	t	PROPN
dpc-4609	172	4	er	er	INTJ
dpc-4609	172	5	m	m	VERB
dpc-4609	172	6	in	in	ADP
dpc-4609	172	7	al	al	PROPN
dpc-4609	172	8	h	h	PROPN
dpc-4609	173	1	ai	ai	VERB
dpc-4609	173	2	r	r	PROPN
dpc-4609	173	3	de	de	ADP
dpc-4609	173	4	n	n	ADV
dpc-4609	173	5	ov	ov	INTJ
dpc-4609	173	6	o	o	PROPN
dpc-4609	174	1	w	w	VERB
dpc-4609	174	2	it	it	PRON
dpc-4609	174	3	ho	ho	PROPN
dpc-4609	174	4	ut	ut	PROPN
dpc-4609	174	5	d	d	PROPN
dpc-4609	174	6	is	be	AUX
dpc-4609	174	7	tu	tu	PROPN
dpc-4609	174	8	rb	rb	NOUN
dpc-4609	174	9	in	in	ADP
dpc-4609	174	10	g	g	PROPN
dpc-4609	174	11	th	th	X
dpc-4609	174	12	e	e	X
dpc-4609	174	13	an	an	DET
dpc-4609	174	14	ag	ag	PROPN
dpc-4609	174	15	en	en	X
dpc-4609	174	16	ph	ph	PROPN
dpc-4609	174	17	as	as	ADP
dpc-4609	174	18	e	e	PROPN
dpc-4609	174	19	of	of	ADP
dpc-4609	174	20	h	h	NOUN
dpc-4609	175	1	ai	ai	VERB
dpc-4609	175	2	r	r	NOUN
dpc-4609	175	3	fo	fo	ADP
dpc-4609	175	4	lli	lli	PROPN
dpc-4609	175	5	cl	cl	NOUN
dpc-4609	175	6	es	es	NOUN
dpc-4609	175	7	.	.	PUNCT
dpc-4609	176	1	y	y	PROPN
dpc-4609	176	2	an	an	DET
dpc-4609	176	3	x	x	X
dpc-4609	176	4	e	e	PROPN
dpc-4609	176	5	t	t	PROPN
dpc-4609	176	6	al	al	PROPN
dpc-4609	176	7	.	.	PUNCT
dpc-4609	177	1	(	(	PUNCT
dpc-4609	177	2	20	20	NUM
dpc-4609	177	3	23	23	NUM
dpc-4609	177	4	)	)	PUNCT
dpc-4609	177	5	1	1	NUM
dpc-4609	177	6	f	f	NOUN
dpc-4609	177	7	4	4	NUM
dpc-4609	177	8	a	a	PRON
dpc-4609	177	9	a	a	DET
dpc-4609	177	10	u	u	NOUN
dpc-4609	177	11	pa	pa	PROPN
dpc-4609	177	12	rt	rt	PROPN
dpc-4609	177	13	ia	ia	PROPN
dpc-4609	177	14	l	l	PROPN
dpc-4609	177	15	r	r	NOUN
dpc-4609	177	16	eg	eg	NOUN
dpc-4609	177	17	ro	ro	X
dpc-4609	177	18	w	w	PROPN
dpc-4609	177	19	th	th	X
dpc-4609	177	20	o	o	X
dpc-4609	177	21	f	f	X
dpc-4609	177	22	th	th	X
dpc-4609	177	23	e	e	X
dpc-4609	177	24	ha	ha	INTJ
dpc-4609	177	25	ir	ir	PROPN
dpc-4609	177	26	;	;	PUNCT
dpc-4609	177	27	e	e	X
dpc-4609	177	28	ye	ye	NOUN
dpc-4609	177	29	br	br	INTJ
dpc-4609	177	30	ow	ow	INTJ
dpc-4609	177	31	s	s	VERB
dpc-4609	177	32	an	an	DET
dpc-4609	177	33	d	d	X
dpc-4609	177	34	ey	ey	X
dpc-4609	177	35	el	el	PROPN
dpc-4609	177	36	as	as	SCONJ
dpc-4609	177	37	he	he	PRON
dpc-4609	177	38	s	s	VERB
dpc-4609	177	39	fu	fu	PROPN
dpc-4609	177	40	lly	lly	ADV
dpc-4609	177	41	re	re	PRON
dpc-4609	177	42	st	st	PROPN
dpc-4609	177	43	or	or	CCONJ
dpc-4609	177	44	ed	ed	PROPN
dpc-4609	177	45	c	c	PROPN
dpc-4609	177	46	ai	ai	VERB
dpc-4609	177	47	l	l	NOUN
dpc-4609	177	48	e	e	NOUN
dpc-4609	177	49	t	t	PROPN
dpc-4609	177	50	al	al	PROPN
dpc-4609	177	51	.	.	PUNCT
dpc-4609	178	1	(	(	PUNCT
dpc-4609	178	2	20	20	NUM
dpc-4609	178	3	23	23	NUM
dpc-4609	178	4	)	)	PUNCT
dpc-4609	178	5	1	1	NUM
dpc-4609	178	6	f	f	PROPN
dpc-4609	178	7	45	45	NUM
dpc-4609	178	8	a	a	PRON
dpc-4609	178	9	a	a	DET
dpc-4609	178	10	u	u	NOUN
dpc-4609	178	11	r	r	NOUN
dpc-4609	178	12	eg	eg	NOUN
dpc-4609	178	13	ro	ro	PROPN
dpc-4609	178	14	w	w	X
dpc-4609	178	15	th	th	X
dpc-4609	178	16	a	a	DET
dpc-4609	178	17	ft	ft	NOUN
dpc-4609	178	18	er	er	INTJ
dpc-4609	178	19	6	6	NUM
dpc-4609	178	20	m	m	NOUN
dpc-4609	178	21	on	on	ADP
dpc-4609	178	22	th	th	NUM
dpc-4609	178	23	s	s	X
dpc-4609	178	24	(	(	PUNCT
dpc-4609	178	25	i	i	NOUN
dpc-4609	178	26	t	t	PROPN
dpc-4609	178	27	is	be	AUX
dpc-4609	178	28	n	n	ADP
dpc-4609	178	29	ot	ot	NOUN
dpc-4609	178	30	s	s	X
dpc-4609	178	31	pe	pe	INTJ
dpc-4609	178	32	ci	ci	PROPN
dpc-4609	178	33	fie	fie	PROPN
dpc-4609	179	1	d	d	PROPN
dpc-4609	179	2	in	in	ADP
dpc-4609	179	3	t	t	PROPN
dpc-4609	179	4	he	he	PRON
dpc-4609	179	5	a	a	DET
dpc-4609	179	6	rt	rt	INTJ
dpc-4609	179	7	ic	ic	INTJ
dpc-4609	179	8	le	le	PROPN
dpc-4609	180	1	if	if	SCONJ
dpc-4609	180	2	pa	pa	PROPN
dpc-4609	180	3	rt	rt	PROPN
dpc-4609	180	4	ia	ia	PROPN
dpc-4609	181	1	l	l	NOUN
dpc-4609	181	2	o	o	NOUN
dpc-4609	182	1	r	r	X
dpc-4609	182	2	co	co	VERB
dpc-4609	182	3	m	m	VERB
dpc-4609	182	4	pl	pl	VERB
dpc-4609	182	5	et	et	NOUN
dpc-4609	182	6	e	e	X
dpc-4609	182	7	re	re	ADP
dpc-4609	182	8	sp	sp	VERB
dpc-4609	182	9	on	on	ADP
dpc-4609	182	10	se	se	X
dpc-4609	182	11	)	)	PUNCT
dpc-4609	182	12	m	m	VERB
dpc-4609	182	13	cf	cf	INTJ
dpc-4609	182	14	ee	ee	INTJ
dpc-4609	182	15	ly	ly	X
dpc-4609	182	16	o	o	NOUN
dpc-4609	182	17	.	.	PUNCT
dpc-4609	183	1	(	(	PUNCT
dpc-4609	183	2	20	20	NUM
dpc-4609	183	3	23	23	NUM
dpc-4609	183	4	)	)	PUNCT
dpc-4609	183	5	1	1	NUM
dpc-4609	183	6	m	m	NOUN
dpc-4609	183	7	1	1	NUM
dpc-4609	183	8	a	a	PRON
dpc-4609	183	9	a	a	DET
dpc-4609	183	10	u	u	NOUN
dpc-4609	183	11	pa	pa	PROPN
dpc-4609	183	12	rt	rt	PROPN
dpc-4609	183	13	ia	ia	PROPN
dpc-4609	183	14	l	l	PROPN
dpc-4609	183	15	r	r	NOUN
dpc-4609	183	16	eg	eg	NOUN
dpc-4609	183	17	ro	ro	X
dpc-4609	183	18	w	w	X
dpc-4609	183	19	th	th	X
dpc-4609	183	20	ta	ta	PROPN
dpc-4609	183	21	nc	nc	PROPN
dpc-4609	183	22	re	re	PROPN
dpc-4609	183	23	di	di	PROPN
dpc-4609	183	24	v	v	PROPN
dpc-4609	183	25	e	e	PROPN
dpc-4609	183	26	t	t	PROPN
dpc-4609	183	27	al	al	PROPN
dpc-4609	183	28	.	.	PUNCT
dpc-4609	184	1	(	(	PUNCT
dpc-4609	184	2	20	20	NUM
dpc-4609	184	3	24	24	NUM
dpc-4609	184	4	)	)	PUNCT
dpc-4609	184	5	1	1	NUM
dpc-4609	184	6	m	m	NOUN
dpc-4609	184	7	12	12	NUM
dpc-4609	184	8	a	a	PRON
dpc-4609	184	9	a	a	PRON
dpc-4609	184	10	w	w	NOUN
dpc-4609	184	11	it	it	PRON
dpc-4609	184	12	h	h	NOUN
dpc-4609	185	1	op	op	NOUN
dpc-4609	185	2	hi	hi	INTJ
dpc-4609	185	3	as	as	SCONJ
dpc-4609	185	4	is	be	AUX
dpc-4609	185	5	p	p	NOUN
dpc-4609	185	6	at	at	ADP
dpc-4609	185	7	te	te	PROPN
dpc-4609	185	8	rn	rn	PROPN
dpc-4609	185	9	c	c	PROPN
dpc-4609	185	10	om	om	PROPN
dpc-4609	185	11	pl	pl	VERB
dpc-4609	185	12	et	et	NOUN
dpc-4609	185	13	e	e	X
dpc-4609	185	14	re	re	X
dpc-4609	185	15	gr	gr	PROPN
dpc-4609	185	16	ow	ow	INTJ
dpc-4609	185	17	th	th	X
dpc-4609	186	1	a	a	PRON
dpc-4609	186	2	ft	ft	INTJ
dpc-4609	186	3	er	er	INTJ
dpc-4609	186	4	2	2	NUM
dpc-4609	186	5	m	m	NOUN
dpc-4609	186	6	on	on	ADP
dpc-4609	186	7	th	th	NUM
dpc-4609	186	8	s	s	X
dpc-4609	186	9	g	g	PROPN
dpc-4609	186	10	ua	ua	PROPN
dpc-4609	186	11	ld	ld	PROPN
dpc-4609	186	12	i	i	PRON
dpc-4609	186	13	g	g	PROPN
dpc-4609	186	14	e	e	PROPN
dpc-4609	186	15	t	t	PROPN
dpc-4609	186	16	al	al	PROPN
dpc-4609	186	17	.	.	PUNCT
dpc-4609	187	1	(	(	PUNCT
dpc-4609	187	2	20	20	NUM
dpc-4609	187	3	24	24	NUM
dpc-4609	187	4	)	)	PUNCT
dpc-4609	187	5	6	6	NUM
dpc-4609	187	6	review	review	NOUN
dpc-4609	187	7	|	|	ADV
dpc-4609	187	8	dermatol	dermatol	ADJ
dpc-4609	187	9	pract	pract	NOUN
dpc-4609	187	10	concept	concept	NOUN
dpc-4609	187	11	.	.	PUNCT
dpc-4609	188	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	188	2	alopecia	alopecia	NOUN
dpc-4609	188	3	areata	areata	NOUN
dpc-4609	188	4	.	.	PUNCT
dpc-4609	189	1	exp	exp	NOUN
dpc-4609	189	2	dermatol	dermatol	NOUN
dpc-4609	189	3	.	.	PUNCT
dpc-4609	190	1	2020;29(8):726	2020;29(8):726	NUM
dpc-4609	190	2	-	-	SYM
dpc-4609	190	3	732	732	NUM
dpc-4609	190	4	.	.	PUNCT
dpc-4609	191	1	doi:10.1111	doi:10.1111	PROPN
dpc-4609	191	2	/exd.14129	/exd.14129	PROPN
dpc-4609	191	3	.	.	PUNCT
dpc-4609	192	1	4	4	X
dpc-4609	192	2	.	.	X
dpc-4609	192	3	renert	renert	NOUN
dpc-4609	192	4	-	-	PUNCT
dpc-4609	192	5	yuval	yuval	PROPN
dpc-4609	192	6	y	y	PROPN
dpc-4609	192	7	,	,	PUNCT
dpc-4609	192	8	guttman	guttman	ADJ
dpc-4609	192	9	-	-	PUNCT
dpc-4609	192	10	yassky	yassky	NOUN
dpc-4609	192	11	e.	e.	PROPN
dpc-4609	193	1	the	the	DET
dpc-4609	193	2	changing	change	VERB
dpc-4609	193	3	landscape	landscape	NOUN
dpc-4609	193	4	of	of	ADP
dpc-4609	193	5	alopecia	alopecia	NOUN
dpc-4609	193	6	areata	areata	NOUN
dpc-4609	193	7	:	:	PUNCT
dpc-4609	193	8	the	the	DET
dpc-4609	193	9	therapeutic	therapeutic	ADJ
dpc-4609	193	10	paradigm	paradigm	NOUN
dpc-4609	193	11	.	.	PUNCT
dpc-4609	194	1	adv	adv	INTJ
dpc-4609	194	2	ther	ther	ADV
dpc-4609	194	3	.	.	PUNCT
dpc-4609	195	1	2017;34(7):1594	2017;34(7):1594	NOUN
dpc-4609	195	2	-	-	PUNCT
dpc-4609	195	3	1609	1609	NUM
dpc-4609	195	4	.	.	PUNCT
dpc-4609	196	1	doi:10.1007	doi:10.1007	PROPN
dpc-4609	196	2	/	/	SYM
dpc-4609	196	3	s12325	s12325	PROPN
dpc-4609	196	4	-	-	PUNCT
dpc-4609	196	5	017	017	NUM
dpc-4609	196	6	-	-	PUNCT
dpc-4609	196	7	0542	0542	NUM
dpc-4609	196	8	-	-	SYM
dpc-4609	196	9	7	7	NUM
dpc-4609	196	10	.	.	NOUN
dpc-4609	196	11	5	5	NUM
dpc-4609	196	12	.	.	PUNCT
dpc-4609	197	1	shohat	shohat	PROPN
dpc-4609	197	2	m	m	PROPN
dpc-4609	197	3	,	,	PUNCT
dpc-4609	197	4	mimouni	mimouni	PROPN
dpc-4609	197	5	d	d	PROPN
dpc-4609	197	6	,	,	PUNCT
dpc-4609	197	7	ben	ben	PROPN
dpc-4609	197	8	-	-	PUNCT
dpc-4609	197	9	amitai	amitai	PROPN
dpc-4609	197	10	d	d	NOUN
dpc-4609	197	11	,	,	PUNCT
dpc-4609	197	12	et	et	PROPN
dpc-4609	197	13	al	al	PROPN
dpc-4609	197	14	.	.	PROPN
dpc-4609	198	1	in	in	ADP
dpc-4609	198	2	vitro	vitro	X
dpc-4609	198	3	cytokine	cytokine	ADJ
dpc-4609	198	4	profile	profile	NOUN
dpc-4609	198	5	in	in	ADP
dpc-4609	198	6	childhood	childhood	NOUN
dpc-4609	198	7	alopecia	alopecia	NOUN
dpc-4609	198	8	areata	areata	ADJ
dpc-4609	198	9	and	and	CCONJ
dpc-4609	198	10	the	the	DET
dpc-4609	198	11	immunomodulatory	immunomodulatory	ADJ
dpc-4609	198	12	effects	effect	NOUN
dpc-4609	198	13	of	of	ADP
dpc-4609	198	14	as-101	as-101	PROPN
dpc-4609	198	15	.	.	PUNCT
dpc-4609	199	1	clin	clin	PROPN
dpc-4609	199	2	exp	exp	NOUN
dpc-4609	199	3	dermatol	dermatol	NOUN
dpc-4609	199	4	.	.	PUNCT
dpc-4609	200	1	2005;30(4):432	2005;30(4):432	NUM
dpc-4609	200	2	-	-	PUNCT
dpc-4609	200	3	434	434	NUM
dpc-4609	200	4	.	.	PUNCT
dpc-4609	201	1	doi:10.1111	doi:10.1111	ADJ
dpc-4609	201	2	/	/	SYM
dpc-4609	201	3	j.1365	j.1365	NOUN
dpc-4609	201	4	-	-	PUNCT
dpc-4609	201	5	2230.2005.01817.x	2230.2005.01817.x	NUM
dpc-4609	201	6	.	.	PUNCT
dpc-4609	201	7	6	6	NUM
dpc-4609	201	8	.	.	PUNCT
dpc-4609	201	9	mitchell	mitchell	PROPN
dpc-4609	201	10	k	k	PROPN
dpc-4609	201	11	,	,	PUNCT
dpc-4609	201	12	levitt	levitt	PROPN
dpc-4609	201	13	j.	j.	PROPN
dpc-4609	201	14	alopecia	alopecia	PROPN
dpc-4609	201	15	areata	areata	VERB
dpc-4609	201	16	after	after	ADP
dpc-4609	201	17	dupilumab	dupilumab	NOUN
dpc-4609	201	18	for	for	ADP
dpc-4609	201	19	atopic	atopic	NOUN
dpc-4609	201	20	dermatitis	dermatitis	NOUN
dpc-4609	201	21	.	.	PUNCT
dpc-4609	202	1	jaad	jaad	PROPN
dpc-4609	202	2	case	case	NOUN
dpc-4609	202	3	rep	rep	PROPN
dpc-4609	202	4	.	.	PROPN
dpc-4609	202	5	2018;4(2):143	2018;4(2):143	PROPN
dpc-4609	202	6	-	-	SYM
dpc-4609	202	7	144	144	NUM
dpc-4609	202	8	.	.	PUNCT
dpc-4609	203	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	203	2	/j.jdcr.2017.11.020	/j.jdcr.2017.11.020	PUNCT
dpc-4609	203	3	.	.	PUNCT
dpc-4609	204	1	7	7	X
dpc-4609	204	2	.	.	X
dpc-4609	204	3	barroso	barroso	PROPN
dpc-4609	204	4	-	-	PUNCT
dpc-4609	204	5	garcía	garcía	ADJ
dpc-4609	204	6	b	b	NOUN
dpc-4609	204	7	,	,	PUNCT
dpc-4609	204	8	rial	rial	ADJ
dpc-4609	204	9	mj	mj	PROPN
dpc-4609	204	10	,	,	PUNCT
dpc-4609	204	11	molina	molina	PROPN
dpc-4609	204	12	a	a	PROPN
dpc-4609	204	13	,	,	PUNCT
dpc-4609	204	14	sastre	sastre	NOUN
dpc-4609	204	15	j.	j.	PROPN
dpc-4609	204	16	alopecia	alopecia	PROPN
dpc-4609	204	17	areata	areata	VERB
dpc-4609	204	18	in	in	ADP
dpc-4609	204	19	severe	severe	ADJ
dpc-4609	204	20	atopic	atopic	NOUN
dpc-4609	204	21	dermatitis	dermatitis	NOUN
dpc-4609	204	22	treated	treat	VERB
dpc-4609	204	23	with	with	ADP
dpc-4609	204	24	dupilumab	dupilumab	NOUN
dpc-4609	204	25	.	.	PUNCT
dpc-4609	205	1	j	j	PROPN
dpc-4609	205	2	investig	investig	PROPN
dpc-4609	205	3	allergol	allergol	PROPN
dpc-4609	205	4	clin	clin	PROPN
dpc-4609	205	5	immunol	immunol	NOUN
dpc-4609	205	6	.	.	PUNCT
dpc-4609	206	1	2018;28(6):420	2018;28(6):420	NUM
dpc-4609	206	2	-	-	SYM
dpc-4609	206	3	421	421	NUM
dpc-4609	206	4	.	.	PUNCT
dpc-4609	206	5	doi:10.18176	doi:10.18176	NOUN
dpc-4609	206	6	/	/	SYM
dpc-4609	206	7	jiaci	jiaci	PROPN
dpc-4609	206	8	.0301	.0301	PROPN
dpc-4609	206	9	.	.	PUNCT
dpc-4609	207	1	8	8	X
dpc-4609	207	2	.	.	PUNCT
dpc-4609	208	1	salgüero	salgüero	NOUN
dpc-4609	208	2	-	-	PUNCT
dpc-4609	208	3	fernández	fernández	PROPN
dpc-4609	208	4	i	i	PRON
dpc-4609	208	5	,	,	PUNCT
dpc-4609	208	6	gonzalez	gonzalez	PROPN
dpc-4609	208	7	de	de	PROPN
dpc-4609	208	8	domingo	domingo	PROPN
dpc-4609	208	9	ma	ma	PROPN
dpc-4609	208	10	,	,	PUNCT
dpc-4609	208	11	suarez	suarez	PROPN
dpc-4609	208	12	d	d	PROPN
dpc-4609	208	13	,	,	PUNCT
dpc-4609	208	14	roustan	roustan	ADJ
dpc-4609	208	15	-	-	PUNCT
dpc-4609	208	16	gullón	gullón	NOUN
dpc-4609	208	17	g.	g.	PROPN
dpc-4609	208	18	dermatitis	dermatitis	PROPN
dpc-4609	208	19	and	and	CCONJ
dpc-4609	208	20	alopecia	alopecia	NOUN
dpc-4609	208	21	in	in	ADP
dpc-4609	208	22	a	a	DET
dpc-4609	208	23	patient	patient	NOUN
dpc-4609	208	24	treated	treat	VERB
dpc-4609	208	25	with	with	ADP
dpc-4609	208	26	dupilumab	dupilumab	NOUN
dpc-4609	208	27	:	:	PUNCT
dpc-4609	208	28	a	a	DET
dpc-4609	208	29	new	new	ADJ
dpc-4609	208	30	adverse	adverse	ADJ
dpc-4609	208	31	effect	effect	NOUN
dpc-4609	208	32	?	?	PUNCT
dpc-4609	209	1	clin	clin	PROPN
dpc-4609	209	2	exp	exp	NOUN
dpc-4609	209	3	dermatol	dermatol	NOUN
dpc-4609	209	4	.	.	PUNCT
dpc-4609	210	1	2019;44(3):e41	2019;44(3):e41	NUM
dpc-4609	210	2	-	-	PUNCT
dpc-4609	210	3	e43	e43	NOUN
dpc-4609	210	4	.	.	PUNCT
dpc-4609	211	1	doi:10.1111	doi:10.1111	ADJ
dpc-4609	211	2	/	/	SYM
dpc-4609	211	3	ced.13858	ced.13858	NOUN
dpc-4609	211	4	.	.	NOUN
dpc-4609	211	5	9	9	NUM
dpc-4609	211	6	.	.	X
dpc-4609	212	1	yazdanyar	yazdanyar	PROPN
dpc-4609	212	2	s	s	PROPN
dpc-4609	212	3	,	,	PUNCT
dpc-4609	212	4	jemec	jemec	PROPN
dpc-4609	212	5	gbe	gbe	PROPN
dpc-4609	212	6	.	.	PUNCT
dpc-4609	212	7	alopecia	alopecia	NOUN
dpc-4609	212	8	areata	areata	VERB
dpc-4609	212	9	after	after	ADP
dpc-4609	212	10	treatment	treatment	NOUN
dpc-4609	212	11	with	with	ADP
dpc-4609	212	12	dupilumab	dupilumab	NOUN
dpc-4609	212	13	.	.	PUNCT
dpc-4609	213	1	dermat	dermat	PROPN
dpc-4609	213	2	contact	contact	PROPN
dpc-4609	213	3	atopic	atopic	NOUN
dpc-4609	213	4	occup	occup	ADJ
dpc-4609	213	5	drug	drug	NOUN
dpc-4609	213	6	.	.	PUNCT
dpc-4609	214	1	2019	2019	NUM
dpc-4609	214	2	;	;	PUNCT
dpc-4609	214	3	30(2):175	30(2):175	NUM
dpc-4609	214	4	-	-	PUNCT
dpc-4609	214	5	176	176	NUM
dpc-4609	214	6	.	.	PUNCT
dpc-4609	215	1	doi:10.1097	doi:10.1097	PROPN
dpc-4609	215	2	/	/	SYM
dpc-4609	216	1	der.0000000000000458	der.0000000000000458	NUM
dpc-4609	216	2	.	.	PUNCT
dpc-4609	217	1	10	10	NUM
dpc-4609	217	2	.	.	PUNCT
dpc-4609	217	3	barbarin	barbarin	PROPN
dpc-4609	217	4	c	c	PROPN
dpc-4609	217	5	,	,	PUNCT
dpc-4609	217	6	hosteing	hostee	VERB
dpc-4609	217	7	s	s	PRON
dpc-4609	217	8	,	,	PUNCT
dpc-4609	217	9	nosbaum	nosbaum	PROPN
dpc-4609	217	10	a	a	PRON
dpc-4609	217	11	,	,	PUNCT
dpc-4609	217	12	allouchery	allouchery	PROPN
dpc-4609	217	13	m	m	PROPN
dpc-4609	217	14	,	,	PUNCT
dpc-4609	217	15	celerier	celerier	NOUN
dpc-4609	217	16	p.	p.	NOUN
dpc-4609	217	17	early	early	ADJ
dpc-4609	217	18	onset	onset	NOUN
dpc-4609	217	19	of	of	ADP
dpc-4609	217	20	alopecia	alopecia	NOUN
dpc-4609	217	21	areata	areata	ADJ
dpc-4609	217	22	after	after	ADP
dpc-4609	217	23	dupilumab	dupilumab	NOUN
dpc-4609	217	24	introduction	introduction	NOUN
dpc-4609	217	25	in	in	ADP
dpc-4609	217	26	a	a	DET
dpc-4609	217	27	patient	patient	NOUN
dpc-4609	217	28	with	with	ADP
dpc-4609	217	29	atopic	atopic	NOUN
dpc-4609	217	30	dermatitis	dermatitis	NOUN
dpc-4609	217	31	.	.	PUNCT
dpc-4609	218	1	eur	eur	PROPN
dpc-4609	218	2	j	j	PROPN
dpc-4609	218	3	dermatol	dermatol	NOUN
dpc-4609	218	4	ejd	ejd	PROPN
dpc-4609	218	5	.	.	PUNCT
dpc-4609	219	1	2019;29(5):542	2019;29(5):542	PROPN
dpc-4609	219	2	-	-	PUNCT
dpc-4609	219	3	543	543	NUM
dpc-4609	219	4	.	.	PUNCT
dpc-4609	220	1	doi:10.1684	doi:10.1684	NOUN
dpc-4609	220	2	/	/	SYM
dpc-4609	220	3	ejd.2019.3626	ejd.2019.3626	PROPN
dpc-4609	220	4	.	.	NOUN
dpc-4609	220	5	11	11	NUM
dpc-4609	220	6	.	.	PUNCT
dpc-4609	221	1	flanagan	flanagan	PROPN
dpc-4609	221	2	k	k	PROPN
dpc-4609	221	3	,	,	PUNCT
dpc-4609	221	4	sperling	sperling	PROPN
dpc-4609	221	5	l	l	PROPN
dpc-4609	221	6	,	,	PUNCT
dpc-4609	221	7	lin	lin	PROPN
dpc-4609	221	8	j.	j.	PROPN
dpc-4609	221	9	drug	drug	PROPN
dpc-4609	221	10	-	-	PUNCT
dpc-4609	221	11	induced	induce	VERB
dpc-4609	221	12	alopecia	alopecia	NOUN
dpc-4609	221	13	after	after	ADP
dpc-4609	221	14	dupilumab	dupilumab	NOUN
dpc-4609	221	15	therapy	therapy	NOUN
dpc-4609	221	16	.	.	PUNCT
dpc-4609	222	1	jaad	jaad	PROPN
dpc-4609	222	2	case	case	NOUN
dpc-4609	222	3	rep	rep	PROPN
dpc-4609	222	4	.	.	PROPN
dpc-4609	222	5	2019;5(1):54	2019;5(1):54	PROPN
dpc-4609	222	6	-	-	SYM
dpc-4609	222	7	56	56	NUM
dpc-4609	222	8	.	.	PUNCT
dpc-4609	222	9	doi:10.1016	doi:10.1016	PROPN
dpc-4609	222	10	/j.jdcr.2018.10.010	/j.jdcr.2018.10.010	PUNCT
dpc-4609	222	11	.	.	PUNCT
dpc-4609	223	1	12	12	NUM
dpc-4609	223	2	.	.	PUNCT
dpc-4609	224	1	kanda	kanda	PROPN
dpc-4609	224	2	n	n	PROPN
dpc-4609	224	3	,	,	PUNCT
dpc-4609	224	4	koto	koto	PROPN
dpc-4609	224	5	m	m	PROPN
dpc-4609	224	6	,	,	PUNCT
dpc-4609	224	7	hoashi	hoashi	PROPN
dpc-4609	224	8	t	t	PROPN
dpc-4609	224	9	,	,	PUNCT
dpc-4609	224	10	saeki	saeki	PROPN
dpc-4609	224	11	h.	h.	PROPN
dpc-4609	224	12	case	case	NOUN
dpc-4609	224	13	of	of	ADP
dpc-4609	224	14	alopecia	alopecia	NOUN
dpc-4609	224	15	areata	areata	VERB
dpc-4609	224	16	during	during	ADP
dpc-4609	224	17	dupilumab	dupilumab	NOUN
dpc-4609	224	18	treatment	treatment	NOUN
dpc-4609	224	19	for	for	ADP
dpc-4609	224	20	atopic	atopic	NOUN
dpc-4609	224	21	dermatitis	dermatitis	NOUN
dpc-4609	224	22	.	.	PUNCT
dpc-4609	225	1	j	j	PROPN
dpc-4609	225	2	dermatol	dermatol	NOUN
dpc-4609	225	3	.	.	PUNCT
dpc-4609	226	1	2019;46(9):e332	2019;46(9):e332	NUM
dpc-4609	226	2	-	-	PUNCT
dpc-4609	226	3	e333	e333	PROPN
dpc-4609	226	4	.	.	PUNCT
dpc-4609	226	5	doi:10.1111/1346	doi:10.1111/1346	NOUN
dpc-4609	226	6	-	-	PUNCT
dpc-4609	226	7	8138.14880	8138.14880	NUM
dpc-4609	226	8	.	.	NOUN
dpc-4609	227	1	13	13	NUM
dpc-4609	227	2	.	.	X
dpc-4609	228	1	ständer	ständer	NOUN
dpc-4609	228	2	s	s	PART
dpc-4609	228	3	,	,	PUNCT
dpc-4609	228	4	trense	trense	PROPN
dpc-4609	228	5	y	y	PROPN
dpc-4609	228	6	,	,	PUNCT
dpc-4609	228	7	thaçi	thaçi	PROPN
dpc-4609	228	8	d	d	PROPN
dpc-4609	228	9	,	,	PUNCT
dpc-4609	228	10	ludwig	ludwig	PROPN
dpc-4609	228	11	rj	rj	PROPN
dpc-4609	228	12	.	.	PUNCT
dpc-4609	229	1	alopecia	alopecia	PROPN
dpc-4609	229	2	areata	areata	ADJ
dpc-4609	229	3	development	development	NOUN
dpc-4609	229	4	in	in	ADP
dpc-4609	229	5	atopic	atopic	NOUN
dpc-4609	229	6	dermatitis	dermatitis	NOUN
dpc-4609	229	7	patients	patient	NOUN
dpc-4609	229	8	treated	treat	VERB
dpc-4609	229	9	with	with	ADP
dpc-4609	229	10	dupilumab	dupilumab	NOUN
dpc-4609	229	11	.	.	PUNCT
dpc-4609	230	1	j	j	PROPN
dpc-4609	230	2	eur	eur	PROPN
dpc-4609	230	3	acad	acad	PROPN
dpc-4609	230	4	dermatol	dermatol	NOUN
dpc-4609	230	5	venereol	venereol	NOUN
dpc-4609	230	6	jeadv	jeadv	NOUN
dpc-4609	230	7	.	.	PUNCT
dpc-4609	231	1	2020;34(10):e612	2020;34(10):e612	PROPN
dpc-4609	231	2	-	-	PUNCT
dpc-4609	231	3	e613	e613	PROPN
dpc-4609	231	4	.	.	PUNCT
dpc-4609	232	1	doi:10.1111	doi:10.1111	PROPN
dpc-4609	232	2	/	/	SYM
dpc-4609	232	3	jdv.16493	jdv.16493	NUM
dpc-4609	232	4	.	.	PUNCT
dpc-4609	233	1	14	14	NUM
dpc-4609	233	2	.	.	PUNCT
dpc-4609	233	3	carnicle	carnicle	PROPN
dpc-4609	233	4	jm	jm	PROPN
dpc-4609	233	5	,	,	PUNCT
dpc-4609	233	6	hendricks	hendricks	PROPN
dpc-4609	233	7	aj	aj	PROPN
dpc-4609	233	8	,	,	PUNCT
dpc-4609	233	9	shi	shi	PROPN
dpc-4609	233	10	vy	vy	PROPN
dpc-4609	233	11	.	.	PUNCT
dpc-4609	234	1	reactivation	reactivation	NOUN
dpc-4609	234	2	of	of	ADP
dpc-4609	234	3	alopecia	alopecia	NOUN
dpc-4609	234	4	areata	areata	VERB
dpc-4609	234	5	after	after	ADP
dpc-4609	234	6	dupilumab	dupilumab	NOUN
dpc-4609	234	7	therapy	therapy	NOUN
dpc-4609	234	8	for	for	ADP
dpc-4609	234	9	atopic	atopic	NOUN
dpc-4609	234	10	dermatitis	dermatitis	NOUN
dpc-4609	234	11	.	.	PUNCT
dpc-4609	235	1	dermat	dermat	PROPN
dpc-4609	235	2	contact	contact	PROPN
dpc-4609	235	3	atopic	atopic	NOUN
dpc-4609	235	4	occup	occup	ADJ
dpc-4609	235	5	drug	drug	NOUN
dpc-4609	235	6	.	.	PUNCT
dpc-4609	236	1	2021;32(1s):e80	2021;32(1s):e80	NUM
dpc-4609	236	2	-	-	PUNCT
dpc-4609	236	3	e82	e82	NOUN
dpc-4609	236	4	.	.	PUNCT
dpc-4609	237	1	doi:10.1097	doi:10.1097	PROPN
dpc-4609	237	2	/	/	SYM
dpc-4609	237	3	der.0000000000000512	der.0000000000000512	NOUN
dpc-4609	237	4	.	.	PUNCT
dpc-4609	238	1	15	15	NUM
dpc-4609	238	2	.	.	PUNCT
dpc-4609	238	3	beaziz	beaziz	PROPN
dpc-4609	238	4	j	j	PROPN
dpc-4609	238	5	,	,	PUNCT
dpc-4609	238	6	bouaziz	bouaziz	PROPN
dpc-4609	238	7	jd	jd	PROPN
dpc-4609	238	8	,	,	PUNCT
dpc-4609	238	9	jachiet	jachiet	PROPN
dpc-4609	238	10	m	m	PROPN
dpc-4609	238	11	,	,	PUNCT
dpc-4609	238	12	fite	fite	PROPN
dpc-4609	238	13	c	c	PROPN
dpc-4609	238	14	,	,	PUNCT
dpc-4609	238	15	lons	lon	NOUN
dpc-4609	238	16	-	-	PUNCT
dpc-4609	238	17	danic	danic	ADJ
dpc-4609	238	18	d.	d.	PROPN
dpc-4609	238	19	dupilumab	dupilumab	NOUN
dpc-4609	238	20	-	-	PUNCT
dpc-4609	238	21	induced	induce	VERB
dpc-4609	238	22	psoriasis	psoriasis	NOUN
dpc-4609	238	23	and	and	CCONJ
dpc-4609	238	24	alopecia	alopecia	NOUN
dpc-4609	238	25	areata	areata	NOUN
dpc-4609	238	26	:	:	PUNCT
dpc-4609	238	27	case	case	NOUN
dpc-4609	238	28	report	report	NOUN
dpc-4609	238	29	and	and	CCONJ
dpc-4609	238	30	review	review	NOUN
dpc-4609	238	31	of	of	ADP
dpc-4609	238	32	the	the	DET
dpc-4609	238	33	literature	literature	NOUN
dpc-4609	238	34	.	.	PUNCT
dpc-4609	239	1	ann	ann	PROPN
dpc-4609	239	2	dermatol	dermatol	PROPN
dpc-4609	239	3	venereol	venereol	NOUN
dpc-4609	239	4	.	.	PUNCT
dpc-4609	240	1	2021	2021	NUM
dpc-4609	240	2	;	;	PUNCT
dpc-4609	240	3	148(3):198	148(3):198	NUM
dpc-4609	240	4	-	-	PUNCT
dpc-4609	240	5	201	201	NUM
dpc-4609	240	6	.	.	PUNCT
dpc-4609	241	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	241	2	/	/	SYM
dpc-4609	241	3	j.annder.2021.02.003	j.annder.2021.02.003	PROPN
dpc-4609	241	4	.	.	PROPN
dpc-4609	242	1	16	16	NUM
dpc-4609	242	2	.	.	PUNCT
dpc-4609	243	1	penzi	penzi	PROPN
dpc-4609	243	2	lr	lr	PROPN
dpc-4609	243	3	,	,	PUNCT
dpc-4609	243	4	yasuda	yasuda	PROPN
dpc-4609	243	5	m	m	PROPN
dpc-4609	243	6	,	,	PUNCT
dpc-4609	243	7	manatis	manatis	ADJ
dpc-4609	243	8	-	-	NOUN
dpc-4609	243	9	lornell	lornell	NOUN
dpc-4609	243	10	a	a	PRON
dpc-4609	243	11	,	,	PUNCT
dpc-4609	243	12	hagigeorges	hagigeorge	NOUN
dpc-4609	243	13	d	d	NOUN
dpc-4609	243	14	,	,	PUNCT
dpc-4609	243	15	senna	senna	PROPN
dpc-4609	243	16	mm	mm	PROPN
dpc-4609	243	17	.	.	PUNCT
dpc-4609	244	1	hair	hair	NOUN
dpc-4609	244	2	regrowth	regrowth	NOUN
dpc-4609	244	3	in	in	ADP
dpc-4609	244	4	a	a	DET
dpc-4609	244	5	patient	patient	NOUN
dpc-4609	244	6	with	with	ADP
dpc-4609	244	7	long	long	ADV
dpc-4609	244	8	-	-	PUNCT
dpc-4609	244	9	standing	stand	VERB
dpc-4609	244	10	alopecia	alopecia	NOUN
dpc-4609	244	11	totalis	totali	NOUN
dpc-4609	244	12	and	and	CCONJ
dpc-4609	244	13	atopic	atopic	NOUN
dpc-4609	244	14	dermatitis	dermatitis	NOUN
dpc-4609	244	15	treated	treat	VERB
dpc-4609	244	16	with	with	ADP
dpc-4609	244	17	dupilumab	dupilumab	NOUN
dpc-4609	244	18	.	.	PUNCT
dpc-4609	245	1	jama	jama	PROPN
dpc-4609	245	2	dermatol	dermatol	NOUN
dpc-4609	245	3	.	.	PUNCT
dpc-4609	246	1	2018;154(11):1358	2018;154(11):1358	NUM
dpc-4609	246	2	-	-	SYM
dpc-4609	246	3	1360	1360	NUM
dpc-4609	246	4	.	.	PUNCT
dpc-4609	247	1	doi:10.1001	doi:10.1001	PROPN
dpc-4609	247	2	/jamadermatol.2018.2976	/jamadermatol.2018.2976	PROPN
dpc-4609	247	3	.	.	PUNCT
dpc-4609	248	1	17	17	NUM
dpc-4609	248	2	.	.	PUNCT
dpc-4609	248	3	smogorzewski	smogorzewski	PROPN
dpc-4609	248	4	j	j	PROPN
dpc-4609	248	5	,	,	PUNCT
dpc-4609	248	6	sierro	sierro	PROPN
dpc-4609	248	7	t	t	PROPN
dpc-4609	248	8	,	,	PUNCT
dpc-4609	248	9	compoginis	compoginis	NOUN
dpc-4609	248	10	g	g	PROPN
dpc-4609	248	11	,	,	PUNCT
dpc-4609	248	12	kim	kim	PROPN
dpc-4609	248	13	g.	g.	PROPN
dpc-4609	248	14	remission	remission	NOUN
dpc-4609	248	15	of	of	ADP
dpc-4609	248	16	alopecia	alopecia	NOUN
dpc-4609	248	17	universalis	universali	VERB
dpc-4609	248	18	in	in	ADP
dpc-4609	248	19	a	a	DET
dpc-4609	248	20	patient	patient	NOUN
dpc-4609	248	21	with	with	ADP
dpc-4609	248	22	atopic	atopic	NOUN
dpc-4609	248	23	dermatitis	dermatitis	NOUN
dpc-4609	248	24	treated	treat	VERB
dpc-4609	248	25	with	with	ADP
dpc-4609	248	26	dupilumab	dupilumab	NOUN
dpc-4609	248	27	.	.	PUNCT
dpc-4609	249	1	jaad	jaad	PROPN
dpc-4609	249	2	case	case	PROPN
dpc-4609	249	3	rep	rep	PROPN
dpc-4609	249	4	.	.	PROPN
dpc-4609	249	5	2019;5(2):116	2019;5(2):116	PROPN
dpc-4609	249	6	-	-	SYM
dpc-4609	249	7	117	117	NUM
dpc-4609	249	8	.	.	PUNCT
dpc-4609	250	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	250	2	/j.jdcr.2018.11.007	/j.jdcr.2018.11.007	PROPN
dpc-4609	250	3	.	.	PUNCT
dpc-4609	251	1	18	18	NUM
dpc-4609	251	2	.	.	NUM
dpc-4609	251	3	darrigade	darrigade	VERB
dpc-4609	251	4	as	as	ADP
dpc-4609	251	5	,	,	PUNCT
dpc-4609	251	6	legrand	legrand	PROPN
dpc-4609	251	7	a	a	X
dpc-4609	251	8	,	,	PUNCT
dpc-4609	251	9	andreu	andreu	PROPN
dpc-4609	251	10	n	n	CCONJ
dpc-4609	251	11	,	,	PUNCT
dpc-4609	251	12	et	et	PROPN
dpc-4609	251	13	al	al	PROPN
dpc-4609	251	14	.	.	PUNCT
dpc-4609	252	1	dual	dual	ADJ
dpc-4609	252	2	efficacy	efficacy	NOUN
dpc-4609	252	3	of	of	ADP
dpc-4609	252	4	dupilumab	dupilumab	NOUN
dpc-4609	252	5	in	in	ADP
dpc-4609	252	6	a	a	DET
dpc-4609	252	7	patient	patient	NOUN
dpc-4609	252	8	with	with	ADP
dpc-4609	252	9	concomitant	concomitant	ADJ
dpc-4609	252	10	atopic	atopic	NOUN
dpc-4609	252	11	dermatitis	dermatitis	NOUN
dpc-4609	252	12	and	and	CCONJ
dpc-4609	252	13	alopecia	alopecia	NOUN
dpc-4609	252	14	areata	areata	ADJ
dpc-4609	252	15	.	.	PUNCT
dpc-4609	253	1	br	br	PROPN
dpc-4609	253	2	j	j	PROPN
dpc-4609	253	3	dermatol	dermatol	NOUN
dpc-4609	253	4	.	.	PUNCT
dpc-4609	254	1	2018;179(2):534	2018;179(2):534	NUM
dpc-4609	254	2	-	-	SYM
dpc-4609	254	3	536	536	NUM
dpc-4609	254	4	.	.	PUNCT
dpc-4609	255	1	doi:10.1111	doi:10.1111	PROPN
dpc-4609	255	2	/bjd.16711	/bjd.16711	PROPN
dpc-4609	255	3	.	.	PUNCT
dpc-4609	256	1	19	19	NUM
dpc-4609	256	2	.	.	NOUN
dpc-4609	256	3	alniemi	alniemi	PROPN
dpc-4609	256	4	dt	dt	PROPN
dpc-4609	256	5	,	,	PUNCT
dpc-4609	256	6	mcgevna	mcgevna	PROPN
dpc-4609	256	7	l.	l.	PROPN
dpc-4609	256	8	dupilumab	dupilumab	NOUN
dpc-4609	256	9	treatment	treatment	NOUN
dpc-4609	256	10	for	for	ADP
dpc-4609	256	11	atopic	atopic	NOUN
dpc-4609	256	12	dermatitis	dermatitis	NOUN
dpc-4609	256	13	leading	lead	VERB
dpc-4609	256	14	to	to	ADP
dpc-4609	256	15	unexpected	unexpected	ADJ
dpc-4609	256	16	treatment	treatment	NOUN
dpc-4609	256	17	for	for	ADP
dpc-4609	256	18	alopecia	alopecia	NOUN
dpc-4609	256	19	conditions	condition	NOUN
dpc-4609	256	20	[	[	X
dpc-4609	256	21	38	38	NUM
dpc-4609	256	22	]	]	PUNCT
dpc-4609	256	23	.	.	PUNCT
dpc-4609	257	1	this	this	PRON
dpc-4609	257	2	is	be	AUX
dpc-4609	257	3	consistent	consistent	ADJ
dpc-4609	257	4	with	with	ADP
dpc-4609	257	5	prior	prior	ADJ
dpc-4609	257	6	reports	report	NOUN
dpc-4609	257	7	that	that	PRON
dpc-4609	257	8	link	link	VERB
dpc-4609	257	9	such	such	ADJ
dpc-4609	257	10	variability	variability	NOUN
dpc-4609	257	11	to	to	ADP
dpc-4609	257	12	severe	severe	ADJ
dpc-4609	257	13	and/or	and/or	CCONJ
dpc-4609	257	14	long	long	ADV
dpc-4609	257	15	-	-	PUNCT
dpc-4609	257	16	standing	stand	VERB
dpc-4609	257	17	aa	aa	NOUN
dpc-4609	258	1	[	[	X
dpc-4609	258	2	37	37	NUM
dpc-4609	258	3	]	]	PUNCT
dpc-4609	258	4	;	;	PUNCT
dpc-4609	258	5	indeed	indeed	ADV
dpc-4609	258	6	,	,	PUNCT
dpc-4609	258	7	these	these	DET
dpc-4609	258	8	variants	variant	NOUN
dpc-4609	258	9	seem	seem	VERB
dpc-4609	258	10	to	to	PART
dpc-4609	258	11	be	be	AUX
dpc-4609	258	12	related	relate	VERB
dpc-4609	258	13	to	to	ADP
dpc-4609	258	14	a	a	DET
dpc-4609	258	15	higher	high	ADJ
dpc-4609	258	16	chance	chance	NOUN
dpc-4609	258	17	of	of	ADP
dpc-4609	258	18	improvement	improvement	NOUN
dpc-4609	258	19	after	after	ADP
dpc-4609	258	20	dupilumab	dupilumab	NOUN
dpc-4609	258	21	administration	administration	PROPN
dpc-4609	258	22	.	.	PUNCT
dpc-4609	259	1	additionally	additionally	ADV
dpc-4609	259	2	,	,	PUNCT
dpc-4609	259	3	it	it	PRON
dpc-4609	259	4	seems	seem	VERB
dpc-4609	259	5	that	that	SCONJ
dpc-4609	259	6	dupilumab	dupilumab	NOUN
dpc-4609	259	7	is	be	AUX
dpc-4609	259	8	associated	associate	VERB
dpc-4609	259	9	with	with	ADP
dpc-4609	259	10	a	a	DET
dpc-4609	259	11	slow	slow	ADJ
dpc-4609	259	12	onset	onset	NOUN
dpc-4609	259	13	of	of	ADP
dpc-4609	259	14	action	action	NOUN
dpc-4609	259	15	in	in	ADP
dpc-4609	259	16	children	child	NOUN
dpc-4609	259	17	and	and	CCONJ
dpc-4609	259	18	works	work	VERB
dpc-4609	259	19	better	well	ADV
dpc-4609	259	20	when	when	SCONJ
dpc-4609	259	21	combined	combine	VERB
dpc-4609	259	22	with	with	ADP
dpc-4609	259	23	other	other	ADJ
dpc-4609	259	24	therapies	therapy	NOUN
dpc-4609	259	25	such	such	ADJ
dpc-4609	259	26	as	as	ADP
dpc-4609	259	27	oral	oral	ADJ
dpc-4609	259	28	minoxidil	minoxidil	NOUN
dpc-4609	260	1	[	[	X
dpc-4609	260	2	38,39	38,39	NOUN
dpc-4609	260	3	]	]	X
dpc-4609	260	4	.	.	PUNCT
dpc-4609	261	1	lastly	lastly	ADV
dpc-4609	261	2	,	,	PUNCT
dpc-4609	261	3	another	another	DET
dpc-4609	261	4	factor	factor	NOUN
dpc-4609	261	5	that	that	PRON
dpc-4609	261	6	may	may	AUX
dpc-4609	261	7	be	be	AUX
dpc-4609	261	8	linked	link	VERB
dpc-4609	261	9	to	to	ADP
dpc-4609	261	10	the	the	DET
dpc-4609	261	11	varying	vary	VERB
dpc-4609	261	12	response	response	NOUN
dpc-4609	261	13	to	to	ADP
dpc-4609	261	14	dupilumab	dupilumab	NOUN
dpc-4609	261	15	in	in	ADP
dpc-4609	261	16	aa	aa	ADJ
dpc-4609	261	17	patients	patient	NOUN
dpc-4609	261	18	could	could	AUX
dpc-4609	261	19	be	be	AUX
dpc-4609	261	20	ige	ige	PROPN
dpc-4609	261	21	levels	level	NOUN
dpc-4609	261	22	.	.	PUNCT
dpc-4609	262	1	indeed	indeed	ADV
dpc-4609	262	2	,	,	PUNCT
dpc-4609	262	3	guttman	guttman	ADJ
dpc-4609	262	4	-	-	PUNCT
dpc-4609	262	5	yassky	yassky	NOUN
dpc-4609	262	6	et	et	PROPN
dpc-4609	262	7	al	al	PROPN
dpc-4609	262	8	.	.	PROPN
dpc-4609	262	9	conducted	conduct	VERB
dpc-4609	262	10	a	a	DET
dpc-4609	262	11	phase	phase	NOUN
dpc-4609	262	12	2a	2a	NUM
dpc-4609	262	13	clinical	clinical	ADJ
dpc-4609	262	14	trial	trial	NOUN
dpc-4609	262	15	and	and	CCONJ
dpc-4609	262	16	noted	note	VERB
dpc-4609	262	17	that	that	SCONJ
dpc-4609	262	18	progress	progress	NOUN
dpc-4609	262	19	rates	rate	NOUN
dpc-4609	262	20	were	be	AUX
dpc-4609	262	21	higher	high	ADJ
dpc-4609	262	22	in	in	ADP
dpc-4609	262	23	patients	patient	NOUN
dpc-4609	262	24	with	with	ADP
dpc-4609	262	25	baseline	baseline	ADJ
dpc-4609	262	26	ige	ige	PROPN
dpc-4609	262	27	levels	level	NOUN
dpc-4609	262	28	of	of	ADP
dpc-4609	262	29	200	200	NUM
dpc-4609	262	30	iu	iu	NOUN
dpc-4609	262	31	/	/	SYM
dpc-4609	262	32	ml	ml	NOUN
dpc-4609	262	33	or	or	CCONJ
dpc-4609	262	34	more	more	ADJ
dpc-4609	262	35	,	,	PUNCT
dpc-4609	262	36	demonstrating	demonstrate	VERB
dpc-4609	262	37	how	how	SCONJ
dpc-4609	262	38	a	a	DET
dpc-4609	262	39	th2	th2	PROPN
dpc-4609	262	40	-	-	PUNCT
dpc-4609	262	41	directed	direct	VERB
dpc-4609	262	42	therapy	therapy	NOUN
dpc-4609	262	43	could	could	AUX
dpc-4609	262	44	be	be	AUX
dpc-4609	262	45	beneficial	beneficial	ADJ
dpc-4609	262	46	for	for	ADP
dpc-4609	262	47	specific	specific	ADJ
dpc-4609	262	48	aa	aa	NOUN
dpc-4609	262	49	patients	patient	NOUN
dpc-4609	263	1	[	[	X
dpc-4609	263	2	1	1	NUM
dpc-4609	263	3	]	]	PUNCT
dpc-4609	263	4	.	.	PUNCT
dpc-4609	264	1	although	although	SCONJ
dpc-4609	264	2	not	not	PART
dpc-4609	264	3	many	many	ADJ
dpc-4609	264	4	articles	article	NOUN
dpc-4609	264	5	in	in	ADP
dpc-4609	264	6	our	our	PRON
dpc-4609	264	7	review	review	NOUN
dpc-4609	264	8	reported	report	VERB
dpc-4609	264	9	ige	ige	PROPN
dpc-4609	264	10	levels	level	NOUN
dpc-4609	264	11	,	,	PUNCT
dpc-4609	264	12	all	all	DET
dpc-4609	264	13	patients	patient	NOUN
dpc-4609	264	14	with	with	ADP
dpc-4609	264	15	high	high	ADJ
dpc-4609	264	16	ige	ige	PROPN
dpc-4609	264	17	levels	level	NOUN
dpc-4609	264	18	improved	improve	VERB
dpc-4609	264	19	significantly	significantly	ADV
dpc-4609	264	20	,	,	PUNCT
dpc-4609	264	21	which	which	PRON
dpc-4609	264	22	aligns	align	VERB
dpc-4609	264	23	with	with	ADP
dpc-4609	264	24	the	the	DET
dpc-4609	264	25	literature	literature	NOUN
dpc-4609	265	1	[	[	X
dpc-4609	265	2	1	1	NUM
dpc-4609	265	3	]	]	PUNCT
dpc-4609	265	4	.	.	PUNCT
dpc-4609	266	1	we	we	PRON
dpc-4609	266	2	identified	identify	VERB
dpc-4609	266	3	two	two	NUM
dpc-4609	266	4	potential	potential	ADJ
dpc-4609	266	5	limitations	limitation	NOUN
dpc-4609	266	6	of	of	ADP
dpc-4609	266	7	this	this	DET
dpc-4609	266	8	study	study	NOUN
dpc-4609	266	9	that	that	SCONJ
dpc-4609	266	10	we	we	PRON
dpc-4609	266	11	would	would	AUX
dpc-4609	266	12	like	like	VERB
dpc-4609	266	13	to	to	PART
dpc-4609	266	14	state	state	VERB
dpc-4609	266	15	.	.	PUNCT
dpc-4609	267	1	the	the	DET
dpc-4609	267	2	first	first	ADJ
dpc-4609	267	3	is	be	AUX
dpc-4609	267	4	represented	represent	VERB
dpc-4609	267	5	by	by	ADP
dpc-4609	267	6	a	a	DET
dpc-4609	267	7	possible	possible	ADJ
dpc-4609	267	8	selection	selection	NOUN
dpc-4609	267	9	bias	bias	NOUN
dpc-4609	267	10	due	due	ADP
dpc-4609	267	11	to	to	ADP
dpc-4609	267	12	a	a	DET
dpc-4609	267	13	greater	great	ADJ
dpc-4609	267	14	propensity	propensity	NOUN
dpc-4609	267	15	to	to	PART
dpc-4609	267	16	publish	publish	VERB
dpc-4609	267	17	positive	positive	ADJ
dpc-4609	267	18	results	result	NOUN
dpc-4609	267	19	of	of	ADP
dpc-4609	267	20	dupilumab	dupilumab	NOUN
dpc-4609	267	21	on	on	ADP
dpc-4609	267	22	alopecia	alopecia	NOUN
dpc-4609	267	23	areata	areata	ADJ
dpc-4609	267	24	.	.	PUNCT
dpc-4609	268	1	the	the	DET
dpc-4609	268	2	second	second	NOUN
dpc-4609	268	3	is	be	AUX
dpc-4609	268	4	the	the	DET
dpc-4609	268	5	absence	absence	NOUN
dpc-4609	268	6	of	of	ADP
dpc-4609	268	7	an	an	DET
dpc-4609	268	8	indication	indication	NOUN
dpc-4609	268	9	for	for	ADP
dpc-4609	268	10	dupilumab	dupilumab	NOUN
dpc-4609	268	11	for	for	ADP
dpc-4609	268	12	alopecia	alopecia	NOUN
dpc-4609	268	13	areata	areata	NOUN
dpc-4609	268	14	,	,	PUNCT
dpc-4609	268	15	making	make	VERB
dpc-4609	268	16	its	its	PRON
dpc-4609	268	17	use	use	NOUN
dpc-4609	268	18	more	more	ADV
dpc-4609	268	19	difficult	difficult	ADJ
dpc-4609	268	20	in	in	ADP
dpc-4609	268	21	patients	patient	NOUN
dpc-4609	268	22	affected	affect	VERB
dpc-4609	268	23	solely	solely	ADV
dpc-4609	268	24	by	by	ADP
dpc-4609	268	25	alopecia	alopecia	NOUN
dpc-4609	268	26	areata	areata	NOUN
dpc-4609	268	27	.	.	PUNCT
dpc-4609	269	1	conclusion	conclusion	NOUN
dpc-4609	269	2	in	in	ADP
dpc-4609	269	3	conclusion	conclusion	NOUN
dpc-4609	269	4	,	,	PUNCT
dpc-4609	269	5	our	our	PRON
dpc-4609	269	6	research	research	NOUN
dpc-4609	269	7	highlights	highlight	NOUN
dpc-4609	269	8	once	once	ADV
dpc-4609	269	9	more	more	ADV
dpc-4609	269	10	the	the	DET
dpc-4609	269	11	important	important	ADJ
dpc-4609	269	12	yet	yet	CCONJ
dpc-4609	269	13	intricate	intricate	ADJ
dpc-4609	269	14	relationship	relationship	NOUN
dpc-4609	269	15	linking	link	VERB
dpc-4609	269	16	aa	aa	NOUN
dpc-4609	269	17	,	,	PUNCT
dpc-4609	269	18	ad	ad	NOUN
dpc-4609	269	19	,	,	PUNCT
dpc-4609	269	20	and	and	CCONJ
dpc-4609	269	21	dupilumab	dupilumab	NOUN
dpc-4609	269	22	.	.	PUNCT
dpc-4609	270	1	while	while	SCONJ
dpc-4609	270	2	the	the	DET
dpc-4609	270	3	pathogenesis	pathogenesis	NOUN
dpc-4609	270	4	of	of	ADP
dpc-4609	270	5	aa	aa	PROPN
dpc-4609	270	6	is	be	AUX
dpc-4609	270	7	still	still	ADV
dpc-4609	270	8	debated	debate	VERB
dpc-4609	270	9	,	,	PUNCT
dpc-4609	270	10	our	our	PRON
dpc-4609	270	11	findings	finding	NOUN
dpc-4609	270	12	underscore	underscore	VERB
dpc-4609	270	13	the	the	DET
dpc-4609	270	14	existence	existence	NOUN
dpc-4609	270	15	of	of	ADP
dpc-4609	270	16	th1	th1	PROPN
dpc-4609	270	17	-	-	PUNCT
dpc-4609	270	18	skewed	skewed	ADJ
dpc-4609	270	19	and	and	CCONJ
dpc-4609	270	20	th2	th2	PROPN
dpc-4609	270	21	-	-	PUNCT
dpc-4609	270	22	skewed	skewed	ADJ
dpc-4609	270	23	aa	aa	PROPN
dpc-4609	270	24	subtypes	subtype	NOUN
dpc-4609	270	25	.	.	PUNCT
dpc-4609	271	1	additionally	additionally	ADV
dpc-4609	271	2	,	,	PUNCT
dpc-4609	271	3	we	we	PRON
dpc-4609	271	4	identified	identify	VERB
dpc-4609	271	5	how	how	SCONJ
dpc-4609	271	6	different	different	ADJ
dpc-4609	271	7	factors	factor	NOUN
dpc-4609	271	8	,	,	PUNCT
dpc-4609	271	9	such	such	ADJ
dpc-4609	271	10	as	as	ADP
dpc-4609	271	11	sex	sex	NOUN
dpc-4609	271	12	,	,	PUNCT
dpc-4609	271	13	age	age	NOUN
dpc-4609	271	14	,	,	PUNCT
dpc-4609	271	15	severity	severity	NOUN
dpc-4609	271	16	,	,	PUNCT
dpc-4609	271	17	and	and	CCONJ
dpc-4609	271	18	disease	disease	NOUN
dpc-4609	271	19	duration	duration	NOUN
dpc-4609	271	20	,	,	PUNCT
dpc-4609	271	21	might	might	AUX
dpc-4609	271	22	affect	affect	VERB
dpc-4609	271	23	the	the	DET
dpc-4609	271	24	response	response	NOUN
dpc-4609	271	25	of	of	ADP
dpc-4609	271	26	aa	aa	NOUN
dpc-4609	271	27	patients	patient	NOUN
dpc-4609	271	28	to	to	PART
dpc-4609	271	29	dupilumab	dupilumab	VERB
dpc-4609	271	30	.	.	PUNCT
dpc-4609	272	1	this	this	PRON
dpc-4609	272	2	is	be	AUX
dpc-4609	272	3	of	of	ADP
dpc-4609	272	4	paramount	paramount	ADJ
dpc-4609	272	5	importance	importance	NOUN
dpc-4609	272	6	as	as	SCONJ
dpc-4609	272	7	it	it	PRON
dpc-4609	272	8	underscores	underscore	VERB
dpc-4609	272	9	the	the	DET
dpc-4609	272	10	need	need	NOUN
dpc-4609	272	11	to	to	PART
dpc-4609	272	12	consider	consider	VERB
dpc-4609	272	13	comorbidities	comorbiditie	NOUN
dpc-4609	272	14	in	in	ADP
dpc-4609	272	15	aa	aa	PROPN
dpc-4609	272	16	patients	patient	NOUN
dpc-4609	272	17	,	,	PUNCT
dpc-4609	272	18	especially	especially	ADV
dpc-4609	272	19	those	those	PRON
dpc-4609	272	20	dealing	deal	VERB
dpc-4609	272	21	with	with	ADP
dpc-4609	272	22	both	both	CCONJ
dpc-4609	272	23	aa	aa	NOUN
dpc-4609	272	24	and	and	CCONJ
dpc-4609	272	25	ad	ad	NOUN
dpc-4609	272	26	.	.	PUNCT
dpc-4609	273	1	future	future	ADJ
dpc-4609	273	2	studies	study	NOUN
dpc-4609	273	3	are	be	AUX
dpc-4609	273	4	necessary	necessary	ADJ
dpc-4609	273	5	to	to	PART
dpc-4609	273	6	determine	determine	VERB
dpc-4609	273	7	how	how	SCONJ
dpc-4609	273	8	different	different	ADJ
dpc-4609	273	9	cytokine	cytokine	NOUN
dpc-4609	273	10	pathways	pathway	NOUN
dpc-4609	273	11	underlying	underlie	VERB
dpc-4609	273	12	aa	aa	NOUN
dpc-4609	273	13	can	can	AUX
dpc-4609	273	14	influence	influence	VERB
dpc-4609	273	15	dupilumab	dupilumab	NOUN
dpc-4609	273	16	’s	’s	PART
dpc-4609	273	17	effect	effect	NOUN
dpc-4609	273	18	,	,	PUNCT
dpc-4609	273	19	with	with	ADP
dpc-4609	273	20	the	the	DET
dpc-4609	273	21	ultimate	ultimate	ADJ
dpc-4609	273	22	goal	goal	NOUN
dpc-4609	273	23	of	of	ADP
dpc-4609	273	24	creating	create	VERB
dpc-4609	273	25	more	more	ADV
dpc-4609	273	26	personalized	personalized	ADJ
dpc-4609	273	27	and	and	CCONJ
dpc-4609	273	28	effective	effective	ADJ
dpc-4609	273	29	treatment	treatment	NOUN
dpc-4609	273	30	protocols	protocol	NOUN
dpc-4609	273	31	.	.	PUNCT
dpc-4609	274	1	references	reference	NOUN
dpc-4609	274	2	1	1	NUM
dpc-4609	274	3	.	.	PUNCT
dpc-4609	274	4	guttman	guttman	ADJ
dpc-4609	274	5	-	-	PUNCT
dpc-4609	274	6	yassky	yassky	NOUN
dpc-4609	274	7	e	e	NOUN
dpc-4609	274	8	,	,	PUNCT
dpc-4609	274	9	renert	renert	NOUN
dpc-4609	274	10	-	-	PUNCT
dpc-4609	274	11	yuval	yuval	PROPN
dpc-4609	274	12	y	y	PROPN
dpc-4609	274	13	,	,	PUNCT
dpc-4609	274	14	bares	bares	PROPN
dpc-4609	274	15	j	j	PROPN
dpc-4609	274	16	,	,	PUNCT
dpc-4609	274	17	et	et	PROPN
dpc-4609	274	18	al	al	PROPN
dpc-4609	274	19	.	.	PROPN
dpc-4609	274	20	phase	phase	PROPN
dpc-4609	274	21	2a	2a	NUM
dpc-4609	274	22	randomized	randomize	VERB
dpc-4609	274	23	clinical	clinical	ADJ
dpc-4609	274	24	trial	trial	NOUN
dpc-4609	274	25	of	of	ADP
dpc-4609	274	26	dupilumab	dupilumab	NOUN
dpc-4609	274	27	(	(	PUNCT
dpc-4609	274	28	anti	anti	ADJ
dpc-4609	274	29	-	-	ADJ
dpc-4609	274	30	il-4rα	il-4rα	ADJ
dpc-4609	274	31	)	)	PUNCT
dpc-4609	274	32	for	for	ADP
dpc-4609	274	33	alopecia	alopecia	NOUN
dpc-4609	274	34	areata	areata	ADJ
dpc-4609	274	35	patients	patient	NOUN
dpc-4609	274	36	.	.	PUNCT
dpc-4609	275	1	allergy	allergy	NOUN
dpc-4609	275	2	.	.	PUNCT
dpc-4609	276	1	2022;77(3):897	2022;77(3):897	PROPN
dpc-4609	276	2	-	-	PUNCT
dpc-4609	276	3	906	906	NUM
dpc-4609	276	4	.	.	PUNCT
dpc-4609	277	1	doi:10.1111	doi:10.1111	PROPN
dpc-4609	277	2	/all.15071	/all.15071	PROPN
dpc-4609	277	3	.	.	PUNCT
dpc-4609	278	1	2	2	X
dpc-4609	278	2	.	.	X
dpc-4609	278	3	harada	harada	PROPN
dpc-4609	278	4	k	k	PROPN
dpc-4609	278	5	,	,	PUNCT
dpc-4609	278	6	irisawa	irisawa	PROPN
dpc-4609	278	7	r	r	PROPN
dpc-4609	278	8	,	,	PUNCT
dpc-4609	278	9	ito	ito	PROPN
dpc-4609	278	10	t	t	PROPN
dpc-4609	278	11	,	,	PUNCT
dpc-4609	278	12	uchiyama	uchiyama	NOUN
dpc-4609	278	13	m	m	PROPN
dpc-4609	278	14	,	,	PUNCT
dpc-4609	278	15	tsuboi	tsuboi	PROPN
dpc-4609	278	16	r.	r.	PROPN
dpc-4609	278	17	the	the	DET
dpc-4609	278	18	effectiveness	effectiveness	NOUN
dpc-4609	278	19	of	of	ADP
dpc-4609	278	20	dupilumab	dupilumab	NOUN
dpc-4609	278	21	in	in	ADP
dpc-4609	278	22	patients	patient	NOUN
dpc-4609	278	23	with	with	ADP
dpc-4609	278	24	alopecia	alopecia	NOUN
dpc-4609	278	25	areata	areata	NOUN
dpc-4609	278	26	who	who	PRON
dpc-4609	278	27	have	have	VERB
dpc-4609	278	28	atopic	atopic	NOUN
dpc-4609	278	29	dermatitis	dermatitis	NOUN
dpc-4609	278	30	:	:	PUNCT
dpc-4609	278	31	a	a	DET
dpc-4609	278	32	case	case	NOUN
dpc-4609	278	33	series	series	NOUN
dpc-4609	278	34	of	of	ADP
dpc-4609	278	35	seven	seven	NUM
dpc-4609	278	36	patients	patient	NOUN
dpc-4609	278	37	.	.	PUNCT
dpc-4609	279	1	br	br	PROPN
dpc-4609	279	2	j	j	PROPN
dpc-4609	279	3	dermatol	dermatol	NOUN
dpc-4609	279	4	.	.	PUNCT
dpc-4609	280	1	2020;183(2):396	2020;183(2):396	NUM
dpc-4609	280	2	-	-	SYM
dpc-4609	280	3	397	397	NUM
dpc-4609	280	4	.	.	PUNCT
dpc-4609	281	1	doi:10.1111	doi:10.1111	NOUN
dpc-4609	281	2	/	/	SYM
dpc-4609	281	3	bjd.18976	bjd.18976	NOUN
dpc-4609	281	4	.	.	NOUN
dpc-4609	282	1	3	3	NUM
dpc-4609	282	2	.	.	X
dpc-4609	282	3	ito	ito	PROPN
dpc-4609	282	4	t	t	PROPN
dpc-4609	282	5	,	,	PUNCT
dpc-4609	282	6	kageyama	kageyama	PROPN
dpc-4609	282	7	r	r	PROPN
dpc-4609	282	8	,	,	PUNCT
dpc-4609	282	9	nakazawa	nakazawa	PROPN
dpc-4609	282	10	s	s	PROPN
dpc-4609	282	11	,	,	PUNCT
dpc-4609	282	12	honda	honda	NOUN
dpc-4609	282	13	t.	t.	PROPN
dpc-4609	282	14	understanding	understand	VERB
dpc-4609	282	15	the	the	DET
dpc-4609	282	16	significance	significance	NOUN
dpc-4609	282	17	of	of	ADP
dpc-4609	282	18	cytokines	cytokine	NOUN
dpc-4609	282	19	and	and	CCONJ
dpc-4609	282	20	chemokines	chemokine	NOUN
dpc-4609	282	21	in	in	ADP
dpc-4609	282	22	the	the	DET
dpc-4609	282	23	pathogenesis	pathogenesis	NOUN
dpc-4609	282	24	of	of	ADP
dpc-4609	282	25	review	review	NOUN
dpc-4609	282	26	|	|	ADV
dpc-4609	282	27	dermatol	dermatol	ADJ
dpc-4609	282	28	pract	pract	NOUN
dpc-4609	282	29	concept	concept	NOUN
dpc-4609	282	30	.	.	PUNCT
dpc-4609	283	1	2024;14(4):e2024270	2024;14(4):e2024270	NUM
dpc-4609	283	2	7	7	NUM
dpc-4609	283	3	30	30	NUM
dpc-4609	283	4	.	.	PUNCT
dpc-4609	284	1	ushida	ushida	PROPN
dpc-4609	284	2	m	m	PROPN
dpc-4609	284	3	,	,	PUNCT
dpc-4609	284	4	ohshita	ohshita	PROPN
dpc-4609	284	5	a	a	PROPN
dpc-4609	284	6	,	,	PUNCT
dpc-4609	284	7	arakawa	arakawa	PROPN
dpc-4609	284	8	y	y	PROPN
dpc-4609	284	9	,	,	PUNCT
dpc-4609	284	10	kanehisa	kanehisa	NOUN
dpc-4609	284	11	f	f	PROPN
dpc-4609	284	12	,	,	PUNCT
dpc-4609	284	13	katoh	katoh	NOUN
dpc-4609	284	14	n	n	CCONJ
dpc-4609	284	15	,	,	PUNCT
dpc-4609	284	16	asai	asai	PROPN
dpc-4609	284	17	j.	j.	PROPN
dpc-4609	284	18	dupilumab	dupilumab	PROPN
dpc-4609	284	19	therapy	therapy	NOUN
dpc-4609	284	20	rapidly	rapidly	ADV
dpc-4609	284	21	improved	improve	VERB
dpc-4609	284	22	alopecia	alopecia	NOUN
dpc-4609	284	23	areata	areata	NOUN
dpc-4609	284	24	associated	associate	VERB
dpc-4609	284	25	with	with	ADP
dpc-4609	284	26	trichotillomania	trichotillomania	NOUN
dpc-4609	284	27	in	in	ADP
dpc-4609	284	28	an	an	DET
dpc-4609	284	29	atopic	atopic	NOUN
dpc-4609	284	30	dermatitis	dermatitis	NOUN
dpc-4609	284	31	patient	patient	NOUN
dpc-4609	284	32	.	.	PUNCT
dpc-4609	285	1	allergol	allergol	PROPN
dpc-4609	285	2	int	int	PROPN
dpc-4609	285	3	off	off	ADP
dpc-4609	285	4	j	j	PROPN
dpc-4609	285	5	jpn	jpn	PROPN
dpc-4609	285	6	soc	soc	PROPN
dpc-4609	285	7	allergol	allergol	PROPN
dpc-4609	285	8	.	.	PUNCT
dpc-4609	286	1	2020;69(3):480	2020;69(3):480	PROPN
dpc-4609	286	2	-	-	SYM
dpc-4609	286	3	482	482	PROPN
dpc-4609	286	4	.	.	PUNCT
dpc-4609	286	5	doi:10.1016	doi:10.1016	PROPN
dpc-4609	286	6	/j.alit.2020.02.009	/j.alit.2020.02.009	PUNCT
dpc-4609	286	7	.	.	PUNCT
dpc-4609	287	1	31	31	NUM
dpc-4609	287	2	.	.	PUNCT
dpc-4609	287	3	yan	yan	PROPN
dpc-4609	288	1	x	x	SYM
dpc-4609	288	2	,	,	PUNCT
dpc-4609	288	3	tayier	tayier	NOUN
dpc-4609	288	4	m	m	PROPN
dpc-4609	288	5	,	,	PUNCT
dpc-4609	288	6	cheang	cheang	PROPN
dpc-4609	288	7	st	st	PROPN
dpc-4609	288	8	,	,	PUNCT
dpc-4609	288	9	et	et	PROPN
dpc-4609	288	10	al	al	PROPN
dpc-4609	288	11	.	.	PROPN
dpc-4609	288	12	hair	hair	NOUN
dpc-4609	288	13	repigmentation	repigmentation	NOUN
dpc-4609	288	14	and	and	CCONJ
dpc-4609	288	15	regrowth	regrowth	NOUN
dpc-4609	288	16	in	in	ADP
dpc-4609	288	17	a	a	DET
dpc-4609	288	18	dupilumab	dupilumab	NOUN
dpc-4609	288	19	-	-	PUNCT
dpc-4609	288	20	treated	treat	VERB
dpc-4609	288	21	paediatric	paediatric	ADJ
dpc-4609	288	22	patient	patient	NOUN
dpc-4609	288	23	with	with	ADP
dpc-4609	288	24	alopecia	alopecia	NOUN
dpc-4609	288	25	areata	areata	ADJ
dpc-4609	288	26	and	and	CCONJ
dpc-4609	288	27	atopic	atopic	NOUN
dpc-4609	288	28	dermatitis	dermatitis	NOUN
dpc-4609	288	29	:	:	PUNCT
dpc-4609	288	30	a	a	DET
dpc-4609	288	31	case	case	NOUN
dpc-4609	288	32	report	report	NOUN
dpc-4609	288	33	.	.	PUNCT
dpc-4609	289	1	ther	ther	VERB
dpc-4609	289	2	adv	adv	PROPN
dpc-4609	289	3	chronic	chronic	ADJ
dpc-4609	289	4	dis	dis	PROPN
dpc-4609	289	5	.	.	PUNCT
dpc-4609	290	1	2023;14:20406223231191049	2023;14:20406223231191049	NUM
dpc-4609	290	2	.	.	PUNCT
dpc-4609	290	3	doi:10.1177/20406223231	doi:10.1177/20406223231	NOUN
dpc-4609	290	4	191049	191049	NUM
dpc-4609	290	5	.	.	PUNCT
dpc-4609	291	1	32	32	NUM
dpc-4609	291	2	.	.	PUNCT
dpc-4609	292	1	cai	cai	PROPN
dpc-4609	292	2	l	l	PROPN
dpc-4609	292	3	,	,	PUNCT
dpc-4609	292	4	wei	wei	PROPN
dpc-4609	292	5	y	y	PROPN
dpc-4609	292	6	,	,	PUNCT
dpc-4609	292	7	zhao	zhao	PROPN
dpc-4609	292	8	m	m	PROPN
dpc-4609	292	9	,	,	PUNCT
dpc-4609	292	10	zhuo	zhuo	PROPN
dpc-4609	292	11	j	j	PROPN
dpc-4609	292	12	,	,	PUNCT
dpc-4609	292	13	tao	tao	PROPN
dpc-4609	292	14	x	x	PROPN
dpc-4609	292	15	,	,	PUNCT
dpc-4609	292	16	lin	lin	PROPN
dpc-4609	292	17	m.	m.	NOUN
dpc-4609	292	18	case	case	NOUN
dpc-4609	292	19	report	report	NOUN
dpc-4609	292	20	:	:	PUNCT
dpc-4609	292	21	dupilumab	dupilumab	NOUN
dpc-4609	292	22	therapy	therapy	NOUN
dpc-4609	292	23	for	for	ADP
dpc-4609	292	24	alopecia	alopecia	NOUN
dpc-4609	292	25	areata	areata	VERB
dpc-4609	292	26	in	in	ADP
dpc-4609	292	27	a	a	DET
dpc-4609	292	28	4	4	NUM
dpc-4609	292	29	-	-	PUNCT
dpc-4609	292	30	year	year	NOUN
dpc-4609	292	31	-	-	PUNCT
dpc-4609	292	32	old	old	ADJ
dpc-4609	292	33	patient	patient	NOUN
dpc-4609	292	34	resistant	resistant	ADJ
dpc-4609	292	35	to	to	ADP
dpc-4609	292	36	baricitinib	baricitinib	NOUN
dpc-4609	292	37	.	.	PUNCT
dpc-4609	293	1	front	front	PROPN
dpc-4609	293	2	med	med	PROPN
dpc-4609	293	3	.	.	PUNCT
dpc-4609	294	1	2023;10:1253795	2023;10:1253795	NUM
dpc-4609	294	2	.	.	PUNCT
dpc-4609	294	3	doi:10.3389	doi:10.3389	PROPN
dpc-4609	294	4	/fmed.2023.1253795	/fmed.2023.1253795	PUNCT
dpc-4609	294	5	.	.	PUNCT
dpc-4609	295	1	33	33	NUM
dpc-4609	295	2	.	.	PUNCT
dpc-4609	296	1	chromy	chromy	PROPN
dpc-4609	296	2	d	d	NOUN
dpc-4609	296	3	,	,	PUNCT
dpc-4609	296	4	bartosik	bartosik	PROPN
dpc-4609	296	5	t	t	PROPN
dpc-4609	296	6	,	,	PUNCT
dpc-4609	296	7	brkic	brkic	PROPN
dpc-4609	296	8	ff	ff	NOUN
dpc-4609	296	9	,	,	PUNCT
dpc-4609	296	10	et	et	PROPN
dpc-4609	296	11	al	al	PROPN
dpc-4609	296	12	.	.	PUNCT
dpc-4609	296	13	dupilumab	dupilumab	NOUN
dpc-4609	296	14	-	-	PUNCT
dpc-4609	296	15	induced	induce	VERB
dpc-4609	296	16	skin	skin	NOUN
dpc-4609	296	17	-	-	PUNCT
dpc-4609	296	18	associated	associate	VERB
dpc-4609	296	19	side	side	NOUN
dpc-4609	296	20	effects	effect	NOUN
dpc-4609	296	21	in	in	ADP
dpc-4609	296	22	patients	patient	NOUN
dpc-4609	296	23	with	with	ADP
dpc-4609	296	24	chronic	chronic	ADJ
dpc-4609	296	25	rhinosinusitis	rhinosinusitis	NOUN
dpc-4609	296	26	with	with	ADP
dpc-4609	296	27	nasal	nasal	PROPN
dpc-4609	296	28	polyposis	polyposis	NOUN
dpc-4609	296	29	.	.	PUNCT
dpc-4609	297	1	j	j	PROPN
dpc-4609	297	2	dermatol	dermatol	NOUN
dpc-4609	297	3	.	.	PUNCT
dpc-4609	298	1	2023;50(1):89	2023;50(1):89	NUM
dpc-4609	298	2	-	-	SYM
dpc-4609	298	3	93	93	NUM
dpc-4609	298	4	.	.	PUNCT
dpc-4609	299	1	doi:10.1111/1346	doi:10.1111/1346	NOUN
dpc-4609	299	2	-	-	PUNCT
dpc-4609	299	3	8138.16595	8138.16595	NUM
dpc-4609	299	4	.	.	PUNCT
dpc-4609	300	1	34	34	NUM
dpc-4609	300	2	.	.	PUNCT
dpc-4609	301	1	tancredi	tancredi	PROPN
dpc-4609	301	2	v	v	PROPN
dpc-4609	301	3	,	,	PUNCT
dpc-4609	301	4	babino	babino	PROPN
dpc-4609	301	5	g	g	PROPN
dpc-4609	301	6	,	,	PUNCT
dpc-4609	301	7	fulgione	fulgione	NOUN
dpc-4609	301	8	e	e	NOUN
dpc-4609	301	9	,	,	PUNCT
dpc-4609	301	10	caccavale	caccavale	PROPN
dpc-4609	301	11	s	s	PROPN
dpc-4609	301	12	,	,	PUNCT
dpc-4609	301	13	argenziano	argenziano	ADJ
dpc-4609	301	14	g.	g.	NOUN
dpc-4609	302	1	an	an	DET
dpc-4609	302	2	unusual	unusual	ADJ
dpc-4609	302	3	case	case	NOUN
dpc-4609	302	4	of	of	ADP
dpc-4609	302	5	lichen	lichen	NOUN
dpc-4609	302	6	striatus	striatus	NOUN
dpc-4609	302	7	onset	onset	VERB
dpc-4609	302	8	under	under	ADP
dpc-4609	302	9	dupilumab	dupilumab	NOUN
dpc-4609	302	10	in	in	ADP
dpc-4609	302	11	a	a	DET
dpc-4609	302	12	patient	patient	NOUN
dpc-4609	302	13	with	with	ADP
dpc-4609	302	14	alopecia	alopecia	NOUN
dpc-4609	302	15	areata	areata	ADJ
dpc-4609	302	16	.	.	PUNCT
dpc-4609	303	1	dermatol	dermatol	NOUN
dpc-4609	303	2	pract	pract	PROPN
dpc-4609	303	3	concept	concept	NOUN
dpc-4609	303	4	.	.	PUNCT
dpc-4609	304	1	2024;14(1):e2024016	2024;14(1):e2024016	NUM
dpc-4609	304	2	.	.	PUNCT
dpc-4609	304	3	doi:10.5826	doi:10.5826	PROPN
dpc-4609	304	4	/	/	SYM
dpc-4609	305	1	dpc.1401a16	dpc.1401a16	PROPN
dpc-4609	305	2	.	.	PROPN
dpc-4609	306	1	35	35	NUM
dpc-4609	306	2	.	.	PUNCT
dpc-4609	306	3	gualdi	gualdi	PROPN
dpc-4609	306	4	g	g	PROPN
dpc-4609	306	5	,	,	PUNCT
dpc-4609	306	6	lougaris	lougaris	PROPN
dpc-4609	306	7	v	v	PROPN
dpc-4609	306	8	,	,	PUNCT
dpc-4609	306	9	amerio	amerio	ADP
dpc-4609	306	10	p	p	NOUN
dpc-4609	306	11	,	,	PUNCT
dpc-4609	306	12	petruzzellis	petruzzellis	PROPN
dpc-4609	306	13	a	a	DET
dpc-4609	306	14	,	,	PUNCT
dpc-4609	306	15	parodi	parodi	NOUN
dpc-4609	306	16	a	a	PRON
dpc-4609	306	17	,	,	PUNCT
dpc-4609	306	18	burlando	burlando	PROPN
dpc-4609	306	19	m.	m.	NOUN
dpc-4609	306	20	prurigo	prurigo	PROPN
dpc-4609	306	21	-	-	PUNCT
dpc-4609	306	22	like	like	ADJ
dpc-4609	306	23	atopic	atopic	NOUN
dpc-4609	306	24	dermatitis	dermatitis	NOUN
dpc-4609	306	25	in	in	ADP
dpc-4609	306	26	a	a	DET
dpc-4609	306	27	child	child	NOUN
dpc-4609	306	28	with	with	ADP
dpc-4609	306	29	card11	card11	NOUN
dpc-4609	306	30	-	-	PUNCT
dpc-4609	306	31	associated	associate	VERB
dpc-4609	306	32	severe	severe	ADJ
dpc-4609	306	33	combined	combine	VERB
dpc-4609	306	34	immunodeficiency	immunodeficiency	NOUN
dpc-4609	306	35	successfully	successfully	ADV
dpc-4609	306	36	treated	treat	VERB
dpc-4609	306	37	with	with	ADP
dpc-4609	306	38	dupilumab	dupilumab	NOUN
dpc-4609	306	39	.	.	PUNCT
dpc-4609	307	1	pediatr	pediatr	ADJ
dpc-4609	307	2	dermatol	dermatol	NOUN
dpc-4609	307	3	.	.	PUNCT
dpc-4609	308	1	2024;41(1	2024;41(1	NUM
dpc-4609	308	2	):	):	PUNCT
dpc-4609	308	3	158	158	NUM
dpc-4609	308	4	-	-	SYM
dpc-4609	308	5	159	159	NUM
dpc-4609	308	6	.	.	PUNCT
dpc-4609	309	1	doi:10.1111	doi:10.1111	ADJ
dpc-4609	309	2	/	/	SYM
dpc-4609	309	3	pde.15453	pde.15453	NOUN
dpc-4609	309	4	.	.	PUNCT
dpc-4609	310	1	36	36	NUM
dpc-4609	310	2	.	.	PUNCT
dpc-4609	311	1	mcfeely	mcfeely	ADV
dpc-4609	311	2	o	o	NOUN
dpc-4609	311	3	,	,	PUNCT
dpc-4609	311	4	blasco	blasco	PROPN
dpc-4609	311	5	mc	mc	PROPN
dpc-4609	311	6	,	,	PUNCT
dpc-4609	311	7	doyle	doyle	PROPN
dpc-4609	311	8	c	c	PROPN
dpc-4609	311	9	,	,	PUNCT
dpc-4609	311	10	et	et	PROPN
dpc-4609	311	11	al	al	PROPN
dpc-4609	311	12	.	.	PUNCT
dpc-4609	312	1	“	"	PUNCT
dpc-4609	312	2	i	i	PRON
dpc-4609	312	3	feel	feel	VERB
dpc-4609	312	4	like	like	ADP
dpc-4609	312	5	a	a	DET
dpc-4609	312	6	new	new	ADJ
dpc-4609	312	7	woman	woman	NOUN
dpc-4609	312	8	”	"	PUNCT
dpc-4609	312	9	:	:	PUNCT
dpc-4609	312	10	atopic	atopic	NOUN
dpc-4609	312	11	dermatitis	dermatitis	NOUN
dpc-4609	312	12	and	and	CCONJ
dpc-4609	312	13	alopecia	alopecia	NOUN
dpc-4609	312	14	areata	areata	PROPN
dpc-4609	312	15	treated	treat	VERB
dpc-4609	312	16	successfully	successfully	ADV
dpc-4609	312	17	by	by	ADP
dpc-4609	312	18	dupilumab	dupilumab	NOUN
dpc-4609	312	19	.	.	PUNCT
dpc-4609	313	1	clin	clin	PROPN
dpc-4609	313	2	exp	exp	NOUN
dpc-4609	313	3	dermatol	dermatol	NOUN
dpc-4609	313	4	.	.	PUNCT
dpc-4609	314	1	2023;48(3):266	2023;48(3):266	NUM
dpc-4609	314	2	-	-	SYM
dpc-4609	314	3	267	267	NUM
dpc-4609	314	4	.	.	PUNCT
dpc-4609	315	1	doi:10.1093	doi:10.1093	NOUN
dpc-4609	315	2	/ced	/ced	PROPN
dpc-4609	315	3	/	/	SYM
dpc-4609	315	4	llac088	llac088	PROPN
dpc-4609	315	5	.	.	PUNCT
dpc-4609	316	1	37	37	NUM
dpc-4609	316	2	.	.	PUNCT
dpc-4609	316	3	marks	mark	VERB
dpc-4609	316	4	dh	dh	PROPN
dpc-4609	316	5	,	,	PUNCT
dpc-4609	316	6	mesinkovska	mesinkovska	PROPN
dpc-4609	316	7	n	n	CCONJ
dpc-4609	316	8	,	,	PUNCT
dpc-4609	316	9	senna	senna	PROPN
dpc-4609	316	10	mm	mm	PROPN
dpc-4609	316	11	.	.	PUNCT
dpc-4609	316	12	cause	cause	NOUN
dpc-4609	316	13	or	or	CCONJ
dpc-4609	316	14	cure	cure	VERB
dpc-4609	316	15	?	?	PUNCT
dpc-4609	317	1	review	review	NOUN
dpc-4609	317	2	of	of	ADP
dpc-4609	317	3	dupilumab	dupilumab	NOUN
dpc-4609	317	4	and	and	CCONJ
dpc-4609	317	5	alopecia	alopecia	NOUN
dpc-4609	317	6	areata	areata	ADJ
dpc-4609	317	7	.	.	PUNCT
dpc-4609	318	1	j	j	PROPN
dpc-4609	318	2	am	be	AUX
dpc-4609	318	3	acad	acad	ADJ
dpc-4609	318	4	dermatol	dermatol	NOUN
dpc-4609	318	5	.	.	PUNCT
dpc-4609	319	1	2023;88(3):651	2023;88(3):651	NUM
dpc-4609	319	2	-	-	PUNCT
dpc-4609	319	3	653	653	NUM
dpc-4609	319	4	.	.	PUNCT
dpc-4609	320	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	320	2	/	/	SYM
dpc-4609	320	3	j.jaad.2019.06.010	j.jaad.2019.06.010	PROPN
dpc-4609	320	4	.	.	PROPN
dpc-4609	321	1	38	38	NUM
dpc-4609	321	2	.	.	PUNCT
dpc-4609	321	3	mckenzie	mckenzie	PROPN
dpc-4609	321	4	pl	pl	PROPN
dpc-4609	321	5	,	,	PUNCT
dpc-4609	321	6	castelo	castelo	PROPN
dpc-4609	321	7	-	-	PUNCT
dpc-4609	321	8	soccio	soccio	NOUN
dpc-4609	321	9	l.	l.	NOUN
dpc-4609	321	10	dupilumab	dupilumab	NOUN
dpc-4609	321	11	therapy	therapy	NOUN
dpc-4609	321	12	for	for	ADP
dpc-4609	321	13	alopecia	alopecia	NOUN
dpc-4609	321	14	areata	areata	ADJ
dpc-4609	321	15	in	in	ADP
dpc-4609	321	16	pediatric	pediatric	ADJ
dpc-4609	321	17	patients	patient	NOUN
dpc-4609	321	18	with	with	ADP
dpc-4609	321	19	concomitant	concomitant	ADJ
dpc-4609	321	20	atopic	atopic	NOUN
dpc-4609	321	21	dermatitis	dermatitis	NOUN
dpc-4609	321	22	.	.	PUNCT
dpc-4609	322	1	j	j	PROPN
dpc-4609	322	2	am	be	AUX
dpc-4609	322	3	acad	acad	ADJ
dpc-4609	322	4	dermatol	dermatol	NOUN
dpc-4609	322	5	.	.	PUNCT
dpc-4609	323	1	2021;84(6):1691	2021;84(6):1691	NUM
dpc-4609	323	2	-	-	SYM
dpc-4609	323	3	1694	1694	NUM
dpc-4609	323	4	.	.	PUNCT
dpc-4609	324	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	324	2	/j.jaad.2021.01.046	/j.jaad.2021.01.046	PUNCT
dpc-4609	324	3	.	.	PUNCT
dpc-4609	325	1	39	39	NUM
dpc-4609	325	2	.	.	PUNCT
dpc-4609	326	1	cho	cho	PROPN
dpc-4609	326	2	sk	sk	PROPN
dpc-4609	326	3	,	,	PUNCT
dpc-4609	326	4	craiglow	craiglow	PROPN
dpc-4609	326	5	bg	bg	PROPN
dpc-4609	326	6	.	.	PUNCT
dpc-4609	326	7	dupilumab	dupilumab	NOUN
dpc-4609	326	8	for	for	ADP
dpc-4609	326	9	the	the	DET
dpc-4609	326	10	treatment	treatment	NOUN
dpc-4609	326	11	of	of	ADP
dpc-4609	326	12	alopecia	alopecia	NOUN
dpc-4609	326	13	areata	areata	ADJ
dpc-4609	326	14	in	in	ADP
dpc-4609	326	15	children	child	NOUN
dpc-4609	326	16	with	with	ADP
dpc-4609	326	17	atopic	atopic	NOUN
dpc-4609	326	18	dermatitis	dermatitis	NOUN
dpc-4609	326	19	.	.	PUNCT
dpc-4609	327	1	jaad	jaad	PROPN
dpc-4609	327	2	case	case	NOUN
dpc-4609	327	3	rep	rep	PROPN
dpc-4609	327	4	.	.	PROPN
dpc-4609	327	5	2021;16:82	2021;16:82	NUM
dpc-4609	327	6	-	-	SYM
dpc-4609	327	7	85	85	NUM
dpc-4609	327	8	.	.	PUNCT
dpc-4609	328	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	328	2	/	/	SYM
dpc-4609	328	3	j.jdcr.2021.07.015	j.jdcr.2021.07.015	PROPN
dpc-4609	328	4	.	.	PUNCT
dpc-4609	328	5	universalis	universalis	PROPN
dpc-4609	328	6	.	.	PUNCT
dpc-4609	329	1	jaad	jaad	NOUN
dpc-4609	329	2	case	case	NOUN
dpc-4609	329	3	rep	rep	PROPN
dpc-4609	329	4	.	.	PROPN
dpc-4609	329	5	2019;5(2):111	2019;5(2):111	PROPN
dpc-4609	329	6	-	-	SYM
dpc-4609	329	7	112	112	NUM
dpc-4609	329	8	.	.	PUNCT
dpc-4609	330	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	330	2	/j.jdcr.2018.11.006	/j.jdcr.2018.11.006	PUNCT
dpc-4609	330	3	.	.	PUNCT
dpc-4609	331	1	20	20	NUM
dpc-4609	331	2	.	.	X
dpc-4609	331	3	alotaibi	alotaibi	PROPN
dpc-4609	331	4	l	l	PROPN
dpc-4609	331	5	,	,	PUNCT
dpc-4609	331	6	alfawzan	alfawzan	PROPN
dpc-4609	331	7	a	a	X
dpc-4609	331	8	,	,	PUNCT
dpc-4609	331	9	alharthi	alharthi	PROPN
dpc-4609	331	10	r	r	NOUN
dpc-4609	331	11	,	,	PUNCT
dpc-4609	331	12	al	al	PROPN
dpc-4609	331	13	sheikh	sheikh	PROPN
dpc-4609	331	14	a.	a.	NOUN
dpc-4609	331	15	improvement	improvement	NOUN
dpc-4609	331	16	of	of	ADP
dpc-4609	331	17	atopic	atopic	NOUN
dpc-4609	331	18	dermatitis	dermatitis	NOUN
dpc-4609	331	19	and	and	CCONJ
dpc-4609	331	20	alopecia	alopecia	NOUN
dpc-4609	331	21	universalis	universali	VERB
dpc-4609	331	22	with	with	ADP
dpc-4609	331	23	dupilumab	dupilumab	NOUN
dpc-4609	331	24	.	.	PUNCT
dpc-4609	332	1	dermatol	dermatol	PROPN
dpc-4609	332	2	rep	rep	PROPN
dpc-4609	332	3	.	.	PROPN
dpc-4609	332	4	2022;14(2):9359	2022;14(2):9359	PROPN
dpc-4609	332	5	.	.	PUNCT
dpc-4609	333	1	doi:10.4081	doi:10.4081	PROPN
dpc-4609	333	2	/	/	SYM
dpc-4609	333	3	dr.2022.9359	dr.2022.9359	PROPN
dpc-4609	333	4	.	.	PUNCT
dpc-4609	334	1	21	21	NUM
dpc-4609	334	2	.	.	PUNCT
dpc-4609	335	1	call	call	PROPN
dpc-4609	335	2	je	je	PROPN
dpc-4609	335	3	,	,	PUNCT
dpc-4609	335	4	sahni	sahni	PROPN
dpc-4609	335	5	s	s	PROPN
dpc-4609	335	6	,	,	PUNCT
dpc-4609	335	7	zug	zug	PROPN
dpc-4609	335	8	ka	ka	PROPN
dpc-4609	335	9	.	.	PROPN
dpc-4609	335	10	effectiveness	effectiveness	NOUN
dpc-4609	335	11	of	of	ADP
dpc-4609	335	12	dupilumab	dupilumab	NOUN
dpc-4609	335	13	in	in	ADP
dpc-4609	335	14	the	the	DET
dpc-4609	335	15	treatment	treatment	NOUN
dpc-4609	335	16	of	of	ADP
dpc-4609	335	17	both	both	DET
dpc-4609	335	18	atopic	atopic	NOUN
dpc-4609	335	19	dermatitis	dermatitis	NOUN
dpc-4609	335	20	and	and	CCONJ
dpc-4609	335	21	alopecia	alopecia	NOUN
dpc-4609	335	22	universalis	universali	VERB
dpc-4609	335	23	.	.	PUNCT
dpc-4609	336	1	clin	clin	PROPN
dpc-4609	336	2	case	case	PROPN
dpc-4609	336	3	rep	rep	PROPN
dpc-4609	336	4	.	.	PROPN
dpc-4609	336	5	2020;8(8):1337	2020;8(8):1337	NUM
dpc-4609	336	6	-	-	SYM
dpc-4609	336	7	1339	1339	NUM
dpc-4609	336	8	.	.	PUNCT
dpc-4609	337	1	doi:10.1002	doi:10.1002	NOUN
dpc-4609	337	2	/	/	SYM
dpc-4609	337	3	ccr3.2915	ccr3.2915	NOUN
dpc-4609	337	4	.	.	PUNCT
dpc-4609	338	1	22	22	NUM
dpc-4609	338	2	.	.	PUNCT
dpc-4609	339	1	gruenstein	gruenstein	PROPN
dpc-4609	339	2	d	d	PROPN
dpc-4609	339	3	,	,	PUNCT
dpc-4609	339	4	malik	malik	PROPN
dpc-4609	339	5	k	k	PROPN
dpc-4609	339	6	,	,	PUNCT
dpc-4609	339	7	levitt	levitt	PROPN
dpc-4609	339	8	j.	j.	PROPN
dpc-4609	339	9	full	full	ADJ
dpc-4609	339	10	scalp	scalp	NOUN
dpc-4609	339	11	hair	hair	NOUN
dpc-4609	339	12	regrowth	regrowth	NOUN
dpc-4609	339	13	in	in	ADP
dpc-4609	339	14	a	a	DET
dpc-4609	339	15	4	4	NUM
dpc-4609	339	16	-	-	PUNCT
dpc-4609	339	17	year	year	NOUN
dpc-4609	339	18	-	-	PUNCT
dpc-4609	339	19	old	old	ADJ
dpc-4609	339	20	girl	girl	NOUN
dpc-4609	339	21	with	with	ADP
dpc-4609	339	22	alopecia	alopecia	NOUN
dpc-4609	339	23	areata	areata	ADJ
dpc-4609	339	24	and	and	CCONJ
dpc-4609	339	25	atopic	atopic	NOUN
dpc-4609	339	26	dermatitis	dermatitis	NOUN
dpc-4609	339	27	treated	treat	VERB
dpc-4609	339	28	with	with	ADP
dpc-4609	339	29	dupilumab	dupilumab	NOUN
dpc-4609	339	30	.	.	PUNCT
dpc-4609	340	1	jaad	jaad	PROPN
dpc-4609	340	2	case	case	NOUN
dpc-4609	340	3	rep	rep	PROPN
dpc-4609	340	4	.	.	PROPN
dpc-4609	340	5	2020;6(12):1286	2020;6(12):1286	NUM
dpc-4609	340	6	-	-	PUNCT
dpc-4609	340	7	1287	1287	NUM
dpc-4609	340	8	.	.	PUNCT
dpc-4609	341	1	doi:10.1016	doi:10.1016	PROPN
dpc-4609	341	2	/	/	SYM
dpc-4609	341	3	j.jdcr.2020.10.010	j.jdcr.2020.10.010	PROPN
dpc-4609	341	4	.	.	PUNCT
dpc-4609	342	1	23	23	NUM
dpc-4609	342	2	.	.	PUNCT
dpc-4609	343	1	reinhold	reinhold	PROPN
dpc-4609	343	2	l	l	PROPN
dpc-4609	343	3	,	,	PUNCT
dpc-4609	343	4	lange	lange	PROPN
dpc-4609	343	5	k	k	PROPN
dpc-4609	343	6	,	,	PUNCT
dpc-4609	343	7	lindhof	lindhof	PROPN
dpc-4609	343	8	h	h	PROPN
dpc-4609	343	9	,	,	PUNCT
dpc-4609	343	10	homey	homey	ADJ
dpc-4609	343	11	b	b	PROPN
dpc-4609	343	12	,	,	PUNCT
dpc-4609	343	13	firouzi	firouzi	PROPN
dpc-4609	343	14	-	-	PUNCT
dpc-4609	343	15	memarpuri	memarpuri	PROPN
dpc-4609	344	1	p.	p.	NOUN
dpc-4609	345	1	[	[	X
dpc-4609	345	2	hair	hair	NOUN
dpc-4609	345	3	growth	growth	NOUN
dpc-4609	345	4	with	with	ADP
dpc-4609	345	5	dupilumab	dupilumab	NOUN
dpc-4609	345	6	in	in	ADP
dpc-4609	345	7	alopecia	alopecia	NOUN
dpc-4609	345	8	areata	areata	ADJ
dpc-4609	345	9	universalis	universali	NOUN
dpc-4609	345	10	and	and	CCONJ
dpc-4609	345	11	atopic	atopic	NOUN
dpc-4609	345	12	dermatitis	dermatitis	NOUN
dpc-4609	345	13	]	]	PUNCT
dpc-4609	345	14	.	.	PUNCT
dpc-4609	346	1	dermatol	dermatol	NOUN
dpc-4609	346	2	heidelb	heidelb	PROPN
dpc-4609	346	3	ger	ger	PROPN
dpc-4609	346	4	.	.	PUNCT
dpc-4609	347	1	2022;73(7	2022;73(7	NUM
dpc-4609	347	2	):	):	PUNCT
dpc-4609	347	3	556	556	NUM
dpc-4609	347	4	-	-	SYM
dpc-4609	347	5	559	559	NUM
dpc-4609	347	6	.	.	PUNCT
dpc-4609	347	7	doi:10.1007	doi:10.1007	VERB
dpc-4609	347	8	/	/	SYM
dpc-4609	347	9	s00105	s00105	PROPN
dpc-4609	347	10	-	-	PUNCT
dpc-4609	347	11	021	021	NUM
dpc-4609	347	12	-	-	PUNCT
dpc-4609	347	13	04898	04898	NUM
dpc-4609	347	14	-	-	PUNCT
dpc-4609	347	15	y.	y.	NOUN
dpc-4609	347	16	24	24	NUM
dpc-4609	347	17	.	.	PUNCT
dpc-4609	348	1	aszodi	aszodi	PROPN
dpc-4609	348	2	n	n	CCONJ
dpc-4609	348	3	,	,	PUNCT
dpc-4609	348	4	pumnea	pumnea	PROPN
dpc-4609	348	5	t	t	PROPN
dpc-4609	348	6	,	,	PUNCT
dpc-4609	348	7	wollenberg	wollenberg	PROPN
dpc-4609	348	8	a.	a.	PROPN
dpc-4609	349	1	[	[	X
dpc-4609	349	2	dupilumabassociated	dupilumabassociate	VERB
dpc-4609	349	3	healing	healing	NOUN
dpc-4609	349	4	of	of	ADP
dpc-4609	349	5	alopecia	alopecia	NOUN
dpc-4609	349	6	areata	areata	ADJ
dpc-4609	349	7	in	in	ADP
dpc-4609	349	8	an	an	DET
dpc-4609	349	9	atopic	atopic	NOUN
dpc-4609	349	10	dermatitis	dermatitis	NOUN
dpc-4609	349	11	patient	patient	NOUN
dpc-4609	349	12	]	]	PUNCT
dpc-4609	349	13	.	.	PUNCT
dpc-4609	350	1	dtsch	dtsch	PROPN
dpc-4609	350	2	med	med	PROPN
dpc-4609	350	3	wochenschr	wochenschr	PROPN
dpc-4609	350	4	1946	1946	NUM
dpc-4609	350	5	.	.	PUNCT
dpc-4609	351	1	2019;144(9):602	2019;144(9):602	NUM
dpc-4609	351	2	-	-	SYM
dpc-4609	351	3	605	605	NUM
dpc-4609	351	4	.	.	PUNCT
dpc-4609	351	5	doi:10.1055	doi:10.1055	NOUN
dpc-4609	351	6	/a-0836	/a-0836	PUNCT
dpc-4609	351	7	-	-	PUNCT
dpc-4609	351	8	3119	3119	NUM
dpc-4609	351	9	.	.	PUNCT
dpc-4609	352	1	25	25	NUM
dpc-4609	352	2	.	.	PUNCT
dpc-4609	353	1	szekely	szekely	ADV
dpc-4609	353	2	s	s	PROPN
dpc-4609	353	3	,	,	PUNCT
dpc-4609	353	4	vaccari	vaccari	ADJ
dpc-4609	353	5	d	d	PROPN
dpc-4609	353	6	,	,	PUNCT
dpc-4609	353	7	salmaso	salmaso	PROPN
dpc-4609	353	8	r	r	NOUN
dpc-4609	353	9	,	,	PUNCT
dpc-4609	353	10	belloni	belloni	NOUN
dpc-4609	353	11	-	-	PUNCT
dpc-4609	353	12	fortina	fortina	PROPN
dpc-4609	353	13	a	a	PRON
dpc-4609	353	14	,	,	PUNCT
dpc-4609	353	15	alaibac	alaibac	PROPN
dpc-4609	353	16	m.	m.	NOUN
dpc-4609	353	17	onset	onset	NOUN
dpc-4609	353	18	of	of	ADP
dpc-4609	353	19	schamberg	schamberg	PROPN
dpc-4609	353	20	disease	disease	NOUN
dpc-4609	353	21	and	and	CCONJ
dpc-4609	353	22	resolution	resolution	NOUN
dpc-4609	353	23	of	of	ADP
dpc-4609	353	24	alopecia	alopecia	NOUN
dpc-4609	353	25	areata	areata	VERB
dpc-4609	353	26	during	during	ADP
dpc-4609	353	27	treatment	treatment	NOUN
dpc-4609	353	28	of	of	ADP
dpc-4609	353	29	atopic	atopic	NOUN
dpc-4609	353	30	dermatitis	dermatitis	NOUN
dpc-4609	353	31	with	with	ADP
dpc-4609	353	32	dupilumab	dupilumab	NOUN
dpc-4609	353	33	.	.	PUNCT
dpc-4609	354	1	j	j	PROPN
dpc-4609	354	2	investig	investig	PROPN
dpc-4609	354	3	allergol	allergol	PROPN
dpc-4609	354	4	clin	clin	PROPN
dpc-4609	354	5	immunol	immunol	NOUN
dpc-4609	354	6	.	.	PUNCT
dpc-4609	355	1	2021;31(1):65	2021;31(1):65	NUM
dpc-4609	355	2	-	-	SYM
dpc-4609	355	3	66	66	NUM
dpc-4609	355	4	.	.	PUNCT
dpc-4609	356	1	doi:10.18176	doi:10.18176	NOUN
dpc-4609	356	2	/jiaci.0541	/jiaci.0541	PUNCT
dpc-4609	356	3	.	.	PUNCT
dpc-4609	357	1	26	26	NUM
dpc-4609	357	2	.	.	PUNCT
dpc-4609	358	1	ludriksone	ludriksone	PROPN
dpc-4609	358	2	l	l	NOUN
dpc-4609	358	3	,	,	PUNCT
dpc-4609	358	4	elsner	elsner	NOUN
dpc-4609	358	5	p	p	NOUN
dpc-4609	358	6	,	,	PUNCT
dpc-4609	358	7	schliemann	schliemann	PROPN
dpc-4609	358	8	s.	s.	PROPN
dpc-4609	358	9	zwei	zwei	PROPN
dpc-4609	358	10	patienten	patienten	VERB
dpc-4609	358	11	mit	mit	PROPN
dpc-4609	358	12	abheilung	abheilung	NOUN
dpc-4609	358	13	einer	einer	NOUN
dpc-4609	358	14	alopecia	alopecia	NOUN
dpc-4609	358	15	areata	areata	ADJ
dpc-4609	358	16	unter	unter	NOUN
dpc-4609	358	17	dupilumab	dupilumab	NOUN
dpc-4609	358	18	.	.	PUNCT
dpc-4609	359	1	j	j	PROPN
dpc-4609	359	2	dtsch	dtsch	PROPN
dpc-4609	359	3	dermatol	dermatol	NOUN
dpc-4609	359	4	ges	ges	PROPN
dpc-4609	359	5	j	j	PROPN
dpc-4609	359	6	ger	ger	PROPN
dpc-4609	359	7	soc	soc	NOUN
dpc-4609	359	8	dermatol	dermatol	NOUN
dpc-4609	359	9	jddg	jddg	NOUN
dpc-4609	359	10	.	.	PUNCT
dpc-4609	360	1	2019;17	2019;17	NUM
dpc-4609	360	2	suppl	suppl	ADJ
dpc-4609	360	3	2:1	2:1	NUM
dpc-4609	360	4	-	-	SYM
dpc-4609	360	5	3	3	NUM
dpc-4609	360	6	.	.	PUNCT
dpc-4609	360	7	doi:10.1111	doi:10.1111	PROPN
dpc-4609	360	8	/	/	SYM
dpc-4609	360	9	ddg.13778	ddg.13778	NOUN
dpc-4609	360	10	.	.	PUNCT
dpc-4609	360	11	27	27	NUM
dpc-4609	360	12	.	.	PUNCT
dpc-4609	361	1	uchida	uchida	PROPN
dpc-4609	361	2	h	h	PROPN
dpc-4609	361	3	,	,	PUNCT
dpc-4609	361	4	kamata	kamata	PROPN
dpc-4609	361	5	m	m	PROPN
dpc-4609	361	6	,	,	PUNCT
dpc-4609	361	7	watanabe	watanabe	PROPN
dpc-4609	361	8	a	a	PROPN
dpc-4609	361	9	,	,	PUNCT
dpc-4609	361	10	et	et	PROPN
dpc-4609	361	11	al	al	PROPN
dpc-4609	361	12	.	.	PROPN
dpc-4609	361	13	dupilumab	dupilumab	NOUN
dpc-4609	361	14	improved	improve	VERB
dpc-4609	361	15	alopecia	alopecia	NOUN
dpc-4609	361	16	areata	areata	ADJ
dpc-4609	361	17	in	in	ADP
dpc-4609	361	18	a	a	DET
dpc-4609	361	19	patient	patient	NOUN
dpc-4609	361	20	with	with	ADP
dpc-4609	361	21	atopic	atopic	NOUN
dpc-4609	361	22	dermatitis	dermatitis	NOUN
dpc-4609	361	23	:	:	PUNCT
dpc-4609	361	24	a	a	DET
dpc-4609	361	25	case	case	NOUN
dpc-4609	361	26	report	report	NOUN
dpc-4609	361	27	.	.	PUNCT
dpc-4609	362	1	acta	acta	PROPN
dpc-4609	362	2	derm	derm	PROPN
dpc-4609	362	3	venereol	venereol	NOUN
dpc-4609	362	4	.	.	PUNCT
dpc-4609	363	1	2019;99(7):675	2019;99(7):675	NUM
dpc-4609	363	2	-	-	SYM
dpc-4609	363	3	676	676	NUM
dpc-4609	363	4	.	.	PUNCT
dpc-4609	363	5	doi:10.2340	doi:10.2340	NOUN
dpc-4609	363	6	/00015555	/00015555	PUNCT
dpc-4609	363	7	-	-	PUNCT
dpc-4609	363	8	3183	3183	NUM
dpc-4609	363	9	.	.	PUNCT
dpc-4609	364	1	28	28	NUM
dpc-4609	364	2	.	.	PUNCT
dpc-4609	364	3	magdaleno	magdaleno	NOUN
dpc-4609	364	4	-	-	PUNCT
dpc-4609	364	5	tapial	tapial	PROPN
dpc-4609	364	6	j	j	PROPN
dpc-4609	364	7	,	,	PUNCT
dpc-4609	364	8	valenzuela	valenzuela	PROPN
dpc-4609	364	9	-	-	PUNCT
dpc-4609	364	10	oñate	oñate	NOUN
dpc-4609	364	11	c	c	NOUN
dpc-4609	364	12	,	,	PUNCT
dpc-4609	364	13	garcía	garcía	ADJ
dpc-4609	364	14	-	-	PUNCT
dpc-4609	364	15	legazmartínez	legazmartínez	NOUN
dpc-4609	364	16	m	m	NOUN
dpc-4609	364	17	,	,	PUNCT
dpc-4609	364	18	martínez	martínez	PROPN
dpc-4609	364	19	-	-	PUNCT
dpc-4609	364	20	domenech	domenech	PROPN
dpc-4609	364	21	á	á	PROPN
dpc-4609	364	22	,	,	PUNCT
dpc-4609	364	23	pérez	pérez	NOUN
dpc-4609	364	24	-	-	PUNCT
dpc-4609	364	25	ferriols	ferriol	NOUN
dpc-4609	364	26	a.	a.	NOUN
dpc-4609	364	27	improvement	improvement	NOUN
dpc-4609	364	28	of	of	ADP
dpc-4609	364	29	alopecia	alopecia	NOUN
dpc-4609	364	30	areata	areata	ADJ
dpc-4609	364	31	with	with	ADP
dpc-4609	364	32	dupilumab	dupilumab	NOUN
dpc-4609	364	33	in	in	ADP
dpc-4609	364	34	a	a	DET
dpc-4609	364	35	patient	patient	NOUN
dpc-4609	364	36	with	with	ADP
dpc-4609	364	37	severe	severe	ADJ
dpc-4609	364	38	atopic	atopic	NOUN
dpc-4609	364	39	dermatitis	dermatitis	NOUN
dpc-4609	364	40	and	and	CCONJ
dpc-4609	364	41	review	review	NOUN
dpc-4609	364	42	of	of	ADP
dpc-4609	364	43	the	the	DET
dpc-4609	364	44	literature	literature	NOUN
dpc-4609	364	45	.	.	PUNCT
dpc-4609	365	1	australas	australas	PROPN
dpc-4609	365	2	j	j	PROPN
dpc-4609	365	3	dermatol	dermatol	NOUN
dpc-4609	365	4	.	.	PUNCT
dpc-4609	366	1	2020;61(2):e223	2020;61(2):e223	NUM
dpc-4609	366	2	-	-	PUNCT
dpc-4609	366	3	e225	e225	PROPN
dpc-4609	366	4	.	.	PUNCT
dpc-4609	367	1	doi:10.1111	doi:10.1111	PROPN
dpc-4609	367	2	/	/	SYM
dpc-4609	367	3	ajd.13208	ajd.13208	NUM
dpc-4609	367	4	.	.	NOUN
dpc-4609	368	1	29	29	NUM
dpc-4609	368	2	.	.	PUNCT
dpc-4609	369	1	kulkarni	kulkarni	PROPN
dpc-4609	369	2	m	m	PROPN
dpc-4609	369	3	,	,	PUNCT
dpc-4609	369	4	rohan	rohan	PROPN
dpc-4609	369	5	ca	ca	PROPN
dpc-4609	369	6	,	,	PUNCT
dpc-4609	369	7	travers	traver	NOUN
dpc-4609	369	8	jb	jb	PROPN
dpc-4609	369	9	,	,	PUNCT
dpc-4609	369	10	serrao	serrao	PROPN
dpc-4609	369	11	r.	r.	PROPN
dpc-4609	369	12	long	long	ADJ
dpc-4609	369	13	-	-	PUNCT
dpc-4609	369	14	term	term	NOUN
dpc-4609	369	15	efficacy	efficacy	NOUN
dpc-4609	369	16	of	of	ADP
dpc-4609	369	17	dupilumab	dupilumab	NOUN
dpc-4609	369	18	in	in	ADP
dpc-4609	369	19	alopecia	alopecia	NOUN
dpc-4609	369	20	areata	areata	ADJ
dpc-4609	369	21	.	.	PUNCT
dpc-4609	370	1	am	be	AUX
dpc-4609	370	2	j	j	PROPN
dpc-4609	370	3	case	case	NOUN
dpc-4609	370	4	rep	rep	PROPN
dpc-4609	370	5	.	.	PROPN
dpc-4609	370	6	2022;23	2022;23	NUM
dpc-4609	370	7	:	:	PUNCT
dpc-4609	370	8	e936488	e936488	PROPN
dpc-4609	370	9	.	.	PUNCT
dpc-4609	370	10	doi:10.12659	doi:10.12659	PROPN
dpc-4609	370	11	/	/	SYM
dpc-4609	370	12	ajcr.936488	ajcr.936488	PROPN
dpc-4609	370	13	.	.	PUNCT